Processing 00000000.tx.1: 17-Estradiol: A Brain-Active Estrogen? 

Phrase: "17-Estradiol"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0014912:Estradiol [Hormone,Pharmacologic Substance,Steroid]
   805 E C0699352:Estrace [Hormone,Pharmacologic Substance,Steroid]
   805 E C0878472:Progynon [Hormone,Pharmacologic Substance,Steroid]

Phrase: ":"

Phrase: "A Brain-Active Estrogen?"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
   827   C2936882:Estrogen [Pharmacologic Substance]
   755 E C0720298:Estrogenic [Hormone,Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.2: C. 

Phrase: "C."
Processing 00000000.tx.3: Dominique Toran-Allerand, Alexander A. 

Phrase: "Dominique Toran-Allerand,"

Phrase: "Alexander A."
Processing 00000000.tx.4: Tinnikov, Ravinder J. 

Phrase: "Tinnikov,"

Phrase: "Ravinder J."
Processing 00000000.tx.5: Singh and Imam S. 

Phrase: "Singh"

Phrase: "and"

Phrase: "Imam S."
Processing 00000000.tx.6: Nethrapalli Departments of Anatomy and Cell Biology, Obstetrics and Gynecology, (C.D.T.-A., A.A.T., I.S.N.), and Neurology (C.D.T.-A.) and the Centers for Neurobiology and Behavior and Reproductive Sciences (C.D.T.-A., A.A.T., I.S.N.), Columbia University College of Physicians and Surgeons, New York, New York 10032; 

Phrase: "Nethrapalli Departments of Anatomy"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C1704729:Department [Organization]

Phrase: "and"

Phrase: "Cell Biology,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0010819:Cell Biology [Biomedical Occupation or Discipline]
   861   C0005532:Biology [Biomedical Occupation or Discipline]
   789 E C0205460:Biologic [Qualitative Concept]
   789 E C2979985:BIOLOGIC [Biologically Active Substance,Pharmacologic Substance]

Phrase: "Obstetrics"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0028773:Obstetrics [Biomedical Occupation or Discipline]

Phrase: "and"

Phrase: "Gynecology,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0018417:Gynaecology [Biomedical Occupation or Discipline]
  1000   C0237419:Gynecology [Professional or Occupational Group]
   928 E C0205480:Gynaecologic [Spatial Concept]

Phrase: "(C.D.T.-A.,"

Phrase: "A.A.T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   913   C0193959:a t [Therapeutic or Preventive Procedure]

Phrase: "I.S.N."

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "Neurology"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0027855:Neurology [Biomedical Occupation or Discipline]
   928 E C0205494:Neurologic [Qualitative Concept]
   928 E C2707261:Neurological [Clinical Attribute]
   907 E C0027763:Nervous System [Body System]
   907 E C0422837:NERVOUS SYSTEM [Finding]
   907 E C1269560:Nervous system [Body System]

Phrase: "(C.D.T.-A.)"

Phrase: "and"

Phrase: "the Centers for Neurobiology"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0205099:centers [Spatial Concept]

Phrase: "and"

Phrase: "Behavior"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0004927:Behavior [Individual Behavior]
  1000   C2707008:Behavior [Clinical Attribute]
   928 E C2986890:Behavioral [Idea or Concept]

Phrase: "and"

Phrase: "Reproductive Sciences"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Sciences [Occupation or Discipline]

Phrase: "(C.D.T.-A.,"

Phrase: "A.A.T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   913   C0193959:a t [Therapeutic or Preventive Procedure]

Phrase: "I.S.N."

Phrase: ")"

Phrase: ","

Phrase: "Columbia University College of Physicians"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0557806:College [Manufactured Object]

Phrase: "and"

Phrase: "Surgeons,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0582175:surgeons [Professional or Occupational Group]

Phrase: "New York,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027976:New York [Geographic Area]
   861   C0205314:New [Temporal Concept]

Phrase: "New York 10032"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0027976:New York [Geographic Area]
   827   C0205314:New [Temporal Concept]

Phrase: ";"
Processing 00000000.tx.7: and Department of Laboratory Medicine and Pathology (R.J.S.), Mayo Clinic and Foundation, Rochester, Minnesota 55905 Address all correspondence and requests for reprints to: Dr. 

Phrase: "and"

Phrase: "Department of Laboratory Medicine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1704729:Department [Organization]

Phrase: "and"

Phrase: "Pathology"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0030664:Pathology [Biomedical Occupation or Discipline]
  1000   C0205469:pathology [Functional Concept]
  1000   C0677042:pathology [Pathologic Function]
   928 E C1521733:Pathologic [Functional Concept]

Phrase: "(R.J.S."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0205090:R- [Spatial Concept]
   827   C0684010:R. [Professional or Occupational Group]
   827   C2603358:R' [Clinical Attribute]

Phrase: ")"

Phrase: ","

Phrase: "Mayo Clinic"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0002424:Clinic [Health Care Related Organization,Manufactured Object]
   861   C0442592:Clinic [Health Care Related Organization,Manufactured Object]
   789 E C0205210:Clinical [Qualitative Concept]

Phrase: "and"

Phrase: "Foundation,"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0016617:Foundation [Organization]
   916 E C0002055:base [Inorganic Chemical]
   916 E C0178499:Base [Chemical Viewed Functionally]
   916 E C1626935:Bases [Quantitative Concept]
   916 E C1880279:Base [Biomedical or Dental Material]
   893 E C0205112:Basal [Spatial Concept]

Phrase: "Rochester,"

Phrase: "Minnesota 55905"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0026183:Minnesota [Geographic Area]

Phrase: "Address"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0376649:Address [Intellectual Product]
  1000   C1442065:Address [Spatial Concept]

Phrase: "all correspondence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0282413:Correspondence [Intellectual Product]

Phrase: "and"

Phrase: "requests for reprints"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   882   C0686900:Request for [Functional Concept]
           request
   790   C1272683:Request [Functional Concept]
   790   C1522634:Request [Intellectual Product]
   756   C3273171:Reprint [Intellectual Product]

Phrase: "to"

Phrase: ":"

Phrase: "Dr."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0031831:DR [Professional or Occupational Group]
  1000   C1707664:DR [Biomedical or Dental Material]
  1000   C2348314:Dr. [Conceptual Entity]
  1000   C3540849:DR [Idea or Concept]
Processing 00000000.tx.8: C. 

Phrase: "C."
Processing 00000000.tx.9: Dominique Toran-Allerand, Department of Anatomy and Cell Biology, Columbia University College of Physicians and Surgeons, 650 West 168th Street, Black Building, Room 1615, New York, New York 10032. 

Phrase: "Dominique Toran-Allerand,"

Phrase: "Department of Anatomy"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1704729:Department [Organization]

Phrase: "and"

Phrase: "Cell Biology,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0010819:Cell Biology [Biomedical Occupation or Discipline]
   861   C0005532:Biology [Biomedical Occupation or Discipline]
   789 E C0205460:Biologic [Qualitative Concept]
   789 E C2979985:BIOLOGIC [Biologically Active Substance,Pharmacologic Substance]

Phrase: "Columbia University College of Physicians"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0557806:College [Manufactured Object]

Phrase: "and"

Phrase: "Surgeons,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0582175:surgeons [Professional or Occupational Group]

Phrase: "650 West 168th Street,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0442658:Street [Manufactured Object]
   812   C1301826:Street [Finding]

Phrase: "Black Building,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1547706:Building [Functional Concept]
   861   C1999269:Building [Manufactured Object]

Phrase: "Room 1615,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1547703:Room [Spatial Concept]

Phrase: "New York,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027976:New York [Geographic Area]
   861   C0205314:New [Temporal Concept]

Phrase: "New York 10032."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0027976:New York [Geographic Area]
   827   C0205314:New [Temporal Concept]
Processing 00000000.tx.10: E-mail: cdt2{at}columbia.edu .  Abstract Top Abstract Introduction Materials and Methods Results Discussion References  The estrogen 17-estradiol has profound effects on the brain throughout life, whereas 17-estradiol, the natural optical isomer, is generally considered less active because it binds less avidly to estrogen receptors. 

Phrase: "E-mail"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0013849:E-Mail [Intellectual Product]
  1000   C1705961:E-mail [Intellectual Product]
   861   C0024492:Mail [Manufactured Object]
   861   C1538057:MAIL [Gene or Genome]
   861   C1547565:Mail [Idea or Concept]

Phrase: ":"

Phrase: "cdt2{at}columbia.edu .  Abstract Top Abstract Introduction Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   791   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "Methods Results Discussion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "The estrogen 17-estradiol"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0014912:Estradiol [Hormone,Pharmacologic Substance,Steroid]
   771 E C0699352:Estrace [Hormone,Pharmacologic Substance,Steroid]
   771 E C0878472:Progynon [Hormone,Pharmacologic Substance,Steroid]

Phrase: "has"

Phrase: "profound effects on the brain"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C1280500:effects [Qualitative Concept]
   726 E C2348382:Effect [Qualitative Concept]

Phrase: "throughout life,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0376558:Life [Idea or Concept]
   916 E C0595998:lives [Finding]

Phrase: "whereas"

Phrase: "17-estradiol,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0014912:Estradiol [Hormone,Pharmacologic Substance,Steroid]
   805 E C0699352:Estrace [Hormone,Pharmacologic Substance,Steroid]
   805 E C0878472:Progynon [Hormone,Pharmacologic Substance,Steroid]

Phrase: "the natural optical isomer,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0022203:Isomer [Natural Phenomenon or Process]

Phrase: "is"

Phrase: "generally"

Phrase: "considered"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750591:considered [Idea or Concept]

Phrase: "less active"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205177:Active [Functional Concept]

Phrase: "because"

Phrase: "it"

Phrase: "binds"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1145667:Bind [Activity]
  1000   C1167622:bind [Molecular Function]

Phrase: "less avidly to estrogen receptors."
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   806   C0034804:Estrogen Receptors [Amino Acid, Peptide, or Protein,Receptor]
   773 E C1414461:ESTROGEN RECEPTOR [Gene or Genome]
   773 E C1521863:Estrogen Receptor [Amino Acid, Peptide, or Protein,Receptor]
   760   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
   760   C0439092:less [Intellectual Product]
   760   C0547044:Less [Qualitative Concept]
   760   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]
   760   C2936882:Estrogen [Pharmacologic Substance]
Processing 00000000.tx.11: On the contrary, recent studies in the brain document that 17-estradiol elicits rapid and sustained activation of the MAPK/ERK and phosphatidylinositol 3-kinase-Akt signaling pathways; 

Phrase: "On the contrary,"

Phrase: "recent studies in the brain"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   760   C0947630:studies [Laboratory Procedure]
   726 E C0557651:Study [Manufactured Object]
   726 E C2603343:Study [Research Activity]

Phrase: "document"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1301746:document [Intellectual Product]
  1000   C1547673:Document [Intellectual Product]

Phrase: "that 17-estradiol"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0014912:Estradiol [Hormone,Pharmacologic Substance,Steroid]
   805 E C0699352:Estrace [Hormone,Pharmacologic Substance,Steroid]
   805 E C0878472:Progynon [Hormone,Pharmacologic Substance,Steroid]

Phrase: "elicits"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449265:elicit [Qualitative Concept]

Phrase: "rapid"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439831:Rapid [Qualitative Concept]

Phrase: "and"

Phrase: "sustained activation of the MAPK/ERK"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   783   C1155551:MAPK activation [Molecular Function]
   753   C1879547:Activation [Activity]

Phrase: "and"

Phrase: "phosphatidylinositol 3-kinase-Akt signaling pathways"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   850   C1515844:AKT Signaling Pathway [Molecular Function]
   810   C0037080:Signal Pathways [Molecular Function]
   810   C0037083:signaling pathway [Cell Function]
   810   C0086982:Signaling Pathway [Molecular Function]
   799   C1704259:Pathways [Molecular Function]
   799   C1705987:Pathways [Conceptual Entity]

Phrase: ";"
Processing 00000000.tx.12: is neuroprotective, after an ischemic stroke and oxidative stress, and in transgenic mice with Alzheimers disease; 

Phrase: "is"

Phrase: "neuroprotective,"

Phrase: "after"

Phrase: "an ischemic stroke"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0948008:Ischaemic stroke [Disease or Syndrome]
  1000   C3272363:Ischemic Stroke [Disease or Syndrome]
   861   C0038454:Stroke [Disease or Syndrome]
   861   C0475224:Ischaemic [Functional Concept]

Phrase: "and"

Phrase: "oxidative stress,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   861   C0038435:Stress [Finding]
   861   C0311404:Oxidative [Functional Concept]
   789 E C0231297:Stressful [Functional Concept]

Phrase: "and in transgenic mice"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C0025936:Mice, Transgenic [Mammal]
   770   C0003069:Transgenic [Animal]
   770   C0025914:Mice [Mammal]
   770   C0025929:mice [Mammal]
   770   C0026809:Mice [Mammal]
   770   C1515981:And [Idea or Concept]

Phrase: "with Alzheimers disease"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0002395:Alzheimers disease [Disease or Syndrome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: ";"
Processing 00000000.tx.13: and influences spatial memory and hippocampal-dependent synaptic plasticity. 

Phrase: "and"

Phrase: "influences"

Phrase: "spatial memory"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0814087:spatial memory [Mental Process]
   861   C0025260:Memory [Mental Process]
   861   C0700327:memory [Finding]
   861   C1706377:Memory [Manufactured Object]
   805 E C0679055:mnemonic [Mental Process]

Phrase: "and"

Phrase: "hippocampal-dependent synaptic plasticity."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0678558:Plasticity [Natural Phenomenon or Process]
   741 E C0032167:Plastic [Substance]
Processing 00000000.tx.14: The present study measured the endogenous content of 17-estradiol in the brain and further clarified its actions and kinetics. 

Phrase: "The present study"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0150312:Present [Quantitative Concept]
   861   C0449450:Present [Idea or Concept]
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]

Phrase: "measured"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0444706:Measured [Qualitative Concept]
  1000   C3541902:MEASURED [Diagnostic Procedure]
   966 E C0079809:Measure [Quantitative Concept]
   966 E C0242485:Measure [Functional Concept]

Phrase: "the endogenous content of 17-estradiol"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C1555325:endogenous content [Intellectual Product]
   753   C0423896:Content [Mental Process]
   753   C0456205:Content [Conceptual Entity]

Phrase: "in the brain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006104:Brain [Body Part, Organ, or Organ Component]
  1000   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "further"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "clarified"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986669:Clarified [Activity]

Phrase: "its actions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0441472:actions [Functional Concept]
   966 E C3266814:Action [Activity]

Phrase: "and"

Phrase: "kinetics."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0022702:Kinetics [Natural Phenomenon or Process]
  1000   C0220865:kinetics [Functional Concept]
  1000   C2825046:Kinetics [Occupation or Discipline]
Processing 00000000.tx.15: Here we report that: 1) endogenous levels of 17-estradiol and its precursor estrone are significantly elevated in the postnatal and adult mouse brain and adrenal gland of both sexes, as determined by liquid chromatography/tandem mass spectrometry; 

Phrase: "Here"

Phrase: "we"

Phrase: "report"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0684224:Report [Intellectual Product]
  1000   C0700287:Report [Health Care Activity]
  1000   C3273238:Report [Intellectual Product]

Phrase: "that"

Phrase: ":"

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "endogenous levels of 17-estradiol"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   781   C0337434:Oestradiol level [Laboratory Procedure]
   760   C0441889:Levels [Qualitative Concept]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]

Phrase: "and"

Phrase: "its precursor estrone"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0014942:Estrone [Hormone,Pharmacologic Substance,Steroid]
   805 E C0700903:Folliculin [Hormone,Pharmacologic Substance,Steroid]
   805 E C1123064:Theelin [Hormone,Pharmacologic Substance,Steroid]
   805 E C1539518:FOLLICULIN [Gene or Genome]

Phrase: "are"

Phrase: "significantly"

Phrase: "elevated in the postnatal"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0205250:Elevated [Qualitative Concept]
   770   C0443281:Postnatal [Temporal Concept]
   770   C3163633:Elevated [Qualitative Concept]

Phrase: "and"

Phrase: "adult mouse brain"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C1521713:Mouse Brain [Tissue]
   827   C0006104:Brain [Body Part, Organ, or Organ Component]
   827   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "adrenal gland of both sexes,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C0001625:Adrenal gland [Body Part, Organ, or Organ Component]
   806   C1268989:Adrenal gland [Body Part, Organ, or Organ Component]
   806   C1515890:GLAND, ADRENAL [Tissue]
   760   C1285092:Gland [Body Part, Organ, or Organ Component]

Phrase: "as"

Phrase: "determined by liquid chromatography/tandem mass spectrometry"
Meta Candidates (Total=15; Excluded=0; Pruned=0; Remaining=15)
   835   C0872318:Liquid Chromatography Mass Spectrometry [Laboratory Procedure]
   814   C0599748:Tandem Mass Spectrometry [Molecular Biology Research Technique]
   778   C0008565:Liquid Chromatography [Laboratory Procedure]
   778   C0037813:Mass Spectrometry [Laboratory Procedure]
   774   C2945612:chromatography mass [Laboratory Procedure]
   748   C0008550:Chromatography [Laboratory Procedure]
   748   C0075804:TANDEM [Organic Chemical,Pharmacologic Substance]
   748   C0302908:Liquid [Substance]
   748   C0436196:Spectrometry [Laboratory Procedure]
   748   C0577559:Mass [Finding]
   748   C1304698:Liquid [Finding]
   748   C1306372:*Mass [Quantitative Concept]
   748   C1546699:Liquid NOS [Intellectual Product]
   748   C1561501:Liquid NOS [Substance]
   748   C3152252:Mass [Quantitative Concept]

Phrase: ";"
Processing 00000000.tx.16: 2) 17-estradiol and 17-estradiol bind estrogen receptors with similar binding affinities; 

Phrase: "2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ")"

Phrase: "17-estradiol"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0014912:Estradiol [Hormone,Pharmacologic Substance,Steroid]
   805 E C0699352:Estrace [Hormone,Pharmacologic Substance,Steroid]
   805 E C0878472:Progynon [Hormone,Pharmacologic Substance,Steroid]

Phrase: "and"

Phrase: "17-estradiol"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0014912:Estradiol [Hormone,Pharmacologic Substance,Steroid]
   805 E C0699352:Estrace [Hormone,Pharmacologic Substance,Steroid]
   805 E C0878472:Progynon [Hormone,Pharmacologic Substance,Steroid]

Phrase: "bind"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1145667:Bind [Activity]
  1000   C1167622:bind [Molecular Function]

Phrase: "estrogen receptors with similar binding affinities"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   804   C1149369:estrogen receptor binding [Molecular Function]
   790   C0034804:Estrogen Receptors [Amino Acid, Peptide, or Protein,Receptor]
   767   C0597358:Receptor Binding [Molecular Function]
   756 E C1414461:ESTROGEN RECEPTOR [Gene or Genome]
   756 E C1521863:Estrogen Receptor [Amino Acid, Peptide, or Protein,Receptor]
   753   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
   753   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]
   753   C2936882:Estrogen [Pharmacologic Substance]

Phrase: ";"
Processing 00000000.tx.17: 3) 17-estradiol transactivates an estrogen-responsive reporter gene; 

Phrase: "3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: ")"

Phrase: "17-estradiol"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0014912:Estradiol [Hormone,Pharmacologic Substance,Steroid]
   805 E C0699352:Estrace [Hormone,Pharmacologic Substance,Steroid]
   805 E C0878472:Progynon [Hormone,Pharmacologic Substance,Steroid]

Phrase: "transactivates"

Phrase: "an estrogen-responsive reporter gene"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0206414:Reporter Gene [Gene or Genome]
   812   C0017337:Gene [Gene or Genome]

Phrase: ";"
Processing 00000000.tx.18: and 4) unlike 17-estradiol, 17-estradiol does not bind -fetoprotein or SHBG, the estrogen-binding plasma proteins of the developing rodent and primate, respectively. 

Phrase: "and"

Phrase: "4"

Phrase: ")"

Phrase: "unlike 17-estradiol,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0014912:Estradiol [Hormone,Pharmacologic Substance,Steroid]
   805 E C0699352:Estrace [Hormone,Pharmacologic Substance,Steroid]
   805 E C0878472:Progynon [Hormone,Pharmacologic Substance,Steroid]

Phrase: "17-estradiol"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0014912:Estradiol [Hormone,Pharmacologic Substance,Steroid]
   805 E C0699352:Estrace [Hormone,Pharmacologic Substance,Steroid]
   805 E C0878472:Progynon [Hormone,Pharmacologic Substance,Steroid]

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "bind -"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1145667:Bind [Activity]
  1000   C1167622:bind [Molecular Function]

Phrase: "fetoprotein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015950:Fetoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "or"

Phrase: "SHBG,"

Phrase: "the estrogen-binding plasma proteins of the developing rodent"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   773   C0059672:Estrogen binding protein [Amino Acid, Peptide, or Protein,Receptor]
   764   C0032120:Plasma Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   762   C0242210:Binding Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   745 E C0033618:Protein Binding [Molecular Function]
   745 E C1168405:protein plasma [Laboratory Procedure]
   742   C0032105:Plasma [Body Substance]
   742   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   731 E C0036825:Plasma Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "primate,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033147:Primate [Mammal]

Phrase: "respectively."
Processing 00000000.tx.19: 17-Estradiol was also found in the brains of gonadectomized or gonadectomized/adrenalectomized mice, supporting the hypothesis that 17-estradiol is locally synthesized in the brain. 

Phrase: "17-Estradiol"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0014912:Estradiol [Hormone,Pharmacologic Substance,Steroid]
   805 E C0699352:Estrace [Hormone,Pharmacologic Substance,Steroid]
   805 E C0878472:Progynon [Hormone,Pharmacologic Substance,Steroid]

Phrase: "was"

Phrase: "also"

Phrase: "found in the brains of gonadectomized"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   753   C0006104:Brains [Body Part, Organ, or Organ Component]
   753   C0150312:Found [Quantitative Concept]
   719 E C0243095:Find [Finding]
   719 E C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "or"

Phrase: "gonadectomized"

Phrase: "/adrenalectomized mice,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]

Phrase: "supporting"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0183683:Support [Medical Device]
   966   C1521721:Support [Conceptual Entity]

Phrase: "the hypothesis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1512571:Hypothesis [Idea or Concept]

Phrase: "that 17-estradiol"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0014912:Estradiol [Hormone,Pharmacologic Substance,Steroid]
   805 E C0699352:Estrace [Hormone,Pharmacologic Substance,Steroid]
   805 E C0878472:Progynon [Hormone,Pharmacologic Substance,Steroid]

Phrase: "is"

Phrase: "locally"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517927:Locally [Spatial Concept]

Phrase: "synthesized in the brain."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0006104:Brain [Body Part, Organ, or Organ Component]
   770   C1269537:Brain [Body Part, Organ, or Organ Component]
   770   C1883254:Synthesized [Activity]
Processing 00000000.tx.20: These findings challenge the view that 17-estradiol is without biological significance and suggest that 17-estradiol and its selective receptor, ER-X, are not part of a classical hormone/receptor endocrine system but of a system with important autocrine/paracrine functions in the developing and adult brain. 

Phrase: "These findings challenge"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0798503:Challenge [Clinical Attribute]
   861   C0805586:Challenge [Health Care Activity]
   861   C3274764:Challenge [Conceptual Entity]

Phrase: "the view"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "that 17-estradiol"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0014912:Estradiol [Hormone,Pharmacologic Substance,Steroid]
   805 E C0699352:Estrace [Hormone,Pharmacologic Substance,Steroid]
   805 E C0878472:Progynon [Hormone,Pharmacologic Substance,Steroid]

Phrase: "is without biological significance"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0005532:Biological [Biomedical Occupation or Discipline]
   770   C0205460:biological [Qualitative Concept]
   770   C0237881:Significance [Quantitative Concept]
   770   C0750502:Significance [Idea or Concept]

Phrase: "and"

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that 17-estradiol"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0014912:Estradiol [Hormone,Pharmacologic Substance,Steroid]
   805 E C0699352:Estrace [Hormone,Pharmacologic Substance,Steroid]
   805 E C0878472:Progynon [Hormone,Pharmacologic Substance,Steroid]

Phrase: "and"

Phrase: "its selective receptor,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "ER-X,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   734   C0034804:Estrogen receptor [Amino Acid, Peptide, or Protein,Receptor]
   734   C1414461:ESTROGEN RECEPTOR [Gene or Genome]
   734   C1521863:Estrogen Receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "are"

Phrase: "not part of a classical hormone/receptor endocrine system"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   784   C1516847:Endocrine System Part [Body Part, Organ, or Organ Component]
   764   C1292711:Part of [Spatial Concept]
   742   C0449719:Part [Spatial Concept]
   742   C1709471:Part [Quantitative Concept]

Phrase: "but of a system"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0233535:but [Mental or Behavioral Dysfunction]
   770   C0449913:System [Functional Concept]
   770   C1553451:System [Manufactured Object]
   770   C1704459:System [Medical Device]

Phrase: "with important autocrine/paracrine functions"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   812   C0542341:Functions [Functional Concept]
   779 E C0031843:function [Physiologic Function]
   779 E C0700205:FUNCTION [Classification]
   779 E C1705273:Function [Intellectual Product]
   729 E C0205245:Functional [Functional Concept]
   729 E C2700217:Functional [Conceptual Entity]

Phrase: "in the developing"

Phrase: "and"

Phrase: "adult brain."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0006104:Brain [Body Part, Organ, or Organ Component]
   861   C1269537:Brain [Body Part, Organ, or Organ Component]
Processing 00000000.tx.21: 17-Estradiol may have enormous implications for hormone replacement strategies at the menopause and in the treatment of such neurodegenerative disorders as Alzheimers disease and ischemic stroke.  

Phrase: "17-Estradiol"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0014912:Estradiol [Hormone,Pharmacologic Substance,Steroid]
   805 E C0699352:Estrace [Hormone,Pharmacologic Substance,Steroid]
   805 E C0878472:Progynon [Hormone,Pharmacologic Substance,Steroid]

Phrase: "may"

Phrase: "have"

Phrase: "enormous implications for hormone replacement strategies"

Phrase: "at the menopause"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0025320:Menopause [Physiologic Function]
  1000   C0567312:Menopause [Finding]

Phrase: "and in the treatment of such neurodegenerative disorders"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   770   C0524851:Neurodegenerative Disorders [Disease or Syndrome]
   770   C1522560:Neurodegenerative Disorders [Functional Concept]
   744   C0012634:Disorders [Disease or Syndrome]
   744   C0039798:treatment [Functional Concept]
   744   C0087111:Treatment [Therapeutic or Preventive Procedure]
   744   C1515981:And [Idea or Concept]
   744   C1522326:Treatment [Functional Concept]
   744   C1533734:Treatment [Therapeutic or Preventive Procedure]
   744   C1705169:Treatment [Conceptual Entity]
   744   C3538994:TREATMENT [Research Activity]

Phrase: "as Alzheimers disease"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0002395:Alzheimers disease [Disease or Syndrome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "and"

Phrase: "ischemic stroke."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0948008:Ischaemic stroke [Disease or Syndrome]
  1000   C3272363:Ischemic Stroke [Disease or Syndrome]
   861   C0038454:Stroke [Disease or Syndrome]
   861   C0475224:Ischaemic [Functional Concept]
Processing 00000000.tx.22: Introduction Top Abstract Introduction Materials and Methods Results Discussion References  IN THE EARLY 1970s, circulating estrogen levels in the postnatal rodent were initially reported to be very elevated (1). 

Phrase: "Introduction Top Abstract Introduction Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "Methods Results Discussion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "References  IN THE EARLY 1970s,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0681756:1970s [Temporal Concept]
   760   C1279919:Early [Temporal Concept]
   760   C1514811:Reference [Idea or Concept]
   760   C1706462:Reference [Conceptual Entity]

Phrase: "circulating"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0175630:Circulating [Functional Concept]

Phrase: "estrogen levels in the postnatal rodent"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   753   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
   753   C0441889:Levels [Qualitative Concept]
   753   C2936882:Estrogen [Pharmacologic Substance]
   719 E C0456079:Level [Classification]
   719 E C1547707:Level [Geographic Area]
   719 E C2946261:Level [Pharmacologic Substance]

Phrase: "were"

Phrase: "initially"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205265:Initially [Temporal Concept]

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "very"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442824:Very [Qualitative Concept]

Phrase: "elevated"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205250:Elevated [Qualitative Concept]
  1000   C3163633:Elevated [Qualitative Concept]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")."
Processing 00000000.tx.23: However, when RIA became sufficiently specific to distinguish 17-estradiol from 17-estradiol, these apparently high estradiol (E2) levels were subsequently termed spurious estrogen because they were not immunoreactive 17-estradiol and disappeared after adrenalectomy (1). 

Phrase: "However,"

Phrase: "when"

Phrase: "RIA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034580:RIA [Laboratory Procedure]

Phrase: "became"

Phrase: "sufficiently specific to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0205369:Specific [Qualitative Concept]
   827   C1552740:specific [Intellectual Product]

Phrase: "distinguish"

Phrase: "17-estradiol from 17-estradiol,"

Phrase: "these apparently high estradiol"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   901   C0860851:high estradiol [Finding]
   827   C0014912:Estradiol [Hormone,Pharmacologic Substance,Steroid]
   771 E C0699352:Estrace [Hormone,Pharmacologic Substance,Steroid]
   771 E C0878472:Progynon [Hormone,Pharmacologic Substance,Steroid]

Phrase: "(E2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3539520:E2 [Gene or Genome]

Phrase: ")"

Phrase: "levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0441889:Levels [Qualitative Concept]
   966 E C0456079:Level [Classification]
   966 E C1547707:Level [Geographic Area]
   966 E C2946261:Level [Pharmacologic Substance]

Phrase: "were"

Phrase: "subsequently"

Phrase: "termed"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1515273:Term [Temporal Concept]
   966   C1705313:Term [Idea or Concept]
   966   C2826302:TERM [Intellectual Product]

Phrase: "spurious estrogen"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
   861   C2936882:Estrogen [Pharmacologic Substance]
   789 E C0720298:Estrogenic [Hormone,Organic Chemical,Pharmacologic Substance]

Phrase: "because"

Phrase: "they"

Phrase: "were"

Phrase: "not immunoreactive 17-estradiol"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   812   C0014912:Estradiol [Hormone,Pharmacologic Substance,Steroid]
   756 E C0699352:Estrace [Hormone,Pharmacologic Substance,Steroid]
   756 E C0878472:Progynon [Hormone,Pharmacologic Substance,Steroid]

Phrase: "and"

Phrase: "disappeared after adrenalectomy"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0001632:Adrenalectomy [Therapeutic or Preventive Procedure]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")."
Processing 00000000.tx.24: Far from being spurious, however, these elevated estrogen levels may have partly represented 17-estradiol, whose precursors epitestosterone and estrone (E1), originate to a certain extent from the adrenal gland and ovary (2). 

Phrase: "Far from"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C0205108:far [Spatial Concept]

Phrase: "being"

Phrase: "spurious, however,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2004457:Spurious [Qualitative Concept]

Phrase: "these elevated estrogen levels"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   827   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
   827   C0441889:Levels [Qualitative Concept]
   827   C2936882:Estrogen [Pharmacologic Substance]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]
   755 E C0720298:Estrogenic [Hormone,Organic Chemical,Pharmacologic Substance]

Phrase: "may"

Phrase: "have"

Phrase: "partly"

Phrase: "represented"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1882932:Represent [Activity]

Phrase: "17-estradiol,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0014912:Estradiol [Hormone,Pharmacologic Substance,Steroid]
   805 E C0699352:Estrace [Hormone,Pharmacologic Substance,Steroid]
   805 E C0878472:Progynon [Hormone,Pharmacologic Substance,Steroid]

Phrase: "whose precursors epitestosterone"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0014594:Epitestosterone [Hormone,Steroid]

Phrase: "and"

Phrase: "estrone"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0014942:Estrone [Hormone,Pharmacologic Substance,Steroid]
   944 E C0700903:Folliculin [Hormone,Pharmacologic Substance,Steroid]
   944 E C1123064:Theelin [Hormone,Pharmacologic Substance,Steroid]
   944 E C1539518:FOLLICULIN [Gene or Genome]

Phrase: "(E1"

Phrase: ")"

Phrase: ","

Phrase: "originate to a certain extent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0439792:Extent [Spatial Concept]

Phrase: "from the adrenal gland"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0001625:Adrenal gland [Body Part, Organ, or Organ Component]
  1000   C1268989:Adrenal gland [Body Part, Organ, or Organ Component]
  1000   C1515890:GLAND, ADRENAL [Tissue]
   861   C1285092:Gland [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "ovary"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0029939:Ovary [Body Part, Organ, or Organ Component]
  1000   C0227898:ovary [Body Part, Organ, or Organ Component]
  1000   C1278992:Ovary [Body Part, Organ, or Organ Component]

Phrase: "(2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ")."
Processing 00000000.tx.25: 17-estradiol was originally isolated from pregnant mare urine (3), but essentially nothing is known about its endogenous content in the blood and other tissues. 

Phrase: "17-estradiol"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0014912:Estradiol [Hormone,Pharmacologic Substance,Steroid]
   805 E C0699352:Estrace [Hormone,Pharmacologic Substance,Steroid]
   805 E C0878472:Progynon [Hormone,Pharmacologic Substance,Steroid]

Phrase: "was"

Phrase: "originally"

Phrase: "isolated from pregnant mare urine"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
   760   C0019944:Mare [Mammal]
   760   C0042036:Urine [Body Substance]
   760   C0042037:urine [Functional Concept]
   760   C0205409:Isolated [Functional Concept]
   760   C0549206:Pregnant [Finding]
   760   C0553641:Pregnant [Functional Concept]
   760   C0600457:PREGNANT [Finding]
   760   C1422420:MARE [Gene or Genome]
   760   C1548221:Isolated [Idea or Concept]
   760   C2963137:Urine [Body Substance]
   726 E C0370215:Isolate [Substance]
   726 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "(3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: ")"

Phrase: ","

Phrase: "but"

Phrase: "essentially"

Phrase: "nothing"

Phrase: "is"

Phrase: "known about its endogenous content"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C1555325:endogenous content [Intellectual Product]
   760   C0205227:Endogenous [Functional Concept]
   760   C0205309:Known [Qualitative Concept]
   760   C0423896:Content [Mental Process]
   760   C0456205:Content [Conceptual Entity]

Phrase: "in the blood"
Meta Candidates (Total=10; Excluded=7; Pruned=0; Remaining=3)
  1000   C0005767:Blood [Tissue]
  1000   C0005768:blood [Body Substance]
  1000   C0229664:Blood [Body Substance]
   928 E C0333275:Bloody [Qualitative Concept]
   916 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   916 E C0392895:Bloods [Population Group]
   916 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   916 E C1511228:VESSEL, BLOOD [Tissue]
   900 E C1558950:VASCULAR [Finding]
   900 E C1801960:Vascular [Qualitative Concept]

Phrase: "and"

Phrase: "other tissues."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0040300:Tissues [Tissue]
   966 E C1547928:Tissue [Intellectual Product]
Processing 00000000.tx.26: The biosynthetic pathways of 17-estradiol are complex and not entirely known (Fig. 1). 

Phrase: "The biosynthetic pathways of 17-estradiol"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C1721101:Biosynthetic Pathways [Molecular Function]
   753   C1704259:Pathways [Molecular Function]
   753   C1705987:Pathways [Conceptual Entity]

Phrase: "are"

Phrase: "complex"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439855:Complex [Qualitative Concept]
  1000   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "and"

Phrase: "not entirely"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Not [Functional Concept]

Phrase: "known"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205309:Known [Qualitative Concept]

Phrase: "(Fig. 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.27: 17-Estradiol is synthesized from aromatization of epitestosterone (also known as 17-testosterone), a natural optical isomer (enantiomer) of testosterone (also known as 17-testosterone), to 17-estradiol by the enzyme cytochrome P450 aromatase (estrogen synthase) (4) in sites that have not been fully characterized but that include the brain (5). 

Phrase: "17-Estradiol"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0014912:Estradiol [Hormone,Pharmacologic Substance,Steroid]
   805 E C0699352:Estrace [Hormone,Pharmacologic Substance,Steroid]
   805 E C0878472:Progynon [Hormone,Pharmacologic Substance,Steroid]

Phrase: "is"

Phrase: "synthesized from aromatization of epitestosterone"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0014594:Epitestosterone [Hormone,Steroid]
   760   C1883254:Synthesized [Activity]

Phrase: "(also"

Phrase: "known as 17-testosterone"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0039601:Testosterone [Hormone,Pharmacologic Substance,Steroid]
   770   C0205309:Known [Qualitative Concept]
   715 E C0113075:Depo-testosterone [Hormone,Pharmacologic Substance,Steroid]

Phrase: ")"

Phrase: ","

Phrase: "a natural optical isomer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0022203:Isomer [Natural Phenomenon or Process]

Phrase: "(enantiomer"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0599473:enantiomer [Chemical Viewed Structurally]
  1000   C3539649:enantiomer [Phenomenon or Process]

Phrase: ")"

Phrase: "of testosterone"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0039601:Testosterone [Hormone,Pharmacologic Substance,Steroid]
   944 E C0113075:Depo-testosterone [Hormone,Pharmacologic Substance,Steroid]

Phrase: "(also"

Phrase: "known as 17-testosterone"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0039601:Testosterone [Hormone,Pharmacologic Substance,Steroid]
   770   C0205309:Known [Qualitative Concept]
   715 E C0113075:Depo-testosterone [Hormone,Pharmacologic Substance,Steroid]

Phrase: ")"

Phrase: ","

Phrase: "to 17-estradiol"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0014912:Estradiol [Hormone,Pharmacologic Substance,Steroid]
   805 E C0699352:Estrace [Hormone,Pharmacologic Substance,Steroid]
   805 E C0878472:Progynon [Hormone,Pharmacologic Substance,Steroid]

Phrase: "by the enzyme cytochrome P450 aromatase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0003805:Aromatase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C1366496:AROMATASE [Gene or Genome]

Phrase: "(estrogen synthase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0003805:Estrogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: ")"

Phrase: "(4"

Phrase: ")"

Phrase: "in sites"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0205145:Sites [Spatial Concept]
   966 E C1515974:Site [Body Location or Region]
   966 E C2825164:Site [Spatial Concept]

Phrase: "that"

Phrase: "have"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "been"

Phrase: "fully"

Phrase: "characterized"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1880022:Characterized [Activity]

Phrase: "but"

Phrase: "that"

Phrase: "include"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332257:include [Functional Concept]
  1000   C1552866:include [Idea or Concept]
  1000   C2700399:Include [Activity]

Phrase: "the brain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006104:Brain [Body Part, Organ, or Organ Component]
  1000   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "(5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.28: In addition, 17-estradiol is interconverted to the estrogen E1 by 17-hydroxysteroid dehydrogenase (6). 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "17-estradiol"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0014912:Estradiol [Hormone,Pharmacologic Substance,Steroid]
   805 E C0699352:Estrace [Hormone,Pharmacologic Substance,Steroid]
   805 E C0878472:Progynon [Hormone,Pharmacologic Substance,Steroid]

Phrase: "is"

Phrase: "interconverted to the estrogen E1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
   760   C2936882:Estrogen [Pharmacologic Substance]

Phrase: "by 17-hydroxysteroid dehydrogenase"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0000165:17-hydroxysteroid dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C0525733:17-hydroxysteroid dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   901   C0020392:hydroxysteroid dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0020393:hydroxysteroid [Steroid]
   827   C0030016:Dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(6"

Phrase: ")."
Processing 00000000.tx.29: However, neither the biosynthetic pathways for 17-estradiol and its most direct precursor epitestosterone nor the site(s) of their formation have been unequivocally confirmed to date. 

Phrase: "However,"

Phrase: "neither"

Phrase: "the biosynthetic pathways for 17-estradiol"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C1721101:Biosynthetic Pathways [Molecular Function]
   753   C1704259:Pathways [Molecular Function]
   753   C1705987:Pathways [Conceptual Entity]

Phrase: "and"

Phrase: "its most direct precursor epitestosterone"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0014594:Epitestosterone [Hormone,Steroid]

Phrase: "nor"

Phrase: "the site"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205145:Site [Spatial Concept]
  1000   C1515974:Site [Body Location or Region]
  1000   C2825164:Site [Spatial Concept]

Phrase: "("

Phrase: "s) of their formation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0220781:formation [Biologic Function]
   770   C0439634:formation [Spatial Concept]
   770   C1522492:Formation [Functional Concept]
   770   C2603362:S' [Clinical Attribute]

Phrase: "have"

Phrase: "been"

Phrase: "unequivocally"

Phrase: "confirmed to date."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   790   C0011008:Date [Temporal Concept]
   790   C0521093:confirmed [Qualitative Concept]
   790   C0750484:Confirmed [Idea or Concept]
   790   C2348077:Date [Food]
   756 E C1456348:Confirm [Qualitative Concept]
Processing 00000000.tx.30: Aromatase is conserved phylogenetically in the central nervous system (7). 

Phrase: "Aromatase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0003805:Aromatase [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1366496:AROMATASE [Gene or Genome]

Phrase: "is"

Phrase: "conserved"

Phrase: "phylogenetically in the central nervous system"
Meta Candidates (Total=13; Excluded=1; Pruned=0; Remaining=12)
   833   C0927232:Central Nervous System [Body System]
   833   C1269563:Central nervous system [Body System]
   790   C0027763:Nervous System [Body System]
   790   C0422837:NERVOUS SYSTEM [Finding]
   790   C1269560:Nervous system [Body System]
   753   C0027769:Nervous [Sign or Symptom]
   753   C0205099:Central [Spatial Concept]
   753   C0449913:System [Functional Concept]
   753   C0599851:Nervous [Functional Concept]
   753   C1553451:System [Manufactured Object]
   753   C1704459:System [Medical Device]
   753   C1879652:Central - [Laboratory Procedure]
   734 E C0205494:Neurologic [Qualitative Concept]

Phrase: "(7"

Phrase: ")."
Processing 00000000.tx.31: Extragonadal estrogen production by aromatization of androgens is a significant source of tissue estrogens, which is independent of circulating estrogen levels. 

Phrase: "Extragonadal estrogen production by aromatization of androgens"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0033268:production [Occupational Activity]

Phrase: "is"

Phrase: "a significant source of tissue estrogens,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0449416:Source [Finding]
   753   C1705919:Source [Idea or Concept]

Phrase: "which"

Phrase: "is independent of circulating estrogen levels."
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   790   C0332291:Independent of [Functional Concept]
   753   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
   753   C0085862:Independent [Idea or Concept]
   753   C0175630:Circulating [Functional Concept]
   753   C0441889:Levels [Qualitative Concept]
   753   C1299583:Independent [Finding]
   753   C2936882:Estrogen [Pharmacologic Substance]
   719 E C0456079:Level [Classification]
   719 E C1547707:Level [Geographic Area]
   719 E C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.32: Expression of aromatase activity is present in various regions of the developing and adult brain, including the basal forebrain, preoptic area, neocortex, hippocampus, and amygdala (5). 

Phrase: "Expression of aromatase activity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "is"

Phrase: "present in various regions of the developing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0150312:Present [Quantitative Concept]
   748   C0449450:Present [Idea or Concept]

Phrase: "and"

Phrase: "adult brain,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0006104:Brain [Body Part, Organ, or Organ Component]
   861   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "the basal forebrain,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C2331620:Basal forebrain [Body Part, Organ, or Organ Component]
   861   C0085140:Fore-Brain [Body Part, Organ, or Organ Component]
   861   C0205112:Basal [Spatial Concept]

Phrase: "preoptic area,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0033063:Preoptic Area [Body Part, Organ, or Organ Component]
   861   C0017446:Area [Geographic Area]
   861   C0205146:Area [Spatial Concept]

Phrase: "neocortex,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0175173:Neocortex [Body Part, Organ, or Organ Component]

Phrase: "hippocampus,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0019564:Hippocampus [Body Part, Organ, or Organ Component]
  1000   C0949582:Hippocampus [Fish]
  1000   C1029104:Hippocampus [Fish]
  1000   C1284077:Hippocampus [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "amygdala"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0002708:Amygdala [Body Part, Organ, or Organ Component]

Phrase: "(5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.33: View larger version (22K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(22K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.34: 1. 

Phrase: "1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]
Processing 00000000.tx.35: The biosynthetic pathways of 17-estradiol are complex and not fully characterized. 

Phrase: "The biosynthetic pathways of 17-estradiol"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C1721101:Biosynthetic Pathways [Molecular Function]
   753   C1704259:Pathways [Molecular Function]
   753   C1705987:Pathways [Conceptual Entity]

Phrase: "are"

Phrase: "complex"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439855:Complex [Qualitative Concept]
  1000   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "and"

Phrase: "not fully"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Not [Functional Concept]

Phrase: "characterized."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1880022:Characterized [Activity]
Processing 00000000.tx.36: 17-HSD, 17-hydroxysteroid dehydrogenase.  

Phrase: "17-HSD,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0000165:17-hydroxysteroid dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C0525733:17-hydroxysteroid dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   901   C0020392:hydroxysteroid dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0020393:hydroxysteroid [Steroid]
   827   C0030016:Dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "17-hydroxysteroid dehydrogenase."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0000165:17-hydroxysteroid dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C0525733:17-hydroxysteroid dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   901   C0020392:hydroxysteroid dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0020393:hydroxysteroid [Steroid]
   827   C0030016:Dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.37: 17-Estradiol has strong neuroprotective activity, as shown by its ability to reduce mortality dramatically in a rat model of middle cerebral artery occlusion (8); 

Phrase: "17-Estradiol"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0014912:Estradiol [Hormone,Pharmacologic Substance,Steroid]
   805 E C0699352:Estrace [Hormone,Pharmacologic Substance,Steroid]
   805 E C0878472:Progynon [Hormone,Pharmacologic Substance,Steroid]

Phrase: "has"

Phrase: "strong neuroprotective activity,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]

Phrase: "as"

Phrase: "shown by its ability to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0085732:Ability [Organism Attribute]
   726   C1547282:Show [Intellectual Product]

Phrase: "reduce"

Phrase: "mortality dramatically in a rat model of middle cerebral artery occlusion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   738   C0026565:Mortality [Quantitative Concept]
   738   C0026566:mortality [Quantitative Concept]

Phrase: "(8"

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.38: decrease the levels of the amyloid -precursor protein in transgenic mice with Alzheimers disease (9); 

Phrase: "decrease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0392756:Decrease [Qualitative Concept]
  1000   C0547047:Decrease [Quantitative Concept]

Phrase: "the levels of the amyloid -precursor protein"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   757   C0428479:Protein level [Laboratory or Test Result]
   748   C0441889:Levels [Qualitative Concept]
   714 E C0456079:Level [Classification]
   714 E C1547707:Level [Geographic Area]
   714 E C2946261:Level [Pharmacologic Substance]

Phrase: "in transgenic mice"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0025936:Mice, Transgenic [Mammal]
   861   C0003069:Transgenic [Animal]
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]

Phrase: "with Alzheimers disease"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0002395:Alzheimers disease [Disease or Syndrome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "(9"

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.39: and rescue PC12 cells from oxidative stress (10). 

Phrase: "and"

Phrase: "rescue PC12 cells from oxidative stress"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   790   C0085262:PC12 Cells [Cell]
   753   C0007634:Cells [Cell]
   753   C3282337:Cells [Cell]
   719 E C1269647:Cell [Cell]
   719 E C1704653:Cell [Medical Device]
   719 E C1948049:Cell [Spatial Concept]

Phrase: "(10"

Phrase: ")."
Processing 00000000.tx.40: Moreover, the ability of 17-estradiol at 1 pM to elicit the rapid and sustained activation of MAPK/ERK1/2 and phosphatidylinositol 3-kinase-Akt (11, 12, 13) and ERK5 (Stl Jr., G., and D. Toran-Allerand, unpublished data), signaling mediators of the differentiative and neuroprotective effects of estrogen in the brain, demonstrates their exquisite sensitivity to this estrogen. 

Phrase: "Moreover,"

Phrase: "the ability of 17-estradiol at 1 pM to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0085732:Ability [Organism Attribute]

Phrase: "elicit"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449265:elicit [Qualitative Concept]

Phrase: "the rapid"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439831:Rapid [Qualitative Concept]

Phrase: "and"

Phrase: "sustained activation of MAPK/ERK1/2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   783   C1155551:MAPK activation [Molecular Function]
   753   C1879547:Activation [Activity]

Phrase: "and"

Phrase: "phosphatidylinositol 3-kinase-Akt"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   812   C0164786:AKT [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0812228:AKT [Gene or Genome]
   756   C0044602:Phosphatidylinositol 3-Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   729 E C2936824:Phosphatidylinositol 3-Kinases [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(11,"

Phrase: "12,"

Phrase: "13"

Phrase: ")"

Phrase: "and"

Phrase: "ERK5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1334481:ERK5 [Gene or Genome]
  1000   C1708804:ERK5 [Gene or Genome]

Phrase: "(Stl Jr.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1708595:Jr [Idea or Concept]
   861   C3280986:JR [Disease or Syndrome]

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "D. Toran-Allerand,"

Phrase: "unpublished data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1511726:Data [Idea or Concept]
   861   C3245479:data [Medical Device]

Phrase: ")"

Phrase: ","

Phrase: "signaling"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0037083:Signaling [Cell Function]
  1000   C3537152:signaling [Biologic Function]
   966 E C1710082:Signal [Phenomenon or Process]

Phrase: "mediators of the differentiative"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0127400:mediators [Organic Chemical,Pharmacologic Substance]
   737 E C1363844:Mediator [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "neuroprotective effects of estrogen"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   833   C0815279:Neuroprotective Effects [Functional Concept]
   819   C0877035:Estrogen Effects [Finding]
   770   C1280500:effects [Qualitative Concept]
   737 E C2348382:Effect [Qualitative Concept]

Phrase: "in the brain,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006104:Brain [Body Part, Organ, or Organ Component]
  1000   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "demonstrates"

Phrase: "their exquisite sensitivity to this estrogen."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   754   C0332324:Sensitive to [Functional Concept]
   753   C0036667:Sensitivity [Quantitative Concept]
   753   C0312418:Sensitivity [Mental Process]
   753   C0427965:Sensitivity [Finding]
   753   C1511883:Sensitivity [Quantitative Concept]
   753   C1522640:Sensitivity [Qualitative Concept]
   753   C2346484:SENSITIVITY [Phenomenon or Process]
   753   C2349185:Sensitivity [Qualitative Concept]
Processing 00000000.tx.41: In addition, that 17-estradiol is able to induce short-latency effects on spatial memory in rats, presumably through influences on hippocampal synaptic plasticity (14), further emphasizes strongly the potential importance of this enantiomer for the brain. 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "that 17-estradiol"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0014912:Estradiol [Hormone,Pharmacologic Substance,Steroid]
   805 E C0699352:Estrace [Hormone,Pharmacologic Substance,Steroid]
   805 E C0878472:Progynon [Hormone,Pharmacologic Substance,Steroid]

Phrase: "is"

Phrase: "able to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0085732:Able [Organism Attribute]
   861   C1299581:Able [Finding]

Phrase: "induce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "short-latency effects on spatial memory"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C1280500:effects [Qualitative Concept]
   719 E C2348382:Effect [Qualitative Concept]

Phrase: "in rats,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034693:rats [Mammal]
  1000   C0034721:Rats [Mammal]

Phrase: "presumably through influences"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   706   C0021399:influential [Idea or Concept]

Phrase: "on hippocampal synaptic plasticity"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0678558:Plasticity [Natural Phenomenon or Process]
   755 E C0032167:Plastic [Substance]

Phrase: "(14"

Phrase: ")"

Phrase: ","

Phrase: "further"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "emphasizes"

Phrase: "strongly"

Phrase: "the potential importance of this enantiomer"

Phrase: "for the brain."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006104:Brain [Body Part, Organ, or Organ Component]
  1000   C1269537:Brain [Body Part, Organ, or Organ Component]
Processing 00000000.tx.42: Here we show by liquid chromatography/tandem mass spectrometry (LC-MS/MS) (15) that the endogenous content of 17-estradiol and E1 in the postnatal and adult neocortex, hippocampus, hypothalamus, and cerebellum of both sexes is significantly elevated, compared with 17-estradiol. 

Phrase: "Here"

Phrase: "we"

Phrase: "show by liquid chromatography/tandem mass spectrometry (LC-MS/MS)"
Meta Candidates (Total=16; Excluded=0; Pruned=0; Remaining=16)
   835   C0872318:Liquid Chromatography Mass Spectrometry [Laboratory Procedure]
   814   C0599748:Tandem Mass Spectrometry [Molecular Biology Research Technique]
   778   C0008565:Liquid Chromatography [Laboratory Procedure]
   778   C0037813:Mass Spectrometry [Laboratory Procedure]
   774   C2945612:chromatography mass [Laboratory Procedure]
   748   C0008550:Chromatography [Laboratory Procedure]
   748   C0075804:TANDEM [Organic Chemical,Pharmacologic Substance]
   748   C0302908:Liquid [Substance]
   748   C0436196:Spectrometry [Laboratory Procedure]
   748   C0577559:Mass [Finding]
   748   C1304698:Liquid [Finding]
   748   C1306372:*Mass [Quantitative Concept]
   748   C1546699:Liquid NOS [Intellectual Product]
   748   C1547282:Show [Intellectual Product]
   748   C1561501:Liquid NOS [Substance]
   748   C3152252:Mass [Quantitative Concept]

Phrase: "(15"

Phrase: ")"

Phrase: "that"

Phrase: "the endogenous content of 17-estradiol"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C1555325:endogenous content [Intellectual Product]
   753   C0423896:Content [Mental Process]
   753   C0456205:Content [Conceptual Entity]

Phrase: "and"

Phrase: "E1 in the postnatal"

Phrase: "and"

Phrase: "adult neocortex,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0175173:Neocortex [Body Part, Organ, or Organ Component]

Phrase: "hippocampus,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0019564:Hippocampus [Body Part, Organ, or Organ Component]
  1000   C0949582:Hippocampus [Fish]
  1000   C1029104:Hippocampus [Fish]
  1000   C1284077:Hippocampus [Body Part, Organ, or Organ Component]

Phrase: "hypothalamus,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0020663:Hypothalamus [Body Part, Organ, or Organ Component]
  1000   C1280712:Hypothalamus [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "cerebellum of both sexes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0007765:Cerebellum [Body Part, Organ, or Organ Component]
   770   C1268981:Cerebellum [Body Part, Organ, or Organ Component]
   770   C1707522:Cerebellum [Tissue]

Phrase: "is"

Phrase: "significantly"

Phrase: "elevated"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205250:Elevated [Qualitative Concept]
  1000   C3163633:Elevated [Qualitative Concept]

Phrase: ","

Phrase: "compared with 17-estradiol."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   770   C0014912:Estradiol [Hormone,Pharmacologic Substance,Steroid]
   770   C1707455:Compared [Activity]
   715 E C0699352:Estrace [Hormone,Pharmacologic Substance,Steroid]
   715 E C0878472:Progynon [Hormone,Pharmacologic Substance,Steroid]
Processing 00000000.tx.43: We further show that 17-estradiol binds to estrogen receptors with binding affinities similar to 17-estradiol; 

Phrase: "We further"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that 17-estradiol"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0014912:Estradiol [Hormone,Pharmacologic Substance,Steroid]
   805 E C0699352:Estrace [Hormone,Pharmacologic Substance,Steroid]
   805 E C0878472:Progynon [Hormone,Pharmacologic Substance,Steroid]

Phrase: "binds to estrogen receptors"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   833   C0034804:Estrogen Receptors [Amino Acid, Peptide, or Protein,Receptor]
   799 E C1414461:ESTROGEN RECEPTOR [Gene or Genome]
   799 E C1521863:Estrogen Receptor [Amino Acid, Peptide, or Protein,Receptor]
   770   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
   770   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]
   770   C1145667:Bind [Activity]
   770   C1167622:bind [Molecular Function]
   770   C2936882:Estrogen [Pharmacologic Substance]

Phrase: "with binding affinities"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1510827:Affinity [Natural Phenomenon or Process]

Phrase: "similar to 17-estradiol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C2348205:Similar [Qualitative Concept]

Phrase: ";"
Processing 00000000.tx.44: is able to transactivate an estrogen-responsive reporter gene; 

Phrase: "is"

Phrase: "able to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0085732:Able [Organism Attribute]
   861   C1299581:Able [Finding]

Phrase: "transactivate"

Phrase: "an estrogen-responsive reporter gene"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0206414:Reporter Gene [Gene or Genome]
   812   C0017337:Gene [Gene or Genome]

Phrase: ";"
Processing 00000000.tx.45: unlike 17-estradiol, does not bind -fetoprotein (AFP) or SHBG, the estrogen-binding plasma proteins of the developing rodent and primate, respectively, and brain levels are unaffected by gonadectomy and/or adrenalectomy.  

Phrase: "unlike 17-estradiol,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0014912:Estradiol [Hormone,Pharmacologic Substance,Steroid]
   805 E C0699352:Estrace [Hormone,Pharmacologic Substance,Steroid]
   805 E C0878472:Progynon [Hormone,Pharmacologic Substance,Steroid]

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "bind -"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1145667:Bind [Activity]
  1000   C1167622:bind [Molecular Function]

Phrase: "fetoprotein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015950:Fetoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(AFP)"

Phrase: "or"

Phrase: "SHBG,"

Phrase: "the estrogen-binding plasma proteins of the developing rodent"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   773   C0059672:Estrogen binding protein [Amino Acid, Peptide, or Protein,Receptor]
   764   C0032120:Plasma Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   762   C0242210:Binding Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   745 E C0033618:Protein Binding [Molecular Function]
   745 E C1168405:protein plasma [Laboratory Procedure]
   742   C0032105:Plasma [Body Substance]
   742   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   731 E C0036825:Plasma Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "primate,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033147:Primate [Mammal]

Phrase: "respectively,"

Phrase: "and"

Phrase: "brain levels"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   861   C0006104:Brain [Body Part, Organ, or Organ Component]
   861   C0441889:Levels [Qualitative Concept]
   861   C1269537:Brain [Body Part, Organ, or Organ Component]
   827 E C0456079:Level [Classification]
   827 E C1547707:Level [Geographic Area]
   827 E C2946261:Level [Pharmacologic Substance]

Phrase: "are"

Phrase: "unaffected by gonadectomy"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C2986417:Unaffected [Conceptual Entity]

Phrase: "and/or"

Phrase: "adrenalectomy."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001632:Adrenalectomy [Therapeutic or Preventive Procedure]
Processing 00000000.tx.46: Materials and Methods Top Abstract Introduction Materials and Methods Results Discussion References  Animals Tissue samples were obtained from postnatal day (P) 1, P7, and adult male and female C57BL/6J mice from a breeding colony under the direction of Dr. 

Phrase: "Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "Methods Top Abstract Introduction Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "Methods Results Discussion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Animals Tissue samples"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   884   C1292533:Tissue Sample [Tissue]
   793   C0370003:Sample [Substance]
   793   C2347026:Sample [Conceptual Entity]
   717   C0229982:Animal tissue [Tissue]

Phrase: "were"

Phrase: "obtained from postnatal day (P) 1,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   760   C0332173:/day [Temporal Concept]
   760   C0439228:day [Temporal Concept]
   760   C0439505:/day [Temporal Concept]
   760   C0443281:Postnatal [Temporal Concept]
   760   C1301820:Obtained [Functional Concept]
   726 E C1706701:Obtain [Activity]

Phrase: "P7,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1424742:p7 [Gene or Genome]

Phrase: "and"

Phrase: "adult male"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   861   C0001675:Adult [Age Group]
   861   C0024554:Male [Finding]
   861   C0086582:male [Population Group]
   861   C1706180:Male [Qualitative Concept]
   861   C1706428:Male [Qualitative Concept]
   861   C1706429:Male [Organism Attribute]
   861   C1706450:Adult [Human]

Phrase: "and"

Phrase: "female C57BL/6J mice from a breeding colony"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   767   C0025921:Mice, C57BL [Mammal]
   744   C0025914:Mice [Mammal]
   744   C0025929:mice [Mammal]
   744   C0026809:Mice [Mammal]

Phrase: "under the direction"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0449738:Direction [Spatial Concept]
   900 E C1707761:Directionality [Functional Concept]
   900 E C3274524:Directionality [Functional Concept]

Phrase: "of Dr."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0031831:DR [Professional or Occupational Group]
  1000   C1707664:DR [Biomedical or Dental Material]
  1000   C2348314:Dr. [Conceptual Entity]
  1000   C3540849:DR [Idea or Concept]
Processing 00000000.tx.47: C. 

Phrase: "C."
Processing 00000000.tx.48: A. 

Phrase: "A."
Processing 00000000.tx.49: Mason (Columbia University, New York, NY). 

Phrase: "Mason"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0331857:Mason [Health Care Related Organization]

Phrase: "(Columbia University,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0041740:University [Manufactured Object,Organization]
   861   C1551442:Columbia [Population Group]
   861   C3245499:Columbia [Health Care Related Organization]
   789 E C1551955:Columbian [Language]

Phrase: "New York,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027976:New York [Geographic Area]
   861   C0205314:New [Temporal Concept]

Phrase: "NY"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027976:NY [Geographic Area]
  1000   C1879958:NY [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.50: Adult (8 wk old) gonadectomized (ovariectomized or castrated) and gonadectomized-adrenalectomized male and female C57BL/6J mice were purchased from the Jackson Laboratory (Bar Harbor, ME). 

Phrase: "Adult"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0001675:Adult [Age Group]
  1000   C1706450:Adult [Human]

Phrase: "(8 wk"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332174:/wk [Temporal Concept]
   861   C0439230:wk [Temporal Concept]

Phrase: "old)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0580836:Old [Temporal Concept]

Phrase: "gonadectomized"

Phrase: "("

Phrase: "ovariectomized"

Phrase: "or"

Phrase: "castrated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   928   C0392747:Altered [Functional Concept]

Phrase: ")"

Phrase: "and"

Phrase: "gonadectomized-"

Phrase: "adrenalectomized male"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0024554:Male [Finding]
   861   C0086582:male [Population Group]
   861   C1706180:Male [Qualitative Concept]
   861   C1706428:Male [Qualitative Concept]
   861   C1706429:Male [Organism Attribute]

Phrase: "and"

Phrase: "female C57BL/6J mice"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   875   C0025921:Mice, C57BL [Mammal]
   812   C0025914:Mice [Mammal]
   812   C0025929:mice [Mammal]
   812   C0026809:Mice [Mammal]

Phrase: "were"

Phrase: "purchased from the Jackson Laboratory"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0022877:Laboratory [Manufactured Object,Organization]
   760   C0869011:purchased [Activity]
   760   C3244292:laboratory [Functional Concept]

Phrase: "(Bar Harbor,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0475311:Harbor [Manufactured Object]

Phrase: "ME"

Phrase: ")."
Processing 00000000.tx.51: Animals were kept under standard laboratory conditions, with tap water and mouse breeder chow ad libitum, under a 10-h light, 14-h dark cycle. 

Phrase: "Animals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003062:Animals [Animal]

Phrase: "were"

Phrase: "kept under standard laboratory conditions,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   760   C0022877:Laboratory [Manufactured Object,Organization]
   760   C1442989:Standard [Qualitative Concept]
   760   C2828392:Standard [Intellectual Product]
   760   C3244292:laboratory [Functional Concept]
   726   C0012634:condition [Disease or Syndrome]
   726   C0333118:Keep [Functional Concept]
   726   C0348080:Condition [Qualitative Concept]
   726   C1705253:Condition [Conceptual Entity]

Phrase: "with tap water"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C2919405:Tap water [Inorganic Chemical,Pharmacologic Substance]
   861   C0034115:Tap [Health Care Activity]
   861   C0043047:Water [Inorganic Chemical,Pharmacologic Substance]
   861   C0599638:WATER [Substance]
   861   C1550678:Water [Inorganic Chemical]
   789 E C0443350:Watery [Qualitative Concept]

Phrase: "and"

Phrase: "mouse breeder chow"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0324335:chow [Mammal]

Phrase: "ad libitum,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1879743:ad libitum [Qualitative Concept]

Phrase: "under a 10-h light,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0023693:Light [Natural Phenomenon or Process]
   812   C1306462:Light [Functional Concept]
   812   C1881376:Light [Qualitative Concept]

Phrase: "14-h dark cycle."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1511572:Cycle [Temporal Concept]
Processing 00000000.tx.52: All experiments conformed strictly to National Institutes of Health and international guidelines on the ethical use of animals in experiments. 

Phrase: "All experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0681814:Experiments [Research Activity]
   966 E C1706386:Experiment [Conceptual Entity]
   916 E C1517586:Experimental [Qualitative Concept]

Phrase: "conformed"

Phrase: "strictly to National Institutes of Health"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   882   C0027468:National Institutes of Health [Health Care Related Organization]
           national health institutes
   753   C0018684:Health [Idea or Concept]
   753   C0021622:Institutes [Organization]
   753   C3245503:national [Intellectual Product]
   719 E C1272753:Institute [Idea or Concept]

Phrase: "and"

Phrase: "international guidelines on the ethical use of animals"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0162791:Guidelines [Intellectual Product]
   744   C0220845:guidelines [Intellectual Product]
   744   C0282423:guidelines [Intellectual Product]

Phrase: "in experiments."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0681814:Experiments [Research Activity]
   966 E C1706386:Experiment [Conceptual Entity]
   916 E C1517586:Experimental [Qualitative Concept]
Processing 00000000.tx.53: Experimental protocols were approved by the Institutional Animal Care and Use Committee of Columbia University. 

Phrase: "Experimental protocols"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0442711:Protocols [Intellectual Product]
   827 E C1507394:Protocol [Intellectual Product]
   827 E C1522729:Protocol [Intellectual Product]
   827 E C2348563:Protocol [Intellectual Product]

Phrase: "were"

Phrase: "approved by the Institutional Animal Care"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0178478:animal care [Occupation or Discipline]
   783   C0868975:Institutional care [Health Care Activity]
   753   C0003062:Animal [Animal]
   753   C0205540:Approved [Qualitative Concept]
   753   C1947933:Care [Activity]

Phrase: "and"

Phrase: "Use Committee of Columbia University."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C2699414:Committee [Group]
Processing 00000000.tx.54: The gonadectomized and gonadectomized/adrenalectomized mice were used after 10 d of surgery. 

Phrase: "The gonadectomized"

Phrase: "and"

Phrase: "gonadectomized"

Phrase: "/adrenalectomized mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]

Phrase: "were"

Phrase: "used after 10 d of surgery."
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   767   C1524063:Use of [Functional Concept]
   753   C0038894:Surgery [Biomedical Occupation or Discipline]
   753   C0038895:surgery [Functional Concept]
   753   C0543467:Surgery [Health Care Activity]
   753   C1273517:used [Finding]
   719 E C0042153:use [Functional Concept]
   719 E C0457083:Use [Functional Concept]
   719 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.55: The gonadectomized/adrenalectomized mice were provided with the tap water containing 0.9% sodium chloride. 

Phrase: "The gonadectomized/adrenalectomized mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]

Phrase: "were"

Phrase: "provided with the tap water"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C2919405:Tap water [Inorganic Chemical,Pharmacologic Substance]
   760   C0034115:Tap [Health Care Activity]
   760   C0043047:Water [Inorganic Chemical,Pharmacologic Substance]
   760   C0599638:WATER [Substance]
   760   C1550678:Water [Inorganic Chemical]
   760   C1999230:Provided [Activity]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "0.9% sodium chloride."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0990166:0.9% sodium chloride [Clinical Drug]
   861   C0037494:Sodium Chloride [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   812   C0008203:Chloride, NOS [Inorganic Chemical]
   812   C0037473:Sodium [Biologically Active Substance,Element, Ion, or Isotope]
   812   C0596019:Chloride [Element, Ion, or Isotope]
   812   C0597484:Sodium+ [Element, Ion, or Isotope,Pharmacologic Substance]
Processing 00000000.tx.56: Reagents [3H]17-estradiol (17-[6,9(n)-3H]estradiol, 34 Ci/mmol) was custom synthesized by Amersham Biosciences UK Ltd. 

Phrase: "Reagents"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034760:Reagents [Indicator, Reagent, or Diagnostic Aid]

Phrase: "[3H"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1442460:3H [Temporal Concept]

Phrase: "]17-estradiol"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0014912:Estradiol [Hormone,Pharmacologic Substance,Steroid]
   805 E C0699352:Estrace [Hormone,Pharmacologic Substance,Steroid]
   805 E C0878472:Progynon [Hormone,Pharmacologic Substance,Steroid]

Phrase: "(17-"

Phrase: "[6,"

Phrase: "9"

Phrase: "(n)-3H"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1442460:3H [Temporal Concept]

Phrase: "]estradiol,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0014912:Estradiol [Hormone,Pharmacologic Substance,Steroid]
   944 E C0699352:Estrace [Hormone,Pharmacologic Substance,Steroid]
   944 E C0878472:Progynon [Hormone,Pharmacologic Substance,Steroid]

Phrase: "34 Ci/mmol)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439190:MMOLE [Quantitative Concept]

Phrase: "was"

Phrase: "custom"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0162343:Custom [Idea or Concept]
  1000   C1880202:Custom [Activity]
   928 E C3242380:customary [Intellectual Product]
   928 E C3538928:Customary [Qualitative Concept]

Phrase: "synthesized by Amersham Biosciences UK Ltd."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1136140:LTD [Organ or Tissue Function]
   753   C1883254:Synthesized [Activity]
Processing 00000000.tx.57: (Buckinghamshire, UK). 

Phrase: "(Buckinghamshire,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0454842:Buckinghamshire [Geographic Area]

Phrase: "UK"

Phrase: ")."
Processing 00000000.tx.58: [3H]17-estradiol, ([2,4,6,7,16,17-3H(N)]estradiol, 110 Ci/mmol) was purchased from NEN Life Science Products, PerkinElmer (Boston, MA). 

Phrase: "[3H"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1442460:3H [Temporal Concept]

Phrase: "]17-estradiol,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0014912:Estradiol [Hormone,Pharmacologic Substance,Steroid]
   805 E C0699352:Estrace [Hormone,Pharmacologic Substance,Steroid]
   805 E C0878472:Progynon [Hormone,Pharmacologic Substance,Steroid]

Phrase: "("

Phrase: "[2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "4,"

Phrase: "6,"

Phrase: "7,"

Phrase: "16,"

Phrase: "17-3H"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1442460:3H [Temporal Concept]

Phrase: "(N)]estradiol,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0014912:Estradiol [Hormone,Pharmacologic Substance,Steroid]
   805 E C0699352:Estrace [Hormone,Pharmacologic Substance,Steroid]
   805 E C0878472:Progynon [Hormone,Pharmacologic Substance,Steroid]

Phrase: "110 Ci/mmol)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439190:MMOLE [Quantitative Concept]

Phrase: "was"

Phrase: "purchased from NEN Life Science Products,"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   833   C0332070:Life Science Products [Health Care Related Organization]
   790   C0005526:Science, Life [Occupation or Discipline]
   753   C0036397:Science [Occupation or Discipline]
   753   C0376558:Life [Idea or Concept]
   753   C0869011:purchased [Activity]
   753   C1514468:Products [Entity]
   719 E C1704444:Product [Quantitative Concept]

Phrase: "PerkinElmer"

Phrase: "(Boston,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006037:Boston [Geographic Area]

Phrase: "MA"

Phrase: ")."
Processing 00000000.tx.59: Unlabeled 17-estradiol and 17-estradiol were purchased from Sigma Chemicals (St. Louis, MO). 

Phrase: "Unlabeled 17-estradiol"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0014912:Estradiol [Hormone,Pharmacologic Substance,Steroid]
   771 E C0699352:Estrace [Hormone,Pharmacologic Substance,Steroid]
   771 E C0878472:Progynon [Hormone,Pharmacologic Substance,Steroid]

Phrase: "and"

Phrase: "17-estradiol"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0014912:Estradiol [Hormone,Pharmacologic Substance,Steroid]
   805 E C0699352:Estrace [Hormone,Pharmacologic Substance,Steroid]
   805 E C0878472:Progynon [Hormone,Pharmacologic Substance,Steroid]

Phrase: "were"

Phrase: "purchased from Sigma Chemicals"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0220806:Chemicals [Chemical]
   770   C0869011:purchased [Activity]
   770   C1719918:Sigma [Intellectual Product]
   737 E C3272558:Chemical [Intellectual Product]

Phrase: "(St. Louis,"

Phrase: "MO"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3538743:MO [Idea or Concept]

Phrase: ")."
Processing 00000000.tx.60: The ERE-tk-luc expression plasmid, human estrogen receptor (ER)-, and mouse ER expression vectors were a generous gift from Dr. 

Phrase: "The ERE-tk-luc expression plasmid,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0032136:Plasmid [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "human estrogen receptor (ER)-,"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   901   C0034804:Estrogen receptor [Amino Acid, Peptide, or Protein,Receptor]
   901   C1414461:ESTROGEN RECEPTOR [Gene or Genome]
   901   C1521863:Estrogen Receptor [Amino Acid, Peptide, or Protein,Receptor]
   827   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
   827   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   827   C2936882:Estrogen [Pharmacologic Substance]
   755 E C0720298:Estrogenic [Hormone,Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "mouse ER expression vectors"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   840   C0599566:expression vectors [Nucleic Acid, Nucleoside, or Nucleotide]
   804   C0086022:Vectors [Nucleic Acid, Nucleoside, or Nucleotide]
   804   C0442335:Vectors [Spatial Concept]
   771 E C1705099:Vector [Idea or Concept]

Phrase: "were"

Phrase: "a generous gift from Dr."
Processing 00000000.tx.61: Maria Sjoberg (Karolinska Institute, Stockholm, Sweden) (16). 

Phrase: "Maria Sjoberg"

Phrase: "(Karolinska Institute,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021622:institute [Organization]
   861   C1272753:Institute [Idea or Concept]

Phrase: "Stockholm,"

Phrase: "Sweden"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0038995:Sweden [Geographic Area]

Phrase: ")"

Phrase: "(16"

Phrase: ")."
Processing 00000000.tx.62: The pRL-CMV expression plasmid was from Promega (Madison, WI). 

Phrase: "The pRL-CMV expression plasmid"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0032136:Plasmid [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "was from Promega"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0043194:WAS [Disease or Syndrome]
   790   C0072149:Promega [Lipid]
   790   C0258432:WAS [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C1421478:WAS [Gene or Genome]

Phrase: "(Madison,"

Phrase: "WI"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043193:WI [Geographic Area]

Phrase: ")."
Processing 00000000.tx.63: All other reagents were from Sigma. 

Phrase: "All"

Phrase: "other reagents"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034760:Reagents [Indicator, Reagent, or Diagnostic Aid]

Phrase: "were from Sigma."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1719918:Sigma [Intellectual Product]
Processing 00000000.tx.64: Tissue lysates The tissues were homogenized in lysis buffer [50 mM Tris (pH 7.4), 150 mM NaCl, 10% glycerol, 1 mM EGTA, 1 mM Na3VO4, 5 mM ZnCl2, 100 mM NaF, containing antiprotease cocktail mini (Roche, Indianapolis, IN), and 60 mM n-octyl--D-glucopyranoside]. 

Phrase: "Tissue lysates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1881488:Lysate [Physical Object]

Phrase: "The tissues"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0040300:Tissues [Tissue]
   966 E C1547928:Tissue [Intellectual Product]

Phrase: "were"

Phrase: "homogenized in lysis buffer"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   770   C0024348:Lysis [Pathologic Function]
   770   C1536403:lysis [Cell Function]

Phrase: "[50 mM Tris"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0041175:TRIS [Organic Chemical,Pharmacologic Substance]
   827   C0077281:Tris [Hazardous or Poisonous Substance,Organophosphorus Compound]
   827   C0814229:TRI [Intellectual Product]

Phrase: "(pH 7.4"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   913   C2678549:PH-4 [Gene or Genome]
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: ")"

Phrase: ","

Phrase: "150 mM NaCl,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   827   C1959973:% NaCl [Quantitative Concept]

Phrase: "10% glycerol,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017861:Glycerol [Biologically Active Substance,Organic Chemical,Pharmacologic Substance]

Phrase: "1 mM EGTA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0013714:EGTA [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "1 mM Na3VO4,"

Phrase: "5 mM ZnCl2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0078774:ZnCl2 [Hazardous or Poisonous Substance,Inorganic Chemical,Pharmacologic Substance]

Phrase: "100 mM NaF,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0037508:NaF [Biomedical or Dental Material,Inorganic Chemical]
   827   C1366571:NAF [Gene or Genome]
   827   C1705592:NAF [Gene or Genome]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "antiprotease cocktail mini"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0445542:Mini [Organism Attribute]

Phrase: "(Roche,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0331965:Roche [Health Care Related Organization]

Phrase: "Indianapolis,"

Phrase: "IN"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "60 mM n-octyl"

Phrase: "-"

Phrase: "-"

Phrase: "D-"

Phrase: "glucopyranoside"

Phrase: "]."
Processing 00000000.tx.65: The homogenates were centrifuged at 100,000 x g, and tissue lysate or serum samples were used for analysis by LC-MS/MS. 

Phrase: "The homogenates"

Phrase: "were"

Phrase: "centrifuged at 100,000 x g,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0439267:g% [Quantitative Concept]
   719   C0179834:centrifuge [Medical Device]

Phrase: "and"

Phrase: "tissue lysate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1881488:Lysate [Physical Object]

Phrase: "or"

Phrase: "serum samples"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   983   C0444266:Serum sample [Body Substance]
   827   C0370003:Sample [Substance]
   827   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "used for analysis"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   790   C0002778:Analysis [Laboratory Procedure]
   790   C0936012:Analysis [Research Activity]
   790   C1273517:used [Finding]
   790   C1524024:analysis [Functional Concept]
   756 E C0042153:use [Functional Concept]
   756 E C0457083:Use [Functional Concept]
   756 E C1947944:Use [Intellectual Product]

Phrase: "by LC-MS/MS."
Meta Candidates (Total=16; Excluded=1; Pruned=0; Remaining=15)
   924   C0872318:Liquid Chromatography Mass Spectrometry [Laboratory Procedure]
   884   C0599748:Tandem Mass Spectrometry [Molecular Biology Research Technique]
   853   C2945612:chromatography mass [Laboratory Procedure]
   840   C0008565:Liquid Chromatography [Laboratory Procedure]
   840   C0037813:Mass Spectrometry [Laboratory Procedure]
   804   C0008550:Chromatography [Laboratory Procedure]
   804   C0075804:TANDEM [Organic Chemical,Pharmacologic Substance]
   804   C0302908:Liquid [Substance]
   804   C0436196:Spectrometry [Laboratory Procedure]
   804   C0577559:Mass [Finding]
   804   C1304698:Liquid [Finding]
   804   C1306372:*Mass [Quantitative Concept]
   804   C1546699:Liquid NOS [Intellectual Product]
   804   C1561501:Liquid NOS [Substance]
   804   C3152252:Mass [Quantitative Concept]
   704 E C0302647:chromatograph [Medical Device]
Processing 00000000.tx.66: The protein content in sample lysates was measured by the Bradford reagent (Bio-Rad Laboratories, Hercules, CA). 

Phrase: "The protein content in sample lysates"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0423896:Content [Mental Process]
   753   C0456205:Content [Conceptual Entity]

Phrase: "was"

Phrase: "measured by the Bradford reagent"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   760   C0034760:Reagent [Indicator, Reagent, or Diagnostic Aid]
   760   C0444706:Measured [Qualitative Concept]
   760   C3541902:MEASURED [Diagnostic Procedure]
   726 E C0079809:Measure [Quantitative Concept]
   726 E C0242485:Measure [Functional Concept]

Phrase: "(Bio-Rad Laboratories,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0022877:Laboratories [Manufactured Object,Organization]
   827   C1619828:Laboratories [Intellectual Product]
   793 E C3244292:laboratory [Functional Concept]

Phrase: "Hercules,"

Phrase: "CA)."
Processing 00000000.tx.67: Analysis of estrogens by the LC-MS/MS method LC-MS/MS assay of estrogens was carried out, as described previously (15), and was optimized for simultaneous analyses of 17-estradiol, 17-estradiol, and E1, using deuterium-labeled internal standards. 

Phrase: "Analysis of estrogens"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0002778:Analysis [Laboratory Procedure]
   790   C0936012:Analysis [Research Activity]
   790   C1524024:analysis [Functional Concept]

Phrase: "by the LC-MS/MS method LC-MS/MS assay"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   787   C0005507:Assay [Laboratory Procedure]
   787   C0243073:assay [Qualitative Concept]
   787   C1510438:Assay [Laboratory Procedure]

Phrase: "of estrogens"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0014939:Estrogens [Hormone,Pharmacologic Substance,Steroid]
   966 E C2936882:Estrogen [Pharmacologic Substance]
   916 E C0720298:Estrogenic [Hormone,Organic Chemical,Pharmacologic Substance]

Phrase: "was"

Phrase: "carried"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0206243:carried [Activity]
  1000   C0699809:carried [Finding]

Phrase: "out,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439787:Out [Spatial Concept]
  1000   C0849355:Out [Qualitative Concept]

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "(15"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "was"

Phrase: "optimized for simultaneous analyses of 17-estradiol,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   748   C0014912:Estradiol [Hormone,Pharmacologic Substance,Steroid]
   748   C0521115:Simultaneous [Temporal Concept]
   748   C1548968:Simultaneous [Idea or Concept]
   714   C0002778:Analysis [Laboratory Procedure]
   714   C0936012:Analysis [Research Activity]
   714   C1524024:analysis [Functional Concept]

Phrase: "17-estradiol,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0014912:Estradiol [Hormone,Pharmacologic Substance,Steroid]
   805 E C0699352:Estrace [Hormone,Pharmacologic Substance,Steroid]
   805 E C0878472:Progynon [Hormone,Pharmacologic Substance,Steroid]

Phrase: "and"

Phrase: "E1,"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "deuterium-labeled internal standards."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   812   C0038137:standards [Intellectual Product]
   812   C0175675:Standards [Qualitative Concept]
   812   C0205102:Internal [Spatial Concept]
   812   C1553872:Internal [Intellectual Product]
   812   C1619620:Internal [Intellectual Product]
   779 E C1442989:Standard [Qualitative Concept]
   779 E C2828392:Standard [Intellectual Product]
Processing 00000000.tx.68: Samples were extracted with 6 ml methylene chloride, the upper aqueous layer removed, and the remaining solvent transferred to clean 13 x 100-mm glass tubes. 

Phrase: "Samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0370003:Sample [Substance]
   966   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "extracted with 6 ml methylene chloride,"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   790   C0025748:methylene chloride [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]
   753   C0008203:Chloride, NOS [Inorganic Chemical]
   753   C0054666:methylene [Organic Chemical,Pharmacologic Substance]
   753   C0185115:Extracted [Therapeutic or Preventive Procedure]
   753   C0439526:/mL [Quantitative Concept]
   753   C0596019:Chloride [Element, Ion, or Isotope]
   753   C3541890:EXTRACTED [Finding]
   719 E C2828366:Extract [Substance]

Phrase: "the upper aqueous layer"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0934502:Layer [Body Part, Organ, or Organ Component]
   827   C1522408:Layer [Qualitative Concept]
   827   C1561599:Layer [Intellectual Product]

Phrase: "removed"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0849355:Removed [Qualitative Concept]
   966 E C1883720:Remove [Activity]
   966 E C3244314:remove [Functional Concept]

Phrase: ","

Phrase: "and"

Phrase: "the remaining solvent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0037638:Solvent [Indicator, Reagent, or Diagnostic Aid]

Phrase: "transferred"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0348011:transferred [Functional Concept]
   966 E C0040671:Transfer [Mental Process]
   966 E C1705822:Transfer [Activity]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "clean"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1947930:Clean [Activity]

Phrase: "13 x 100-mm glass tubes."
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   810   C0336635:Glass tube [Medical Device]
   799   C0175730:tubes [Medical Device]
   799   C1547937:Tubes [Intellectual Product]
   799   C1704474:Tubes [Quantitative Concept]
   766 E C1561954:tube [Conceptual Entity]
   766 E C1704730:TUBE [Medical Device]
Processing 00000000.tx.69: The solvent was evaporated under nitrogen in a 45 C water bath, and the dried residue was redissolved in 50 l sodium bicarbonate buffer [100 mmol/liter (pH 10.5)]. 

Phrase: "The solvent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0037638:Solvent [Indicator, Reagent, or Diagnostic Aid]

Phrase: "was"

Phrase: "evaporated under nitrogen"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0028158:Nitrogen [Element, Ion, or Isotope]
   790   C1550581:nitrogen [Human-caused Phenomenon or Process]

Phrase: "in a 45 C water bath,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   812   C0043047:Water [Inorganic Chemical,Pharmacologic Substance]
   812   C0150141:Bath [Therapeutic or Preventive Procedure]
   812   C0599638:WATER [Substance]
   812   C1550678:Water [Inorganic Chemical]
   741 E C0443350:Watery [Qualitative Concept]

Phrase: "and"

Phrase: "the dried residue"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C1709915:Residue [Conceptual Entity]
   861   C1882936:RESIDUE [Phenomenon or Process]
   789 E C1609982:Residual [Qualitative Concept]

Phrase: "was"

Phrase: "redissolved in 50 l sodium bicarbonate buffer"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   778   C0074722:Sodium Bicarbonate [Organic Chemical,Pharmacologic Substance]
   748   C0005367:Bicarbonate [Inorganic Chemical,Pharmacologic Substance]
   748   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   748   C0037473:Sodium [Biologically Active Substance,Element, Ion, or Isotope]
   748   C0597484:Sodium+ [Element, Ion, or Isotope,Pharmacologic Substance]
   748   C0973231:Bicarbonate [Inorganic Chemical]
   748   C2722820:BICARBONATE [Organic Chemical,Pharmacologic Substance]

Phrase: "[100 mmol/liter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0475211:liter [Quantitative Concept]

Phrase: "(pH 10.5"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: ")"

Phrase: "]."
Processing 00000000.tx.70: To derivatize the samples, we then added an equal volume of 1 mg/ml dansyl-chloride in acetone and vortexed each sample for 1 min, followed by incubation in a heating block at 60 C for 3 min. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "derivatize"

Phrase: "the samples,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0370003:Sample [Substance]
   966   C2347026:Sample [Conceptual Entity]

Phrase: "we then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "added"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1524062:Added [Functional Concept]
   966 E C1883712:Add [Functional Concept]

Phrase: "an equal volume of 1 mg/ml dansyl-chloride"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   742   C0449468:*Volume [Quantitative Concept]
   742   C1690016:% volume [Qualitative Concept]
   742   C1705102:Volume [Intellectual Product]
   742   C2700258:Volume [Laboratory Procedure]

Phrase: "in acetone"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001002:Acetone [Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "vortexed"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0439648:vortexed [Spatial Concept]
  1000   C0724378:vortexed [Organic Chemical,Pharmacologic Substance]
   966 E C2719416:Vortex [Pharmacologic Substance]

Phrase: "each sample for 1 min,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0370003:Sample [Substance]
   760   C2347026:Sample [Conceptual Entity]

Phrase: "followed by incubation"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   882   C0332283:Followed by [Temporal Concept]
           followed
   756 E C1719822:Follow [Intellectual Product]

Phrase: "in a heating block"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0181153:BLOCK, HEATING [Medical Device]
   861   C0028778:Block [Pathologic Function]
   861   C0332206:Block [Functional Concept]
   861   C1533157:Block [Substance]
   861   C1706084:Block [Geographic Area]
   861   C2828370:Block [Quantitative Concept]
   789 E C2983591:BLOCKED [Research Activity]

Phrase: "at 60 C"

Phrase: "for 3 min."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]
Processing 00000000.tx.71: Immediately thereafter, the samples were transferred to autosampler glass vials, sealed, and assayed. 

Phrase: "Immediately thereafter,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205548:Immediately [Temporal Concept]

Phrase: "the samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0370003:Sample [Substance]
   966   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "transferred to autosampler glass vials,"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   790   C1708244:Glass Vial [Manufactured Object]
   760   C0017596:Glass [Manufactured Object]
   760   C0184301:vials [Medical Device]
   760   C0348011:transferred [Functional Concept]
   760   C1533199:Vials [Quantitative Concept]
   760   C1947936:Glass [Medical Device]
   726 E C0040671:Transfer [Mental Process]
   726 E C1705822:Transfer [Activity]
   726 E C1706497:VIAL [Medical Device]

Phrase: "sealed"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0036492:Seal [Mammal]
   966   C0325125:seal [Mammal]
   966   C1704637:Seal [Manufactured Object]

Phrase: ","

Phrase: "and"

Phrase: "assayed."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0005507:Assay [Laboratory Procedure]
   966   C0243073:assay [Qualitative Concept]
   966   C1510438:Assay [Laboratory Procedure]
Processing 00000000.tx.72: After dansyl chloride derivatization, samples were separated by fast-gradient chromatography, injected into a tandem mass spectrometer, and ionized by atmospheric pressure chemical ionization. 

Phrase: "After dansyl chloride derivatization,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C0057107:dansyl chloride [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0370003:Sample [Substance]
   966   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "separated by fast-gradient chromatography,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   760   C0008550:Chromatography [Laboratory Procedure]
   760   C0015663:Fast [Finding]
   760   C0086972:Separated [Finding]
   760   C0439182:% gradient [Quantitative Concept]
   760   C0443299:separated [Spatial Concept]
   760   C0456962:Fast [Qualitative Concept]
   760   C0687118:Separated [Functional Concept]
   760   C0812409:Gradient [Quantitative Concept]

Phrase: "injected into a tandem mass spectrometer,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   790   C0183396:Mass Spectrometer [Medical Device]
   753   C0075804:TANDEM [Organic Chemical,Pharmacologic Substance]
   753   C0183395:Spectrometer [Medical Device]
   753   C0577559:Mass [Finding]
   753   C1306372:*Mass [Quantitative Concept]
   753   C1710143:Spectrometer [Manufactured Object]
   753   C3152252:Mass [Quantitative Concept]
   719   C1720154:Inject [Functional Concept]

Phrase: "and"

Phrase: "ionized by atmospheric pressure chemical ionization."
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   790   C0004180:Atmospheric Pressure [Natural Phenomenon or Process]
   790   C0595910:Atmospheric pressure [Clinical Attribute]
   790   C0802868:Atmospheric pressure [Finding]
   753   C0033095:Pressure [Phenomenon or Process]
   753   C0220806:Chemical [Chemical]
   753   C0460139:Pressure [Finding]
   753   C0596801:Ionization [Phenomenon or Process]
   753   C1306345:Pressure [Functional Concept]
   753   C1979910:Ionized [Qualitative Concept]
   753   C3272558:Chemical [Intellectual Product]
Processing 00000000.tx.73: The dansyl derivatives of 17-estradiol, 17-estradiol, and E1 were monitored, using transitions of m/z 506171 and m/z 504171 and quantified using deuterium-labeled 17-estradiol and E1 internal standards (Fig. 2). 

Phrase: "The dansyl derivatives of 17-estradiol,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C0243072:derivatives [Chemical Viewed Structurally]
   719 E C1527240:Derivative [Functional Concept]

Phrase: "17-estradiol,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0014912:Estradiol [Hormone,Pharmacologic Substance,Steroid]
   805 E C0699352:Estrace [Hormone,Pharmacologic Substance,Steroid]
   805 E C0878472:Progynon [Hormone,Pharmacologic Substance,Steroid]

Phrase: "and"

Phrase: "E1"

Phrase: "were"

Phrase: "monitored"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   966   C0030695:monitor [Health Care Activity]
   966   C0150369:monitor [Health Care Activity]
   966   C0181904:Monitor [Medical Device]
   966   C0596972:Monitor [Medical Device]
   966   C1521743:Monitor [Professional or Occupational Group]
   966   C1704646:Monitor [Manufactured Object]

Phrase: ","

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "transitions of"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   799   C0599156:Transition [Cell or Molecular Dysfunction]
   799   C2700061:Transition [Activity]
   750 E C1182674:Transitional [Spatial Concept]
   750 E C1548597:Transitional [Idea or Concept]

Phrase: "m/"

Phrase: "z 506171"

Phrase: "and"

Phrase: "m/"

Phrase: "z 504171"

Phrase: "and"

Phrase: "quantified"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "deuterium-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0011744:Deuterium [Element, Ion, or Isotope]

Phrase: "labeled"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C1708632:Labeled [Qualitative Concept]
   966 E C0181496:Label [Manufactured Object]
   966 E C2827499:Label [Governmental or Regulatory Activity]

Phrase: "17-estradiol"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0014912:Estradiol [Hormone,Pharmacologic Substance,Steroid]
   805 E C0699352:Estrace [Hormone,Pharmacologic Substance,Steroid]
   805 E C0878472:Progynon [Hormone,Pharmacologic Substance,Steroid]

Phrase: "and"

Phrase: "E1 internal standards"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   827   C0038137:standards [Intellectual Product]
   827   C0175675:Standards [Qualitative Concept]
   827   C0205102:Internal [Spatial Concept]
   827   C1553872:Internal [Intellectual Product]
   827   C1619620:Internal [Intellectual Product]
   793 E C1442989:Standard [Qualitative Concept]
   793 E C2828392:Standard [Intellectual Product]

Phrase: "(Fig. 2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.74: The total run time per sample was 5 min. 

Phrase: "The total run time per sample"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0035953:run [Daily or Recreational Activity]
   753   C0040223:Time [Temporal Concept]
   753   C0600140:run [Finding]
   753   C1704688:Run [Functional Concept]
   753   C2346414:Run [Finding]
   753   C3541383:Time [Temporal Concept]

Phrase: "was"

Phrase: "5 min."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]
Processing 00000000.tx.75: The multiple-reaction monitoring ion pairs were m/z 506/171 for 3-dansyl-estradiol and m/z 504/171 for 3-dansyl-estrone. 

Phrase: "The multiple-reaction monitoring ion pairs"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0022023:Ion [Element, Ion, or Isotope]
   804   C1700702:ION [Functional Concept]
   804   C1709450:Pair [Qualitative Concept]

Phrase: "were"

Phrase: "m/"

Phrase: "z 506/171 for 3-dansyl-estradiol"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0014912:Estradiol [Hormone,Pharmacologic Substance,Steroid]
   748   C1566145:DANSYL [Organic Chemical]

Phrase: "and"

Phrase: "m/"

Phrase: "z 504/171 for 3-dansyl-estrone."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0620226:estrone-3-dansyl [Pharmacologic Substance,Steroid]
   748   C0014942:Estrone [Hormone,Pharmacologic Substance,Steroid]
   748   C1566145:DANSYL [Organic Chemical]
Processing 00000000.tx.76: The limits of detection of E1 and E2 by LC-MS/MS assay were 12.9 pmol/liter (3.5 pg/ml) and 23.2 pmol/liter (6.3 pg/ml), respectively. 

Phrase: "The limits of detection of E1"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   833   C2718050:Limits of Detection [Quantitative Concept]
           Detection Limits
   753   C0439801:limits [Functional Concept]
   719 E C1549649:Limit [Idea or Concept]
   719 E C2349209:Limit [Conceptual Entity]

Phrase: "and"

Phrase: "E2 by LC-MS/MS assay"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C3539520:E2 [Gene or Genome]

Phrase: "were"

Phrase: "12.9 pmol/liter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0475211:liter [Quantitative Concept]

Phrase: "(3.5 pg/ml)"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439297:pg/mL [Quantitative Concept]
   812   C0439526:/mL [Quantitative Concept]

Phrase: "and"

Phrase: "23.2 pmol/liter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0475211:liter [Quantitative Concept]

Phrase: "(6.3 pg/ml"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439297:pg/mL [Quantitative Concept]
   812   C0439526:/mL [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "respectively."
Processing 00000000.tx.77: The limits of quantification (functional sensitivity) for E1 and E2 were 44.1 pmol/liter (11.9 pg/ml) and 10.3 pmol/liter (2.8 pg/ml), respectively. 

Phrase: "The limits of quantification"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   770   C0439801:limits [Functional Concept]
   737 E C1549649:Limit [Idea or Concept]
   737 E C2349209:Limit [Conceptual Entity]

Phrase: "(functional sensitivity"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   861   C0036667:Sensitivity [Quantitative Concept]
   861   C0312418:Sensitivity [Mental Process]
   861   C0427965:Sensitivity [Finding]
   861   C1511883:Sensitivity [Quantitative Concept]
   861   C1522640:Sensitivity [Qualitative Concept]
   861   C2346484:SENSITIVITY [Phenomenon or Process]
   861   C2349185:Sensitivity [Qualitative Concept]
   789 E C0332324:Sensitive [Functional Concept]
   789 E C1550474:sensitive [Idea or Concept]

Phrase: ")"

Phrase: "for E1"

Phrase: "and"

Phrase: "E2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3539520:E2 [Gene or Genome]

Phrase: "were"

Phrase: "44.1 pmol/liter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0475211:liter [Quantitative Concept]

Phrase: "(11.9 pg/ml)"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439297:pg/mL [Quantitative Concept]
   812   C0439526:/mL [Quantitative Concept]

Phrase: "and"

Phrase: "10.3 pmol/liter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0475211:liter [Quantitative Concept]

Phrase: "(2.8 pg/ml"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439297:pg/mL [Quantitative Concept]
   812   C0439526:/mL [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "respectively."
Processing 00000000.tx.78: The assay was linear to 2200 pmol/liter (600 pg/ml) for either analyte. 

Phrase: "The assay"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0005507:Assay [Laboratory Procedure]
  1000   C0243073:assay [Qualitative Concept]
  1000   C1510438:Assay [Laboratory Procedure]

Phrase: "was"

Phrase: "linear to 2200 pmol/liter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0205132:Linear [Spatial Concept]

Phrase: "(600 pg/ml) for either analyte."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0439297:pg/mL [Quantitative Concept]
   753   C0439526:/mL [Quantitative Concept]
Processing 00000000.tx.79: Recoveries were 93108% for E1 and 100110% for E2. 

Phrase: "Recoveries"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0237820:recoveries [Activity]
   966 E C1555688:recovery [Idea or Concept]
   966 E C2004454:Recovery [Organism Function]

Phrase: "were"

Phrase: "93108% for E1"

Phrase: "and"

Phrase: "100110% for E2."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C3539520:E2 [Gene or Genome]
Processing 00000000.tx.80: No cross-reactivity was observed. 

Phrase: "No cross-reactivity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0010357:Cross Reactivity [Molecular Function]
  1000   C0872139:cross reactivity [Molecular Function]
  1000   C1880190:CROSS REACTIVITY [Event]
   861   C2828360:Cross [Conceptual Entity]
   789   C0205332:Reactive [Qualitative Concept]

Phrase: "was"

Phrase: "observed."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]
Processing 00000000.tx.81: Method comparison with several different immunoassays revealed that the latter were inaccurate and prone to interferences at low E1 and E2 analyte levels. 

Phrase: "Method comparison with several different immunoassays"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1707455:Comparison [Activity]

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "that"

Phrase: "the latter"

Phrase: "were"

Phrase: "inaccurate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443236:Inaccurate [Qualitative Concept]

Phrase: "and"

Phrase: "prone to interferences"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0033422:Prone [Spatial Concept]

Phrase: "at low E1"

Phrase: "and"

Phrase: "E2 analyte levels."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   827   C0441889:Levels [Qualitative Concept]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.82: The E2 levels were measured, using the calibration curves for all three estrogens, and are presented as picogram per milligram protein in the tissue lysates (Tables 1 and 2). 

Phrase: "The E2 levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0441889:Levels [Qualitative Concept]
   827 E C0456079:Level [Classification]
   827 E C1547707:Level [Geographic Area]
   827 E C2946261:Level [Pharmacologic Substance]

Phrase: "were"

Phrase: "measured"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0444706:Measured [Qualitative Concept]
  1000   C3541902:MEASURED [Diagnostic Procedure]
   966 E C0079809:Measure [Quantitative Concept]
   966 E C0242485:Measure [Functional Concept]

Phrase: ","

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the calibration"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006751:Calibration [Quantitative Concept]

Phrase: "curves for all three estrogens,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   760   C0014939:Estrogens [Hormone,Pharmacologic Substance,Steroid]
   760   C0205134:Curve [Spatial Concept]
   760   C0205449:Three [Quantitative Concept]
   726 E C2936882:Estrogen [Pharmacologic Substance]

Phrase: "and"

Phrase: "are"

Phrase: "presented as picogram"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0439213:picogram [Quantitative Concept]
   790   C0449450:Presented [Idea or Concept]
   756 E C0150312:Present [Quantitative Concept]

Phrase: "per milligram protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "in the tissue lysates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1881488:Lysate [Physical Object]

Phrase: "(Tables 1"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0039224:tables [Manufactured Object]
   861   C1706074:Tables [Intellectual Product]
   827 E C1706073:Table [Medical Device]

Phrase: "and"

Phrase: "2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ")."
Processing 00000000.tx.83: To check for the specificity of 17-estradiol, 17-estradiol, and E1, mouse serum and brain lysates were spiked with known amounts of the three estrogens, and the recovery of all three estrogens was linear (data not shown). 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "check for the specificity of 17-estradiol,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0014912:Estradiol [Hormone,Pharmacologic Substance,Steroid]
   748   C0037791:Specificity [Quantitative Concept]
   748   C1283174:Check [Activity]
   748   C1511884:Specificity [Quantitative Concept]

Phrase: "17-estradiol,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0014912:Estradiol [Hormone,Pharmacologic Substance,Steroid]
   805 E C0699352:Estrace [Hormone,Pharmacologic Substance,Steroid]
   805 E C0878472:Progynon [Hormone,Pharmacologic Substance,Steroid]

Phrase: "and"

Phrase: "E1,"

Phrase: "mouse serum"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0229671:Serum [Body Substance]
   861   C1546774:Serum [Intellectual Product]
   861   C1550100:Serum [Body Substance]

Phrase: "and"

Phrase: "brain lysates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1881488:Lysate [Physical Object]

Phrase: "were"

Phrase: "spiked with known amounts of the three estrogens,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   744   C0014939:Estrogens [Hormone,Pharmacologic Substance,Steroid]
   744   C0205309:Known [Qualitative Concept]
   744   C0205449:Three [Quantitative Concept]
   744   C1265611:amounts [Quantitative Concept]
   711 E C2936882:Estrogen [Pharmacologic Substance]

Phrase: "and"

Phrase: "the recovery of all three estrogens"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0237820:Recovery [Activity]
   753   C1555688:recovery [Idea or Concept]
   753   C2004454:Recovery [Organism Function]

Phrase: "was"

Phrase: "linear"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205132:Linear [Spatial Concept]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.84: To further confirm the specificity of the method, the brain lysates were diluted 1.5 times and 3.0 times with the lysis buffer, and these were measured for 17-estradiol, 17-estradiol, and E1, as above. 

Phrase: "To further"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C1517331:Further [Spatial Concept]
   861   C1883351:To [Qualitative Concept]
   827 E C0205108:far [Spatial Concept]

Phrase: "confirm"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0521093:confirm [Qualitative Concept]
  1000   C0750484:confirm [Idea or Concept]
  1000   C1456348:Confirm [Qualitative Concept]

Phrase: "the specificity of the method,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0037791:Specificity [Quantitative Concept]
   760   C1511884:Specificity [Quantitative Concept]

Phrase: "the brain lysates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1881488:Lysate [Physical Object]

Phrase: "were"

Phrase: "diluted"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1720119:Dilute [Functional Concept]
   966   C1948037:Dilute [Functional Concept]

Phrase: "1.5 times"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   827   C0040223:times [Temporal Concept]
   827   C1632851:Times [Quantitative Concept]
   793 E C3541383:Time [Temporal Concept]
   755 E C0442043:Temporal [Spatial Concept]
   755 E C2362314:Temporal [Temporal Concept]
   734   C0450316:1/5 [Quantitative Concept]

Phrase: "and"

Phrase: "3.0 times with the lysis buffer,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   748   C0040223:times [Temporal Concept]
   748   C1632851:Times [Quantitative Concept]
   714 E C3541383:Time [Temporal Concept]

Phrase: "and"

Phrase: "these"

Phrase: "were"

Phrase: "measured for 17-estradiol,"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   770   C0014912:Estradiol [Hormone,Pharmacologic Substance,Steroid]
   770   C0444706:Measured [Qualitative Concept]
   770   C3541902:MEASURED [Diagnostic Procedure]
   737 E C0079809:Measure [Quantitative Concept]
   737 E C0242485:Measure [Functional Concept]
   715 E C0699352:Estrace [Hormone,Pharmacologic Substance,Steroid]
   715 E C0878472:Progynon [Hormone,Pharmacologic Substance,Steroid]

Phrase: "17-estradiol,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0014912:Estradiol [Hormone,Pharmacologic Substance,Steroid]
   805 E C0699352:Estrace [Hormone,Pharmacologic Substance,Steroid]
   805 E C0878472:Progynon [Hormone,Pharmacologic Substance,Steroid]

Phrase: "and"

Phrase: "E1,"

Phrase: "as"

Phrase: "above."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1282910:Above [Spatial Concept]
  1000   C1552828:above [Idea or Concept]
Processing 00000000.tx.85: Estrogen extractions in these experiments was also linear, as exemplified in Fig. 

Phrase: "Estrogen extractions in these experiments"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0185115:extractions [Therapeutic or Preventive Procedure]
   726 E C0684295:extraction [Laboratory Procedure]

Phrase: "was"

Phrase: "also linear,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205132:Linear [Spatial Concept]

Phrase: "as"

Phrase: "exemplified in Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
Processing 00000000.tx.86: 3. 

Phrase: "3."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]
Processing 00000000.tx.87: View larger version (14K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(14K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.88: 2. 

Phrase: "2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]
Processing 00000000.tx.89: LC-MS/MS profiles for adult mouse ovarian (A) and hippocampal (B) tissue lysates. 

Phrase: "LC-MS/MS profiles for adult mouse"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   708   C1979963:Profile [Laboratory Procedure]
   708   C2003903:Profile [Functional Concept]

Phrase: "ovarian"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205065:Ovarian [Body Part, Organ, or Organ Component]

Phrase: "(A)"

Phrase: "and"

Phrase: "hippocampal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0019564:Hippocampal [Body Part, Organ, or Organ Component]

Phrase: "(B) tissue lysates."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1881488:Lysate [Physical Object]
Processing 00000000.tx.90: LC-MS/MS extracted ion chromatograms of 17-estradiol (17-E2) and 17-estradiol (17-E2) and E1. 

Phrase: "LC-MS/MS"
Meta Candidates (Total=16; Excluded=1; Pruned=0; Remaining=15)
   924   C0872318:Liquid Chromatography Mass Spectrometry [Laboratory Procedure]
   884   C0599748:Tandem Mass Spectrometry [Molecular Biology Research Technique]
   853   C2945612:chromatography mass [Laboratory Procedure]
   840   C0008565:Liquid Chromatography [Laboratory Procedure]
   840   C0037813:Mass Spectrometry [Laboratory Procedure]
   804   C0008550:Chromatography [Laboratory Procedure]
   804   C0075804:TANDEM [Organic Chemical,Pharmacologic Substance]
   804   C0302908:Liquid [Substance]
   804   C0436196:Spectrometry [Laboratory Procedure]
   804   C0577559:Mass [Finding]
   804   C1304698:Liquid [Finding]
   804   C1306372:*Mass [Quantitative Concept]
   804   C1546699:Liquid NOS [Intellectual Product]
   804   C1561501:Liquid NOS [Substance]
   804   C3152252:Mass [Quantitative Concept]
   704 E C0302647:chromatograph [Medical Device]

Phrase: "extracted"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0185115:Extracted [Therapeutic or Preventive Procedure]
  1000   C3541890:EXTRACTED [Finding]
   966 E C2828366:Extract [Substance]

Phrase: "ion chromatograms of 17-estradiol (17-E2)"

Phrase: "and"

Phrase: "17-estradiol"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0014912:Estradiol [Hormone,Pharmacologic Substance,Steroid]
   805 E C0699352:Estrace [Hormone,Pharmacologic Substance,Steroid]
   805 E C0878472:Progynon [Hormone,Pharmacologic Substance,Steroid]

Phrase: "(17-E2"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0014912:Estradiol [Hormone,Pharmacologic Substance,Steroid]
   805 E C0699352:Estrace [Hormone,Pharmacologic Substance,Steroid]
   805 E C0878472:Progynon [Hormone,Pharmacologic Substance,Steroid]

Phrase: ")"

Phrase: "and"

Phrase: "E1."
Processing 00000000.tx.91: The extracted samples were injected, using LC-MS/MS conditions described in Materials and Methods (15 ).  

Phrase: "The extracted samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0370003:Sample [Substance]
   827   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "injected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1720154:Inject [Functional Concept]

Phrase: ","

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "LC-MS/MS conditions"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   766   C0012634:condition [Disease or Syndrome]
   766   C0348080:Condition [Qualitative Concept]
   766   C1705253:Condition [Conceptual Entity]
   728   C0872318:Liquid Chromatography Mass Spectrometry [Laboratory Procedure]
   716 E C0009647:Conditioned [Mental Process]
   716 E C1701901:Conditional [Qualitative Concept]
   716 E C1963686:Conditional [Functional Concept]

Phrase: "described in Materials"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0520510:Materials [Substance]
   790   C1552738:described [Idea or Concept]

Phrase: "and"

Phrase: "Methods"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: "(15"

Phrase: ")."
Processing 00000000.tx.92: View this table: [in this window] [in a new window]  TABLE 1. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  TABLE 1."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]
Processing 00000000.tx.93: 17-Estradiol, 17-estradiol, and estrone levels in mouse tissue lysates (pg/mg protein) and serum (pg/ml)  View this table: [in this window] [in a new window]  TABLE 2. 

Phrase: "17-Estradiol,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0014912:Estradiol [Hormone,Pharmacologic Substance,Steroid]
   805 E C0699352:Estrace [Hormone,Pharmacologic Substance,Steroid]
   805 E C0878472:Progynon [Hormone,Pharmacologic Substance,Steroid]

Phrase: "17-estradiol,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0014912:Estradiol [Hormone,Pharmacologic Substance,Steroid]
   805 E C0699352:Estrace [Hormone,Pharmacologic Substance,Steroid]
   805 E C0878472:Progynon [Hormone,Pharmacologic Substance,Steroid]

Phrase: "and"

Phrase: "estrone levels in mouse tissue lysates"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   753   C0441889:Levels [Qualitative Concept]
   719 E C0456079:Level [Classification]
   719 E C1547707:Level [Geographic Area]
   719 E C2946261:Level [Pharmacologic Substance]

Phrase: "(pg/mg protein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C1627892:pg/mg [Quantitative Concept]

Phrase: ")"

Phrase: "and"

Phrase: "serum"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0229671:Serum [Body Substance]
  1000   C1546774:Serum [Intellectual Product]
  1000   C1550100:Serum [Body Substance]

Phrase: "(pg/ml)"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439297:pg/mL [Quantitative Concept]
   861   C0439526:/mL [Quantitative Concept]

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  TABLE 2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]
Processing 00000000.tx.94: 17-Estradiol, 17-estradiol, and estrone levels in gonadectomized and gonadectomized/adrenalectomized mouse tissue lysates (pg/mg protein)  View larger version (9K): [in this window] [in a new window]  FIG. 

Phrase: "17-Estradiol,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0014912:Estradiol [Hormone,Pharmacologic Substance,Steroid]
   805 E C0699352:Estrace [Hormone,Pharmacologic Substance,Steroid]
   805 E C0878472:Progynon [Hormone,Pharmacologic Substance,Steroid]

Phrase: "17-estradiol,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0014912:Estradiol [Hormone,Pharmacologic Substance,Steroid]
   805 E C0699352:Estrace [Hormone,Pharmacologic Substance,Steroid]
   805 E C0878472:Progynon [Hormone,Pharmacologic Substance,Steroid]

Phrase: "and"

Phrase: "estrone levels in gonadectomized"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   770   C0441889:Levels [Qualitative Concept]
   737 E C0456079:Level [Classification]
   737 E C1547707:Level [Geographic Area]
   737 E C2946261:Level [Pharmacologic Substance]

Phrase: "and"

Phrase: "gonadectomized"

Phrase: "/adrenalectomized mouse tissue lysates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   779   C1881488:Lysate [Physical Object]

Phrase: "(pg/mg protein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C1627892:pg/mg [Quantitative Concept]

Phrase: ")"

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(9K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.95: 3. 

Phrase: "3."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]
Processing 00000000.tx.96: Specificity test for 17-estradiol. 

Phrase: "Specificity test for 17-estradiol."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   797   C0337434:estradiol test [Laboratory Procedure]
   760   C0022885:Test [Laboratory Procedure]
   760   C0039593:Test [Functional Concept]
   760   C0392366:test [Intellectual Product]
Processing 00000000.tx.97: The P7 neocortical lysate was diluted 1.5 and 3.0 times, and the 17-estradiol was measured by LC-MS/MS to check the linearity of estrogen extraction.  

Phrase: "The P7 neocortical lysate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1881488:Lysate [Physical Object]

Phrase: "was"

Phrase: "diluted"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1720119:Dilute [Functional Concept]
   966   C1948037:Dilute [Functional Concept]

Phrase: "1.5"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0450316:1/5 [Quantitative Concept]
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: "and"

Phrase: "3.0 times,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0040223:times [Temporal Concept]
   827   C1632851:Times [Quantitative Concept]
   793 E C3541383:Time [Temporal Concept]
   755 E C0442043:Temporal [Spatial Concept]
   755 E C2362314:Temporal [Temporal Concept]

Phrase: "and"

Phrase: "the 17-estradiol"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0014912:Estradiol [Hormone,Pharmacologic Substance,Steroid]
   805 E C0699352:Estrace [Hormone,Pharmacologic Substance,Steroid]
   805 E C0878472:Progynon [Hormone,Pharmacologic Substance,Steroid]

Phrase: "was"

Phrase: "measured by LC-MS/MS to"
Meta Candidates (Total=20; Excluded=2; Pruned=0; Remaining=18)
   819   C0872318:Liquid Chromatography Mass Spectrometry [Laboratory Procedure]
   800   C0599748:Tandem Mass Spectrometry [Molecular Biology Research Technique]
   770   C0008565:Liquid Chromatography [Laboratory Procedure]
   770   C0037813:Mass Spectrometry [Laboratory Procedure]
   767   C0449768:Measured to [Quantitative Concept]
   767   C2945612:chromatography mass [Laboratory Procedure]
   744   C0008550:Chromatography [Laboratory Procedure]
   744   C0075804:TANDEM [Organic Chemical,Pharmacologic Substance]
   744   C0302908:Liquid [Substance]
   744   C0436196:Spectrometry [Laboratory Procedure]
   744   C0444706:Measured [Qualitative Concept]
   744   C0577559:Mass [Finding]
   744   C1304698:Liquid [Finding]
   744   C1306372:*Mass [Quantitative Concept]
   744   C1546699:Liquid NOS [Intellectual Product]
   744   C1561501:Liquid NOS [Substance]
   744   C3152252:Mass [Quantitative Concept]
   744   C3541902:MEASURED [Diagnostic Procedure]
   711 E C0079809:Measure [Quantitative Concept]
   711 E C0242485:Measure [Functional Concept]

Phrase: "check"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1283174:Check [Activity]

Phrase: "the linearity of estrogen extraction."
Processing 00000000.tx.98: To determine cross reactivity and interferences, we added various amounts of E1, 17-estradiol, 17-estradiol, estriol, ethynylestradiol, and E1-sulfate to a sample pool with previously measured E1 and E2 levels. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "cross reactivity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0010357:Cross Reactivity [Molecular Function]
  1000   C0872139:cross reactivity [Molecular Function]
  1000   C1880190:CROSS REACTIVITY [Event]
   861   C2828360:Cross [Conceptual Entity]
   789   C0205332:Reactive [Qualitative Concept]

Phrase: "and"

Phrase: "interferences,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0521102:Interference [Qualitative Concept]

Phrase: "we"

Phrase: "added"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1524062:Added [Functional Concept]
   966 E C1883712:Add [Functional Concept]

Phrase: "various amounts of E1,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1265611:amounts [Quantitative Concept]

Phrase: "17-estradiol,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0014912:Estradiol [Hormone,Pharmacologic Substance,Steroid]
   805 E C0699352:Estrace [Hormone,Pharmacologic Substance,Steroid]
   805 E C0878472:Progynon [Hormone,Pharmacologic Substance,Steroid]

Phrase: "17-estradiol,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0014912:Estradiol [Hormone,Pharmacologic Substance,Steroid]
   805 E C0699352:Estrace [Hormone,Pharmacologic Substance,Steroid]
   805 E C0878472:Progynon [Hormone,Pharmacologic Substance,Steroid]

Phrase: "estriol,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0014927:Estriol [Hormone,Pharmacologic Substance,Steroid]

Phrase: "ethynylestradiol,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015011:Ethynyl Estradiol [Hormone,Pharmacologic Substance,Steroid]

Phrase: "and"

Phrase: "E1-sulfate to a sample pool"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0038720:Sulfate [Inorganic Chemical]
   753   C0475337:sulfate [Element, Ion, or Isotope,Inorganic Chemical]
   753   C3536965:SULFATE [Element, Ion, or Isotope]

Phrase: "with previously measured E1"

Phrase: "and"

Phrase: "E2 levels."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0441889:Levels [Qualitative Concept]
   827 E C0456079:Level [Classification]
   827 E C1547707:Level [Geographic Area]
   827 E C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.99: More than 100 random samples from patients, as opposed to normal volunteers, were also assayed to detect potential drug or disease-related interferences (data not shown). 

Phrase: "More than 100 random samples"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   773   C0150105:random sample [Research Activity]
   760   C0034656:RANDOM [Research Activity]
   760   C0205172:More [Functional Concept]
   760   C0439605:Random [Qualitative Concept]
   726   C0370003:Sample [Substance]
   726   C2347026:Sample [Conceptual Entity]

Phrase: "from patients,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:Patients [Patient or Disabled Group]

Phrase: "as"

Phrase: "opposed to normal volunteers,"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   833   C3661466:Normal Volunteers [Population Group]
   770   C0042960:Volunteers [Professional or Occupational Group]
   770   C0205307:Normal [Qualitative Concept]
   770   C0439166:% normal [Quantitative Concept]
   770   C2347086:% Normal [Quantitative Concept]
   737 E C1549078:Volunteer [Idea or Concept]
   737 E C1997894:volunteer [Population Group]

Phrase: "were"

Phrase: "also"

Phrase: "assayed"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0005507:Assay [Laboratory Procedure]
   966   C0243073:assay [Qualitative Concept]
   966   C1510438:Assay [Laboratory Procedure]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "detect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442726:detect [Finding]

Phrase: "potential drug"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0013227:Drug [Pharmacologic Substance]
   861   C1254351:Drug [Pharmacologic Substance]
   805 E C0031336:Pharmaceutical [Biomedical Occupation or Discipline]
   805 E C1135440:pharmaceutical [Therapeutic or Preventive Procedure]
   768 E C0456386:Medicament [Pharmacologic Substance]

Phrase: "or"

Phrase: "disease-related interferences"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C0521102:Interference [Qualitative Concept]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.100: Binding assays Recombinant ER and ER were obtained from Panvera-Invitrogen (Carlsbad, CA) and were diluted to 2 nM in the manufacturers recommended assay buffer [10 mM Tris (pH 7.4), containing 1 mM dithiothreitol, 10% glycerol, and 1 mg/ml BSA]. 

Phrase: "Binding assays Recombinant ER"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   840   C0034804:Estrogen receptor [Amino Acid, Peptide, or Protein,Receptor]
   840   C1414461:ESTROGEN RECEPTOR [Gene or Genome]
   840   C1521863:Estrogen Receptor [Amino Acid, Peptide, or Protein,Receptor]
   804   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
   804   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   804   C2936882:Estrogen [Pharmacologic Substance]
   733 E C0720298:Estrogenic [Hormone,Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "ER"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0034804:Estrogen receptor [Amino Acid, Peptide, or Protein,Receptor]
  1000   C1414461:ESTROGEN RECEPTOR [Gene or Genome]
  1000   C1521863:Estrogen Receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
   861   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C2936882:Estrogen [Pharmacologic Substance]
   789 E C0720298:Estrogenic [Hormone,Organic Chemical,Pharmacologic Substance]

Phrase: "were"

Phrase: "obtained from Panvera-Invitrogen"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C1301820:Obtained [Functional Concept]
   737 E C1706701:Obtain [Activity]

Phrase: "(Carlsbad,"

Phrase: "CA)"

Phrase: "and"

Phrase: "were"

Phrase: "diluted to 2 nM"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0312860:NM [Cell Function]
   737   C1720119:Dilute [Functional Concept]
   737   C1948037:Dilute [Functional Concept]

Phrase: "in the manufacturers"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0947322:Manufacturer [Intellectual Product]
   966   C1705426:Manufacturer [Population Group]

Phrase: "recommended"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034866:Recommended [Idea or Concept]

Phrase: "assay buffer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "[10 mM Tris"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0041175:TRIS [Organic Chemical,Pharmacologic Substance]
   827   C0077281:Tris [Hazardous or Poisonous Substance,Organophosphorus Compound]
   827   C0814229:TRI [Intellectual Product]

Phrase: "(pH 7.4"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   913   C2678549:PH-4 [Gene or Genome]
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: ")"

Phrase: ","

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "1 mM dithiothreitol,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0012789:Dithiothreitol [Carbohydrate,Pharmacologic Substance]

Phrase: "10% glycerol,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017861:Glycerol [Biologically Active Substance,Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "1 mg/ml BSA"

Phrase: "]."
Processing 00000000.tx.101: Adult rat or mouse uterus was homogenized in Tris buffer [10 mM Tris, 10% glycerol, 2 mM dithiothreitol (pH 7.4)], and cytosol was obtained by centrifugation of the homogenate at 100,000 x g at 4 C. 

Phrase: "Adult rat"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0034693:Rat, NOS [Mammal]
   861   C0034721:Rat [Mammal]

Phrase: "or"

Phrase: "mouse uterus"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1519876:Mouse Uterus [Tissue]
   861   C0042149:Uterus [Body Part, Organ, or Organ Component]
   861   C1269032:Uterus [Body Part, Organ, or Organ Component]

Phrase: "was"

Phrase: "homogenized in Tris buffer [10 mM Tris,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   778   C0041175:Tris Buffer [Organic Chemical,Pharmacologic Substance]
           TRIS
   748   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   748   C0077281:Tris [Hazardous or Poisonous Substance,Organophosphorus Compound]
   748   C0814229:TRI [Intellectual Product]

Phrase: "10% glycerol,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017861:Glycerol [Biologically Active Substance,Organic Chemical,Pharmacologic Substance]

Phrase: "2 mM dithiothreitol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0012789:Dithiothreitol [Carbohydrate,Pharmacologic Substance]

Phrase: "(pH 7.4"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   913   C2678549:PH-4 [Gene or Genome]
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: ")"

Phrase: "],"

Phrase: "and"

Phrase: "cytosol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1383501:Cytosol [Cell Component]

Phrase: "was"

Phrase: "obtained by centrifugation of the homogenate"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   753   C0007703:Centrifugation [Laboratory Procedure]
   753   C1301820:Obtained [Functional Concept]
   719 E C1706701:Obtain [Activity]

Phrase: "at 100,000 x g"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0439267:g% [Quantitative Concept]

Phrase: "at 4 C."
Processing 00000000.tx.102: Recombinant ER or ER or 50 g of the uterine cytosol protein were incubated in a total volume of 0.1 ml for 16 h at +4 C with 0.25 nM-5 nM of [3H]17-estradiol or [3H]17-estradiol with (for nonspecific binding) or without (for total binding) 500-fold molar excess of the cold ligand. 

Phrase: "Recombinant ER"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   901   C0034804:Estrogen receptor [Amino Acid, Peptide, or Protein,Receptor]
   901   C1414461:ESTROGEN RECEPTOR [Gene or Genome]
   901   C1521863:Estrogen Receptor [Amino Acid, Peptide, or Protein,Receptor]
   827   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
   827   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   827   C2936882:Estrogen [Pharmacologic Substance]
   755 E C0720298:Estrogenic [Hormone,Organic Chemical,Pharmacologic Substance]

Phrase: "or"

Phrase: "ER"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0034804:Estrogen receptor [Amino Acid, Peptide, or Protein,Receptor]
  1000   C1414461:ESTROGEN RECEPTOR [Gene or Genome]
  1000   C1521863:Estrogen Receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
   861   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C2936882:Estrogen [Pharmacologic Substance]
   789 E C0720298:Estrogenic [Hormone,Organic Chemical,Pharmacologic Substance]

Phrase: "or"

Phrase: "50 g of the uterine cytosol protein"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   774   C0060916:protein g [Amino Acid, Peptide, or Protein]
   774   C0086376:G-Protein [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0439267:g% [Quantitative Concept]

Phrase: "were"

Phrase: "incubated in a total volume of 0.1 ml"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   764   C0449468:Total Volume [Quantitative Concept]
           *Volume
   742   C0439175:% total [Quantitative Concept]
   742   C0439526:/mL [Quantitative Concept]
   742   C0439810:Total [Qualitative Concept]
   742   C1439852:Incubated [Laboratory Procedure]
   742   C1690016:% volume [Qualitative Concept]
   742   C1705102:Volume [Intellectual Product]
   742   C2700258:Volume [Laboratory Procedure]

Phrase: "for 16 h at +4 C"

Phrase: "with 0.25 nM-5 nM of [3H"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C1442460:3H [Temporal Concept]

Phrase: "]17-estradiol or [3H"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1442460:3H [Temporal Concept]

Phrase: "]17-estradiol with"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   790   C0014912:Estradiol [Hormone,Pharmacologic Substance,Steroid]
   734 E C0699352:Estrace [Hormone,Pharmacologic Substance,Steroid]
   734 E C0878472:Progynon [Hormone,Pharmacologic Substance,Steroid]

Phrase: "("

Phrase: "for nonspecific binding"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0205370:Non-specific [Qualitative Concept]
   861   C0243122:binding [Functional Concept]
   861   C0750540:Nonspecific [Idea or Concept]
   861   C1145667:Binding [Activity]
   861   C1167622:Binding [Molecular Function]

Phrase: ")"

Phrase: "or without"

Phrase: "("

Phrase: "for total binding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0243122:binding [Functional Concept]
   861   C1145667:Binding [Activity]
   861   C1167622:Binding [Molecular Function]

Phrase: ")"

Phrase: "500-fold molar excess of the cold ligand."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1979886:Excess [Qualitative Concept]
Processing 00000000.tx.103: Unbound E2 was removed by the addition of 0.1 ml of ice-cold 1% dextran-coated charcoal (DCC) suspension in the assay buffer for 5 min. 

Phrase: "Unbound E2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3539520:E2 [Gene or Genome]

Phrase: "was"

Phrase: "removed by the addition of 0.1 ml"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   744   C0439526:/mL [Quantitative Concept]
   744   C0849355:Removed [Qualitative Concept]
   744   C1883712:Addition [Functional Concept]
   711 E C1883720:Remove [Activity]
   711 E C3244314:remove [Functional Concept]

Phrase: "of ice-cold 1% dextran-coated charcoal (DCC) suspension"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   795   C0038960:Suspension [Biomedical or Dental Material]
   795   C1382107:Suspension [Substance]
   795   C1705537:Suspension [Functional Concept]

Phrase: "in the assay buffer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "for 5 min."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]
Processing 00000000.tx.104: The charcoal was removed by centrifugation, and the supernatant was taken for liquid scintillation counting. 

Phrase: "The charcoal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0007955:Charcoal [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "was"

Phrase: "removed by centrifugation,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0007703:Centrifugation [Laboratory Procedure]
   790   C0849355:Removed [Qualitative Concept]
   756 E C1883720:Remove [Activity]
   756 E C3244314:remove [Functional Concept]

Phrase: "and"

Phrase: "the supernatant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1550101:Supernatant [Body Substance]

Phrase: "was"

Phrase: "taken for liquid scintillation counting."
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   806   C0036406:Scintillation Counting [Laboratory Procedure]
   760   C0302908:Liquid [Substance]
   760   C0678573:scintillation [Natural Phenomenon or Process]
   760   C1304698:Liquid [Finding]
   760   C1546699:Liquid NOS [Intellectual Product]
   760   C1561501:Liquid NOS [Substance]
   760   C1883727:Taken [Conceptual Entity]
   726   C0750480:Count [Activity]
   726 E C1515187:Take [Health Care Activity]
   726   C1705566:Count [Quantitative Concept]
Processing 00000000.tx.105: Specific binding was determined as the difference between total and nonspecific binding. 

Phrase: "Specific binding"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0205369:Specific [Qualitative Concept]
   861   C0243122:binding [Functional Concept]
   861   C1145667:Binding [Activity]
   861   C1167622:Binding [Molecular Function]
   861   C1552740:specific [Intellectual Product]

Phrase: "was"

Phrase: "determined as the difference"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1705241:*Difference [Quantitative Concept]
   770   C1705242:Difference [Qualitative Concept]

Phrase: "between total"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439175:% total [Quantitative Concept]
  1000   C0439810:Total [Qualitative Concept]

Phrase: "and"

Phrase: "nonspecific binding."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0205370:Non-specific [Qualitative Concept]
   861   C0243122:binding [Functional Concept]
   861   C0750540:Nonspecific [Idea or Concept]
   861   C1145667:Binding [Activity]
   861   C1167622:Binding [Molecular Function]
Processing 00000000.tx.106: The binding data were analyzed by Scatchard analysis. 

Phrase: "The binding data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1511726:Data [Idea or Concept]
   861   C3245479:data [Medical Device]

Phrase: "were"

Phrase: "analyzed by Scatchard analysis."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0002778:Analysis [Laboratory Procedure]
   770   C0936012:Analysis [Research Activity]
           Analyzed
   770   C1524024:analysis [Functional Concept]
Processing 00000000.tx.107: For displacement studies, the displacement of 2 nM of [3H]17-estradiol from ER, ER or uterine cytosol with different concentrations (1012 to 106 M) of cold 17-estradiol or 17-estradiol was determined. 

Phrase: "For displacement studies,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "the displacement of 2 nM of [3H"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0012725:Displacement [Mental Process]
   748   C0012727:Displacement [Spatial Concept]
   748   C0456080:Displacement [Qualitative Concept]
   748   C2347509:Displacement [Phenomenon or Process]

Phrase: "]17-estradiol from ER,"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   797   C0034803:Estradiol Receptor [Amino Acid, Peptide, or Protein,Receptor]
   797   C0034804:Estradiol Receptor [Amino Acid, Peptide, or Protein,Receptor]
   797   C1521863:Estradiol Receptor [Amino Acid, Peptide, or Protein,Receptor]
   760   C0014912:Estradiol [Hormone,Pharmacologic Substance,Steroid]
   704 E C0699352:Estrace [Hormone,Pharmacologic Substance,Steroid]
   704 E C0878472:Progynon [Hormone,Pharmacologic Substance,Steroid]

Phrase: "ER"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0034804:Estrogen receptor [Amino Acid, Peptide, or Protein,Receptor]
  1000   C1414461:ESTROGEN RECEPTOR [Gene or Genome]
  1000   C1521863:Estrogen Receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
   861   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C2936882:Estrogen [Pharmacologic Substance]
   789 E C0720298:Estrogenic [Hormone,Organic Chemical,Pharmacologic Substance]

Phrase: "or"

Phrase: "uterine cytosol with different concentrations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1383501:Cytosol [Cell Component]

Phrase: "(1012 to 106"

Phrase: "M) of cold 17-estradiol"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   760   C0009264:Cold [Natural Phenomenon or Process]
   760   C0009443:Cold [Disease or Syndrome]
   760   C0014912:Estradiol [Hormone,Pharmacologic Substance,Steroid]
   760   C0234192:Cold [Physiologic Function]
   760   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0441923:M+ [Intellectual Product]
   704 E C0699352:Estrace [Hormone,Pharmacologic Substance,Steroid]
   704 E C0878472:Progynon [Hormone,Pharmacologic Substance,Steroid]

Phrase: "or"

Phrase: "17-estradiol"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0014912:Estradiol [Hormone,Pharmacologic Substance,Steroid]
   805 E C0699352:Estrace [Hormone,Pharmacologic Substance,Steroid]
   805 E C0878472:Progynon [Hormone,Pharmacologic Substance,Steroid]

Phrase: "was"

Phrase: "determined."
Processing 00000000.tx.108: The relative binding affinity (RBA) of 17-estradiol was calculated as the ratio of concentrations of the steroids required to reduce the specific binding by 50% (RBA of 17-estradiol = 100). 

Phrase: "The relative binding affinity (RBA) of 17-estradiol"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   748   C0080103:Relative [Family Group]
   748   C0205345:Relative [Qualitative Concept]
   748   C0243122:binding [Functional Concept]
   748   C1145667:Binding [Activity]
   748   C1167622:Binding [Molecular Function]
   748   C1510827:Affinity [Natural Phenomenon or Process]
   748   C1547039:*Relative [Quantitative Concept]

Phrase: "was"

Phrase: "calculated as the ratio of concentrations of the steroids"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   742   C0038317:Steroids [Steroid]
   742   C0086045:Concentrations [Mental Process]
   742   C0444686:Calculated [Functional Concept]
   742   C0456603:Ratio [Quantitative Concept]
   742   C1441506:Calculated [Activity]
   742   C1443182:Calculated [Laboratory Procedure]
   742   C1547037:Ratio [Intellectual Product]
   708 E C1446561:Concentration [Quantitative Concept]

Phrase: "required"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514873:Required [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "reduce"

Phrase: "the specific binding by 50%"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0205369:Specific [Qualitative Concept]
   760   C0243122:binding [Functional Concept]
   760   C1145667:Binding [Activity]
   760   C1167622:Binding [Molecular Function]
   760   C1552740:specific [Intellectual Product]

Phrase: "(RBA of 17-estradiol"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   753   C0080103:Relative [Family Group]
   753   C0205345:Relative [Qualitative Concept]
   753   C0243122:binding [Functional Concept]
   753   C1145667:Binding [Activity]
   753   C1167622:Binding [Molecular Function]
   753   C1510827:Affinity [Natural Phenomenon or Process]
   753   C1547039:*Relative [Quantitative Concept]

Phrase: "= 100"

Phrase: ")."
Processing 00000000.tx.109: P7 mouse serum, rich in AFP (17), was used to study the binding of estrogens to AFP. 

Phrase: "P7 mouse serum,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0229671:Serum [Body Substance]
   827   C1546774:Serum [Intellectual Product]
   827   C1550100:Serum [Body Substance]

Phrase: "rich in AFP (17"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0699759:Rich [Qualitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "was"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "the binding of estrogens"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0243122:binding [Functional Concept]
   770   C1145667:Binding [Activity]
   770   C1167622:Binding [Molecular Function]

Phrase: "to AFP."
Processing 00000000.tx.110: The serum was treated with an equal volume of 1% DCC suspension for 15 min at 37 C to remove endogenous steroids and other low-molecular-weight substances and then diluted 2000 times in the assay buffer (as was done for the ERs). 

Phrase: "The serum"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0229671:Serum [Body Substance]
  1000   C1546774:Serum [Intellectual Product]
  1000   C1550100:Serum [Body Substance]

Phrase: "was"

Phrase: "treated with an equal volume of 1% DCC suspension"
Meta Candidates (Total=19; Excluded=3; Pruned=0; Remaining=16)
   756   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   754   C0717685:Dextran 1 [Organic Chemical,Pharmacologic Substance]
   738   C0007955:Charcoal [Element, Ion, or Isotope,Pharmacologic Substance]
   738   C0038960:Suspension [Biomedical or Dental Material]
   738   C0086140:Dextran [Carbohydrate,Pharmacologic Substance]
   738   C0205163:Equal [Qualitative Concept]
   738   C0449468:*Volume [Quantitative Concept]
   738   C1382107:Suspension [Substance]
   738   C1522326:Treated [Functional Concept]
   738   C1522408:Coated [Qualitative Concept]
   738   C1549782:Equal [Idea or Concept]
   738   C1690016:% volume [Qualitative Concept]
   738   C1705102:Volume [Intellectual Product]
   738   C1705537:Suspension [Functional Concept]
   738   C2700258:Volume [Laboratory Procedure]
   704 E C0453946:Coat [Manufactured Object]
   704 E C1292734:TREAT [Functional Concept]
   704 E C2987482:Coat [Body Part, Organ, or Organ Component]

Phrase: "for 15 min"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]

Phrase: "at 37 C to"

Phrase: "remove"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0849355:remove [Qualitative Concept]
  1000   C1883720:Remove [Activity]
  1000   C3244314:remove [Functional Concept]

Phrase: "endogenous steroids"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0815055:endogenous steroids [Steroid]
   861   C0038317:Steroids [Steroid]

Phrase: "and"

Phrase: "other low-molecular-weight substances"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0439861:Substances [Substance]
   708   C0041667:Low weight [Finding]

Phrase: "and"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "diluted"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1720119:Dilute [Functional Concept]
   966   C1948037:Dilute [Functional Concept]

Phrase: "2000 times in the assay buffer"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   753   C0040223:times [Temporal Concept]
   753   C1632851:Times [Quantitative Concept]
   719 E C3541383:Time [Temporal Concept]

Phrase: "("

Phrase: "as"

Phrase: "was"

Phrase: "done for the ERs"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C1272695:Done [Qualitative Concept]
   770   C1704489:ERS [Clinical Attribute]
   770   C2746065:Done [Temporal Concept]
   770   C2931783:ERS [Disease or Syndrome]

Phrase: ")."
Processing 00000000.tx.111: The binding assays for [3H]17-estradiol and [3H]17-estradiol were performed, as described above for the ERs. 

Phrase: "The binding assays for"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   737   C0005507:Assay [Laboratory Procedure]
   737   C0243073:assay [Qualitative Concept]
   737   C1510438:Assay [Laboratory Procedure]

Phrase: "[3H"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1442460:3H [Temporal Concept]

Phrase: "]17-estradiol"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0014912:Estradiol [Hormone,Pharmacologic Substance,Steroid]
   805 E C0699352:Estrace [Hormone,Pharmacologic Substance,Steroid]
   805 E C0878472:Progynon [Hormone,Pharmacologic Substance,Steroid]

Phrase: "and ["

Phrase: "3H"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1442460:3H [Temporal Concept]

Phrase: "]17-estradiol"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0014912:Estradiol [Hormone,Pharmacologic Substance,Steroid]
   805 E C0699352:Estrace [Hormone,Pharmacologic Substance,Steroid]
   805 E C0878472:Progynon [Hormone,Pharmacologic Substance,Steroid]

Phrase: "were"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: ","

Phrase: "as"

Phrase: "described above for the ERs."
Processing 00000000.tx.112: Binding of [3H]17-estradiol and [3H]17-estradiol to adult mouse and human serum was performed on serum pretreated with DCC and diluted 200 times. 

Phrase: "Binding of [3H"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1442460:3H [Temporal Concept]

Phrase: "]17-estradiol"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0014912:Estradiol [Hormone,Pharmacologic Substance,Steroid]
   805 E C0699352:Estrace [Hormone,Pharmacologic Substance,Steroid]
   805 E C0878472:Progynon [Hormone,Pharmacologic Substance,Steroid]

Phrase: "and ["

Phrase: "3H"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1442460:3H [Temporal Concept]

Phrase: "]17-estradiol to adult mouse"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   760   C0014912:Estradiol [Hormone,Pharmacologic Substance,Steroid]
   704 E C0699352:Estrace [Hormone,Pharmacologic Substance,Steroid]
   704 E C0878472:Progynon [Hormone,Pharmacologic Substance,Steroid]

Phrase: "and"

Phrase: "human serum"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0086418:Human [Human]
   861   C0229671:Serum [Body Substance]
   861   C1546774:Serum [Intellectual Product]
   861   C1550100:Serum [Body Substance]

Phrase: "was"

Phrase: "performed on serum"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   790   C0229671:Serum [Body Substance]
   790   C0884358:Performed [Functional Concept]
   790   C1546774:Serum [Intellectual Product]
   790   C1550100:Serum [Body Substance]
   756 E C2947996:Perform [Pharmacologic Substance]

Phrase: "pretreated with DCC"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   760   C0007955:Charcoal [Element, Ion, or Isotope,Pharmacologic Substance]
   760   C0086140:Dextran [Carbohydrate,Pharmacologic Substance]
   760   C1522408:Coated [Qualitative Concept]
   726 E C0453946:Coat [Manufactured Object]
   726 E C2987482:Coat [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "diluted"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1720119:Dilute [Functional Concept]
   966   C1948037:Dilute [Functional Concept]

Phrase: "200 times."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0040223:times [Temporal Concept]
   861   C1632851:Times [Quantitative Concept]
   827 E C3541383:Time [Temporal Concept]
   789 E C0442043:Temporal [Spatial Concept]
   789 E C2362314:Temporal [Temporal Concept]
Processing 00000000.tx.113: SHBG was diluted to 1 nM in the assay buffer. 

Phrase: "SHBG"

Phrase: "was"

Phrase: "diluted to 1 nM"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0312860:NM [Cell Function]
   737   C1720119:Dilute [Functional Concept]
   737   C1948037:Dilute [Functional Concept]

Phrase: "in the assay buffer."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
Processing 00000000.tx.114: Binding of 2 nM of [3H]17-estradiol or [3H]17-estradiol to mouse or human serum or to SHBG was measured, as described for the ERs. 

Phrase: "Binding of 2 nM of [3H"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0243122:binding [Functional Concept]
   753   C1145667:Binding [Activity]
   753   C1167622:Binding [Molecular Function]

Phrase: "]17-estradiol or [3H"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1442460:3H [Temporal Concept]

Phrase: "]17-estradiol to mouse"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   770   C0014912:Estradiol [Hormone,Pharmacologic Substance,Steroid]
   715 E C0699352:Estrace [Hormone,Pharmacologic Substance,Steroid]
   715 E C0878472:Progynon [Hormone,Pharmacologic Substance,Steroid]

Phrase: "or"

Phrase: "human serum"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0086418:Human [Human]
   861   C0229671:Serum [Body Substance]
   861   C1546774:Serum [Intellectual Product]
   861   C1550100:Serum [Body Substance]

Phrase: "or to SHBG"

Phrase: "was"

Phrase: "measured"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0444706:Measured [Qualitative Concept]
  1000   C3541902:MEASURED [Diagnostic Procedure]
   966 E C0079809:Measure [Quantitative Concept]
   966 E C0242485:Measure [Functional Concept]

Phrase: ","

Phrase: "as"

Phrase: "described for the ERs."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C1552738:described [Idea or Concept]
   770   C1704489:ERS [Clinical Attribute]
   770   C2931783:ERS [Disease or Syndrome]
Processing 00000000.tx.115: Human serum and SHBG were purchased from Sigma. 

Phrase: "Human serum"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0086418:Human [Human]
   861   C0229671:Serum [Body Substance]
   861   C1546774:Serum [Intellectual Product]
   861   C1550100:Serum [Body Substance]

Phrase: "and"

Phrase: "SHBG"

Phrase: "were"

Phrase: "purchased from Sigma."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0869011:purchased [Activity]
   790   C1719918:Sigma [Intellectual Product]
Processing 00000000.tx.116: Cell culture and transfections COS-7 cells were cultured in DMEM (American Type Culture Collection, Manassas, VA) with 10% fetal bovine serum (Summit Biotechnology, Fort Collins, CO) at 37 C in a humidified 5% CO2 atmosphere. 

Phrase: "Cell culture"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0007585:Cell Culture [Laboratory Procedure]
   861   C0007634:Cell [Cell]
   861   C0010453:Culture [Idea or Concept]
   861   C0220814:culture [Functional Concept]
   861   C0430400:Culture [Laboratory Procedure]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]
   861   C2242979:Culture [Laboratory Procedure]

Phrase: "and"

Phrase: "transfections COS-7 cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   923   C1257858:COS-7 Cells [Cell]
   875   C0376702:COS Cells [Cell]
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "cultured in DMEM"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   756   C0010453:Culture [Idea or Concept]
   756   C0220814:culture [Functional Concept]
   756   C0430400:Culture [Laboratory Procedure]
   756   C2242979:Culture [Laboratory Procedure]

Phrase: "(American Type Culture Collection,"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
  1000   C0598079:American Type Culture Collection [Intellectual Product]
   812   C0010453:Culture [Idea or Concept]
   812   C0220814:culture [Functional Concept]
   812   C0332307:Type [Qualitative Concept]
   812   C0430400:Culture [Laboratory Procedure]
   812   C0596070:American [Population Group]
   812   C1516698:Collection [Functional Concept]
   812   C1547052:*Type [Quantitative Concept]
   812   C1704814:Collection [Idea or Concept]
   812   C2242979:Culture [Laboratory Procedure]
   741 E C1516695:Collected [Idea or Concept]

Phrase: "Manassas,"

Phrase: "VA) with 10% fetal bovine serum"

Phrase: "(Summit Biotechnology,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0005574:Biotechnology [Biomedical Occupation or Discipline]

Phrase: "Fort Collins,"

Phrase: "CO) at 37 C in"

Phrase: "a humidified 5% CO2 atmosphere."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0004178:Atmosphere [Natural Phenomenon or Process]
   812   C0678214:atmosphere [Quantitative Concept]
Processing 00000000.tx.117: For transient transfection assays, the cells were seeded in phenol red-free DMEM (Invitrogen, Carlsbad, CA) supplemented with 2% dextran-charcoal-stripped fetal bovine serum (Gemini, Woodland, CA). 

Phrase: "For transient transfection assays,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C0040669:Transfection [Genetic Function,Molecular Biology Research Technique]
   827   C0040704:Transient [Population Group]
   827   C0205374:Transient [Temporal Concept]
   793   C0005507:Assay [Laboratory Procedure]
   793   C0243073:assay [Qualitative Concept]
   793   C1510438:Assay [Laboratory Procedure]

Phrase: "the cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "seeded in phenol red-free DMEM"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   790   C0031430:Phenol Red [Indicator, Reagent, or Diagnostic Aid,Organic Chemical,Pharmacologic Substance]
   790   C1541709:Red free [Qualitative Concept]
   753   C0031428:phenol [Organic Chemical,Pharmacologic Substance]
   753   C0070570:phenol [Organic Chemical,Pharmacologic Substance]
   753   C0332296:free [Functional Concept]
   753   C0332575:Red [Finding]
   753   C1260956:Red [Qualitative Concept]
   753   C1880497:Free [Qualitative Concept]
   753   C1996904:Free [Qualitative Concept]
   719   C0036563:Seed [Plant]
   719   C1705192:Seed [Laboratory Procedure]
   719   C1882540:{Seed} [Quantitative Concept]
   719   C2346495:Seed [Conceptual Entity]

Phrase: "(Invitrogen,"

Phrase: "Carlsbad,"

Phrase: "CA)"

Phrase: "supplemented with 2% dextran-charcoal-"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0007955:Charcoal [Element, Ion, or Isotope,Pharmacologic Substance]
   760   C0086140:Dextran [Carbohydrate,Pharmacologic Substance]
   726   C0242295:Supplement [Food]
   726   C1947943:Supplement [Intellectual Product]
   726   C2348609:Supplement [Functional Concept]

Phrase: "stripped"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1321564:Strip [Medical Device]

Phrase: "fetal bovine serum"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   827   C0007452:Bovine [Mammal]
   827   C0015965:Fetal [Embryonic Structure]
   827   C0229671:Serum [Body Substance]
   827   C0521457:Fetal [Functional Concept]
   827   C1140701:bovine [Mammal]
   827   C1546774:Serum [Intellectual Product]
   827   C1550100:Serum [Body Substance]

Phrase: "(Gemini,"

Phrase: "Woodland,"

Phrase: "CA)."
Processing 00000000.tx.118: Cells were transfected with 100 ng of reporter plasmid, 50 ng of pRL plasmid, as an internal control, and 50 ng of ER or ER expression plasmids, or empty expression vector pSG5, to a total of 200 ng DNA per well. 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "transfected with 100 ng of reporter plasmid,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C0032136:Plasmid [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0335038:Reporter [Professional or Occupational Group]
   748   C1522485:Reporter [Indicator, Reagent, or Diagnostic Aid]
   748   C1705915:Reporter [Conceptual Entity]
   748   C1709908:Reporter [Group]

Phrase: "50 ng of pRL plasmid,"

Phrase: "as"

Phrase: "an internal control,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0597937:internal control [Mental Process]
   861   C0205102:Internal [Spatial Concept]
   861   C0243148:control [Qualitative Concept]
   861   C1550141:Control [Substance]
   861   C1553872:Internal [Intellectual Product]
   861   C1619620:Internal [Intellectual Product]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]

Phrase: "and"

Phrase: "50 ng of ER"

Phrase: "or"

Phrase: "ER expression plasmids,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0032136:Plasmids [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "or"

Phrase: "empty expression vector pSG5,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1418997:PSG5 [Gene or Genome]

Phrase: "to a total"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439175:% total [Quantitative Concept]
  1000   C0439810:Total [Qualitative Concept]

Phrase: "of 200 ng DNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "per well."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205170:Well [Qualitative Concept]
  1000   C3146287:Well [Manufactured Object]
Processing 00000000.tx.119: The transfection medium was changed after 24 h to phenol red-free DMEM, and 17-estradiol or 17-estradiol (100 pM to 10 nM) with or without ICI 182,780 (107 M) was added, as described in the figure legends. 

Phrase: "The transfection medium"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0009458:Medium [Intellectual Product]
   861   C0439536:Medium [Quantitative Concept]
   861   C1705217:Medium [Substance]
   861   C3244283:medium [Intellectual Product]

Phrase: "was"

Phrase: "changed after 24 h"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   770   C0033727:H+ [Element, Ion, or Isotope]
   770   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0392747:Changed [Functional Concept]
   770   C0441932:H+ [Classification]
   770   C0443172:Changed [Quantitative Concept]
   770   C0564385:/h [Quantitative Concept]
   737 E C1705241:Change [Quantitative Concept]

Phrase: "to phenol red-free DMEM,"

Phrase: "and"

Phrase: "17-estradiol"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0014912:Estradiol [Hormone,Pharmacologic Substance,Steroid]
   805 E C0699352:Estrace [Hormone,Pharmacologic Substance,Steroid]
   805 E C0878472:Progynon [Hormone,Pharmacologic Substance,Steroid]

Phrase: "or"

Phrase: "17-estradiol"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0014912:Estradiol [Hormone,Pharmacologic Substance,Steroid]
   805 E C0699352:Estrace [Hormone,Pharmacologic Substance,Steroid]
   805 E C0878472:Progynon [Hormone,Pharmacologic Substance,Steroid]

Phrase: "(100 pM to 10 nM)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   797   C0662713:PM 100 [Organic Chemical]

Phrase: "with"

Phrase: "or without ICI 182,780"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   862   C1123005:ICI 182,780 [Pharmacologic Substance,Steroid]

Phrase: "(107"

Phrase: "M)"

Phrase: "was"

Phrase: "added"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1524062:Added [Functional Concept]
   966 E C1883712:Add [Functional Concept]

Phrase: ","

Phrase: "as"

Phrase: "described in the figure legends."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1552738:described [Idea or Concept]
   726   C2729544:Legend [Pharmacologic Substance]
Processing 00000000.tx.120: Cells were harvested after 24 h, and a luciferase assay was performed, using the dual luciferase reporter assay system (Promega).  

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "harvested after 24 h,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0033727:H+ [Element, Ion, or Isotope]
   770   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441932:H+ [Classification]
   770   C0564385:/h [Quantitative Concept]
   737   C1512335:Harvest [Health Care Activity]

Phrase: "and"

Phrase: "a luciferase assay"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0005507:Assay [Laboratory Procedure]
   861   C0243073:assay [Qualitative Concept]
   861   C1510438:Assay [Laboratory Procedure]

Phrase: "was"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: ","

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the dual luciferase reporter assay system"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   804   C0449913:System [Functional Concept]
   804   C1553451:System [Manufactured Object]
   804   C1704459:System [Medical Device]
   733 E C0205373:Systemic [Functional Concept]

Phrase: "(Promega"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0072149:Promega [Lipid]

Phrase: ")."
Processing 00000000.tx.121: Results Top Abstract Introduction Materials and Methods Results Discussion References  LC-MS/MS was used to identify and compare the endogenous content of 17-estradiol, 17-estradiol, and E1 in lysates of the brain (neocortex, hippocampus, hypothalamus, and cerebellum), adrenals, ovary, uterus, testis, and serum of P7 and adult male and female C57BL/6J mice (Fig. 2 and Table 1). 

Phrase: "Results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1274040:Result [Functional Concept]
  1000   C1546471:Result [Idea or Concept]
  1000   C2825142:Result [Finding]

Phrase: "Top Abstract Introduction Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "Methods Results Discussion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "LC-MS/MS"
Meta Candidates (Total=16; Excluded=1; Pruned=0; Remaining=15)
   924   C0872318:Liquid Chromatography Mass Spectrometry [Laboratory Procedure]
   884   C0599748:Tandem Mass Spectrometry [Molecular Biology Research Technique]
   853   C2945612:chromatography mass [Laboratory Procedure]
   840   C0008565:Liquid Chromatography [Laboratory Procedure]
   840   C0037813:Mass Spectrometry [Laboratory Procedure]
   804   C0008550:Chromatography [Laboratory Procedure]
   804   C0075804:TANDEM [Organic Chemical,Pharmacologic Substance]
   804   C0302908:Liquid [Substance]
   804   C0436196:Spectrometry [Laboratory Procedure]
   804   C0577559:Mass [Finding]
   804   C1304698:Liquid [Finding]
   804   C1306372:*Mass [Quantitative Concept]
   804   C1546699:Liquid NOS [Intellectual Product]
   804   C1561501:Liquid NOS [Substance]
   804   C3152252:Mass [Quantitative Concept]
   704 E C0302647:chromatograph [Medical Device]

Phrase: "was"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "identify"

Phrase: "and"

Phrase: "compare"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707455:Compare [Activity]

Phrase: "the endogenous content of 17-estradiol,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C1555325:endogenous content [Intellectual Product]
   753   C0423896:Content [Mental Process]
   753   C0456205:Content [Conceptual Entity]

Phrase: "17-estradiol,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0014912:Estradiol [Hormone,Pharmacologic Substance,Steroid]
   805 E C0699352:Estrace [Hormone,Pharmacologic Substance,Steroid]
   805 E C0878472:Progynon [Hormone,Pharmacologic Substance,Steroid]

Phrase: "and"

Phrase: "E1 in lysates of the brain"

Phrase: "(neocortex,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0175173:Neocortex [Body Part, Organ, or Organ Component]

Phrase: "hippocampus,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0019564:Hippocampus [Body Part, Organ, or Organ Component]
  1000   C0949582:Hippocampus [Fish]
  1000   C1029104:Hippocampus [Fish]
  1000   C1284077:Hippocampus [Body Part, Organ, or Organ Component]

Phrase: "hypothalamus,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0020663:Hypothalamus [Body Part, Organ, or Organ Component]
  1000   C1280712:Hypothalamus [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "cerebellum"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0007765:Cerebellum [Body Part, Organ, or Organ Component]
  1000   C1268981:Cerebellum [Body Part, Organ, or Organ Component]
  1000   C1707522:Cerebellum [Tissue]

Phrase: ")"

Phrase: ","

Phrase: "adrenals,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001625:Adrenals [Body Part, Organ, or Organ Component]

Phrase: "ovary,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0029939:Ovary [Body Part, Organ, or Organ Component]
  1000   C0227898:ovary [Body Part, Organ, or Organ Component]
  1000   C1278992:Ovary [Body Part, Organ, or Organ Component]

Phrase: "uterus,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042149:Uterus [Body Part, Organ, or Organ Component]
  1000   C1269032:Uterus [Body Part, Organ, or Organ Component]

Phrase: "testis,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0039597:Testis [Body Part, Organ, or Organ Component]
  1000   C1278981:Testis [Body Part, Organ, or Organ Component]
   916 E C0021358:Testes [Body Part, Organ, or Organ Component]
   907 E C0205070:Testicular [Spatial Concept]
   888 E C1284096:Testicle [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "serum of P7"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0229671:Serum [Body Substance]
   790   C1546774:Serum [Intellectual Product]
   790   C1550100:Serum [Body Substance]

Phrase: "and"

Phrase: "adult male"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   861   C0001675:Adult [Age Group]
   861   C0024554:Male [Finding]
   861   C0086582:male [Population Group]
   861   C1706180:Male [Qualitative Concept]
   861   C1706428:Male [Qualitative Concept]
   861   C1706429:Male [Organism Attribute]
   861   C1706450:Adult [Human]

Phrase: "and"

Phrase: "female C57BL/6J mice"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   875   C0025921:Mice, C57BL [Mammal]
   812   C0025914:Mice [Mammal]
   812   C0025929:mice [Mammal]
   812   C0026809:Mice [Mammal]

Phrase: "(Fig. 2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "and"

Phrase: "Table 1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.122: Whereas significantly elevated levels of 17-estradiol were found predictably in the adult ovary (Fig. 2A) and uterus, 17-estradiol levels in the P1, P7, and adult neocortex, hippocampus (Fig. 2B), hypothalamus, cerebellum, and adrenals of both sexes were below detectable limits (Table 1). 

Phrase: "Whereas"

Phrase: "significantly elevated levels of 17-estradiol"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   767   C0337434:Oestradiol level [Laboratory Procedure]
   753   C0441889:Levels [Qualitative Concept]
   719 E C0456079:Level [Classification]
   719 E C1547707:Level [Geographic Area]
   719 E C2946261:Level [Pharmacologic Substance]

Phrase: "were"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "predictably in the adult ovary"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0001675:Adult [Age Group]
   760   C0029939:Ovary [Body Part, Organ, or Organ Component]
   760   C0227898:ovary [Body Part, Organ, or Organ Component]
   760   C1278992:Ovary [Body Part, Organ, or Organ Component]
   760   C1706450:Adult [Human]

Phrase: "(Fig. 2A"

Phrase: ")"

Phrase: "and"

Phrase: "uterus,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042149:Uterus [Body Part, Organ, or Organ Component]
  1000   C1269032:Uterus [Body Part, Organ, or Organ Component]

Phrase: "17-estradiol levels in the P1,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   773   C0337434:Oestradiol level [Laboratory Procedure]
   753   C0014912:Estradiol [Hormone,Pharmacologic Substance,Steroid]
   753   C0441889:Levels [Qualitative Concept]
   719 E C0456079:Level [Classification]
   719 E C1547707:Level [Geographic Area]
   719 E C2946261:Level [Pharmacologic Substance]

Phrase: "P7,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1424742:p7 [Gene or Genome]

Phrase: "and"

Phrase: "adult neocortex,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0175173:Neocortex [Body Part, Organ, or Organ Component]

Phrase: "hippocampus"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0019564:Hippocampus [Body Part, Organ, or Organ Component]
  1000   C0949582:Hippocampus [Fish]
  1000   C1029104:Hippocampus [Fish]
  1000   C1284077:Hippocampus [Body Part, Organ, or Organ Component]

Phrase: "(Fig. 2B"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450354:2b [Intellectual Product]
   861   C1706096:2B [Research Activity]

Phrase: ")"

Phrase: ","

Phrase: "hypothalamus,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0020663:Hypothalamus [Body Part, Organ, or Organ Component]
  1000   C1280712:Hypothalamus [Body Part, Organ, or Organ Component]

Phrase: "cerebellum,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0007765:Cerebellum [Body Part, Organ, or Organ Component]
  1000   C1268981:Cerebellum [Body Part, Organ, or Organ Component]
  1000   C1707522:Cerebellum [Tissue]

Phrase: "and"

Phrase: "adrenals of both sexes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0001625:Adrenals [Body Part, Organ, or Organ Component]

Phrase: "were below detectable limits"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   770   C0439801:limits [Functional Concept]
   737 E C1549649:Limit [Idea or Concept]
   737 E C2349209:Limit [Conceptual Entity]

Phrase: "(Table 1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.123: However, in striking contrast, this pattern was completely reversed in the P1, P7, and adult brain of both sexes, in which elevated endogenous levels of 17-estradiol and E1 were found (Fig. 2B and Table 1). 

Phrase: "However,"

Phrase: "in striking contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1979874:Contrast [Qualitative Concept]

Phrase: "this pattern"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449774:Pattern [Spatial Concept]

Phrase: "was"

Phrase: "completely"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205197:Completely [Qualitative Concept]

Phrase: "reversed in the P1,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C1555029:Reverse [Idea or Concept]

Phrase: "P7,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1424742:p7 [Gene or Genome]

Phrase: "and"

Phrase: "adult brain of both sexes,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0006104:Brain [Body Part, Organ, or Organ Component]
   760   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "in which"

Phrase: "elevated"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205250:Elevated [Qualitative Concept]
  1000   C3163633:Elevated [Qualitative Concept]

Phrase: "endogenous levels of 17-estradiol"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   781   C0337434:Oestradiol level [Laboratory Procedure]
   760   C0441889:Levels [Qualitative Concept]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]

Phrase: "and"

Phrase: "E1"

Phrase: "were"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "(Fig. 2B"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450354:2b [Intellectual Product]
   861   C1706096:2B [Research Activity]

Phrase: "and"

Phrase: "Table 1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.124: Elevated endogenous levels of 17-estradiol and E1 were also found in the P7 and adult ovary, uterus, and female adrenals (Table 1), whereas levels of these estrogens in P7 and adult serum were very low and frequently at or below the limit of sensitivity of the method (5 pg/ml). 

Phrase: "Elevated endogenous levels of 17-estradiol"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   767   C0337434:Oestradiol level [Laboratory Procedure]
   753   C0441889:Levels [Qualitative Concept]
   719 E C0456079:Level [Classification]
   719 E C1547707:Level [Geographic Area]
   719 E C2946261:Level [Pharmacologic Substance]

Phrase: "and"

Phrase: "E1"

Phrase: "were"

Phrase: "also"

Phrase: "found in the P7"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0150312:Found [Quantitative Concept]
   770   C1424742:p7 [Gene or Genome]
   737 E C0243095:Find [Finding]

Phrase: "and"

Phrase: "adult ovary,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0029939:Ovary [Body Part, Organ, or Organ Component]
   861   C0227898:ovary [Body Part, Organ, or Organ Component]
   861   C1278992:Ovary [Body Part, Organ, or Organ Component]

Phrase: "uterus,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042149:Uterus [Body Part, Organ, or Organ Component]
  1000   C1269032:Uterus [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "female adrenals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0001625:Adrenals [Body Part, Organ, or Organ Component]

Phrase: "(Table 1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "whereas"

Phrase: "levels of these estrogens"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   770   C0441889:Levels [Qualitative Concept]
   737 E C0456079:Level [Classification]
   737 E C1547707:Level [Geographic Area]
   737 E C2946261:Level [Pharmacologic Substance]

Phrase: "in P7"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1424742:p7 [Gene or Genome]

Phrase: "and"

Phrase: "adult serum"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0229671:Serum [Body Substance]
   861   C1546774:Serum [Intellectual Product]
   861   C1550100:Serum [Body Substance]

Phrase: "were"

Phrase: "very low"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0442811:Very low [Finding]
   861   C0205251:low [Qualitative Concept]
   861   C1299352:Low [Qualitative Concept]
   861   C1550472:low [Idea or Concept]

Phrase: "and"

Phrase: "frequently at"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C0332183:Frequently [Temporal Concept]

Phrase: "or below the limit of sensitivity of the method"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   742   C0025663:Method [Intellectual Product]
   742   C0036667:Sensitivity [Quantitative Concept]
   742   C0312418:Sensitivity [Mental Process]
   742   C0427965:Sensitivity [Finding]
   742   C0439801:limit [Functional Concept]
   742   C0449851:Method [Functional Concept]
   742   C0871511:METHOD [Intellectual Product]
   742   C1511883:Sensitivity [Quantitative Concept]
   742   C1522640:Sensitivity [Qualitative Concept]
   742   C1549649:Limit [Idea or Concept]
   742   C2346484:SENSITIVITY [Phenomenon or Process]
   742   C2349185:Sensitivity [Qualitative Concept]
   742   C2349209:Limit [Conceptual Entity]

Phrase: "(5 pg/ml"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0439297:pg/mL [Quantitative Concept]
   827   C0439526:/mL [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.125: The gonadectomized (ovariectomized or castrated) and gonadectomized-adrenalectomized mice of both sexes had even higher levels of 17-estradiol, whereas 17-estradiol was detected only in some samples and E1 was not detected at all (Table 2). 

Phrase: "The gonadectomized"

Phrase: "("

Phrase: "ovariectomized"

Phrase: "or"

Phrase: "castrated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   928   C0392747:Altered [Functional Concept]

Phrase: ")"

Phrase: "and"

Phrase: "gonadectomized-"

Phrase: "adrenalectomized mice of both sexes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0025914:Mice [Mammal]
   760   C0025929:mice [Mammal]
   760   C0026809:Mice [Mammal]

Phrase: "had"

Phrase: "even higher levels of 17-estradiol,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   767   C0337434:Oestradiol level [Laboratory Procedure]
   753   C0441889:Levels [Qualitative Concept]
   719 E C0456079:Level [Classification]
   719 E C1547707:Level [Geographic Area]
   719 E C2946261:Level [Pharmacologic Substance]

Phrase: "whereas"

Phrase: "17-estradiol"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0014912:Estradiol [Hormone,Pharmacologic Substance,Steroid]
   805 E C0699352:Estrace [Hormone,Pharmacologic Substance,Steroid]
   805 E C0878472:Progynon [Hormone,Pharmacologic Substance,Steroid]

Phrase: "was"

Phrase: "detected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442726:Detected [Finding]
  1000   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "only in some samples"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0205171:Only [Quantitative Concept]
   770   C1720467:Only [Intellectual Product]
   737   C0370003:Sample [Substance]
   737   C2347026:Sample [Conceptual Entity]

Phrase: "and"

Phrase: "E1"

Phrase: "was"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "detected at all (Table 2"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0039224:Table [Manufactured Object]
   760   C0442726:Detected [Finding]
   760   C1511790:Detected [Therapeutic or Preventive Procedure]
   760   C1706073:Table [Medical Device]
   760   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.126: As shown in Fig. 

Phrase: "As"

Phrase: "shown in Fig."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   756   C1547282:Show [Intellectual Product]
Processing 00000000.tx.127: 4, [3H]17-estradiol bound to human recombinant ER and ER with affinities similar to those of 17-estradiol [affinity constant (Kd) = 0.4 nM and Kd = 0.5 nM, respectively, a finding confirmed by binding assays performed on adult rat uterine cytosol (Kd = 0.4 nM)]. 

Phrase: "4,"

Phrase: "[3H"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1442460:3H [Temporal Concept]

Phrase: "]17-estradiol"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0014912:Estradiol [Hormone,Pharmacologic Substance,Steroid]
   805 E C0699352:Estrace [Hormone,Pharmacologic Substance,Steroid]
   805 E C0878472:Progynon [Hormone,Pharmacologic Substance,Steroid]

Phrase: "bound to human recombinant ER"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   790   C0034804:Estrogen receptor [Amino Acid, Peptide, or Protein,Receptor]
   790   C1414461:ESTROGEN RECEPTOR [Gene or Genome]
   790   C1521863:Estrogen Receptor [Amino Acid, Peptide, or Protein,Receptor]
   753   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
   753   C0086418:Human [Human]
   753   C0332297:bound [Spatial Concept]
   753   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   753   C1145667:Bound [Activity]
   753   C1167622:Bound [Molecular Function]
   753   C1514798:recombinant [Organism]
   753   C1689898:% bound [Quantitative Concept]
   753   C2349209:Bound [Conceptual Entity]
   753   C2936882:Estrogen [Pharmacologic Substance]

Phrase: "and"

Phrase: "ER with affinities"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C0034804:Estrogen receptor [Amino Acid, Peptide, or Protein,Receptor]
   833   C1414461:ESTROGEN RECEPTOR [Gene or Genome]
   833   C1521863:Estrogen Receptor [Amino Acid, Peptide, or Protein,Receptor]
   770   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
   770   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   770   C2936882:Estrogen [Pharmacologic Substance]

Phrase: "similar to those of 17-estradiol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C2348205:Similar [Qualitative Concept]

Phrase: "[affinity constant"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1510827:Affinity [Natural Phenomenon or Process]
   861   C1547014:*Constant [Quantitative Concept]
   861   C1948059:Constant [Qualitative Concept]

Phrase: "(Kd) = 0.4 nM"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0312860:NM [Cell Function]

Phrase: "and"

Phrase: "Kd = 0.5 nM,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0312860:NM [Cell Function]

Phrase: "respectively,"

Phrase: "a finding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0037088:Finding [Sign or Symptom]
  1000   C0243095:Finding [Finding]
  1000   C2825141:Finding [Finding]

Phrase: "confirmed by binding assays"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   833   C0521093:Confirmed by [Qualitative Concept]
           confirmed
   770   C0243122:binding [Functional Concept]
   770   C0750484:Confirmed [Idea or Concept]
   770   C1145667:Binding [Activity]
   770   C1167622:Binding [Molecular Function]
   737   C0005507:Assay [Laboratory Procedure]
   737   C0243073:assay [Qualitative Concept]
   737 E C1456348:Confirm [Qualitative Concept]
   737   C1510438:Assay [Laboratory Procedure]

Phrase: "performed on adult rat uterine cytosol"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   753   C0001675:Adult [Age Group]
   753   C0034693:Rat, NOS [Mammal]
   753   C0034721:Rat [Mammal]
   753   C0042149:Uterine [Body Part, Organ, or Organ Component]
   753   C0884358:Performed [Functional Concept]
   753   C1383501:Cytosol [Cell Component]
   753   C1706450:Adult [Human]
   719 E C2947996:Perform [Pharmacologic Substance]

Phrase: "(Kd = 0.4 nM)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0312860:NM [Cell Function]

Phrase: "]."
Processing 00000000.tx.128: We studied 17-estradiol displacement of [3H]17-estradiol from recombinant human ER and ER and uterine cytosol receptors. 

Phrase: "We"

Phrase: "studied"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0557651:Study [Manufactured Object]
   966   C2603343:Study [Research Activity]

Phrase: "17-estradiol displacement of [3H"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C1442460:3H [Temporal Concept]

Phrase: "]17-estradiol from recombinant human ER"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   774   C0034803:Estradiol Receptor [Amino Acid, Peptide, or Protein,Receptor]
   774   C0034804:Estradiol Receptor [Amino Acid, Peptide, or Protein,Receptor]
   774   C1521863:Estradiol Receptor [Amino Acid, Peptide, or Protein,Receptor]
   748   C0014912:Estradiol [Hormone,Pharmacologic Substance,Steroid]

Phrase: "and"

Phrase: "ER"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0034804:Estrogen receptor [Amino Acid, Peptide, or Protein,Receptor]
  1000   C1414461:ESTROGEN RECEPTOR [Gene or Genome]
  1000   C1521863:Estrogen Receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
   861   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C2936882:Estrogen [Pharmacologic Substance]
   789 E C0720298:Estrogenic [Hormone,Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "uterine cytosol receptors."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   848   C0872141:cytosolic receptor [Amino Acid, Peptide, or Protein,Receptor]
   827   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]
Processing 00000000.tx.129: In these assays, the RBA of 17-estradiol for ER and ER was 51 and 64%, respectively, of that of 17-estradiol. 

Phrase: "In these assays,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0005507:Assay [Laboratory Procedure]
   966   C0243073:assay [Qualitative Concept]
   966   C1510438:Assay [Laboratory Procedure]

Phrase: "the RBA of 17-estradiol"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   748   C0080103:Relative [Family Group]
   748   C0205345:Relative [Qualitative Concept]
   748   C0243122:binding [Functional Concept]
   748   C1145667:Binding [Activity]
   748   C1167622:Binding [Molecular Function]
   748   C1510827:Affinity [Natural Phenomenon or Process]
   748   C1547039:*Relative [Quantitative Concept]

Phrase: "for ER"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0034804:Estrogen receptor [Amino Acid, Peptide, or Protein,Receptor]
  1000   C1414461:ESTROGEN RECEPTOR [Gene or Genome]
  1000   C1521863:Estrogen Receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
   861   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C2936882:Estrogen [Pharmacologic Substance]
   789 E C0720298:Estrogenic [Hormone,Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "ER"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0034804:Estrogen receptor [Amino Acid, Peptide, or Protein,Receptor]
  1000   C1414461:ESTROGEN RECEPTOR [Gene or Genome]
  1000   C1521863:Estrogen Receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
   861   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C2936882:Estrogen [Pharmacologic Substance]
   789 E C0720298:Estrogenic [Hormone,Organic Chemical,Pharmacologic Substance]

Phrase: "was"

Phrase: "51"

Phrase: "and"

Phrase: "64%,"

Phrase: "respectively,"

Phrase: "of that"

Phrase: "of 17-estradiol."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0014912:Estradiol [Hormone,Pharmacologic Substance,Steroid]
   805 E C0699352:Estrace [Hormone,Pharmacologic Substance,Steroid]
   805 E C0878472:Progynon [Hormone,Pharmacologic Substance,Steroid]
Processing 00000000.tx.130: However, displacement of [3H]17-estradiol by 17-estradiol from uterine cytosol gave an RBA of 15% of 17-estradiol. 

Phrase: "However,"

Phrase: "displacement of [3H"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1442460:3H [Temporal Concept]

Phrase: "]17-estradiol by 17-estradiol"

Phrase: "from uterine cytosol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1383501:Cytosol [Cell Component]

Phrase: "gave"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1947971:Give [Functional Concept]

Phrase: "an RBA of 15% of 17-estradiol."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   742   C0080103:Relative [Family Group]
   742   C0205345:Relative [Qualitative Concept]
   742   C0243122:binding [Functional Concept]
   742   C1145667:Binding [Activity]
   742   C1167622:Binding [Molecular Function]
   742   C1510827:Affinity [Natural Phenomenon or Process]
   742   C1547039:*Relative [Quantitative Concept]
Processing 00000000.tx.131: Pretreatment of the cytosol with DCC suspension, which removed endogenous steroids and low-molecular-weight substances, resulted in a rise of the RBA for 17-estradiol to 65%. 

Phrase: "Pretreatment of the cytosol"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C1550147:Pretreatment [Substance]
   770   C2709094:pre treatment [Temporal Concept]
   770   C3539075:Pretreatment [Temporal Concept]
   770   C3539076:Pretreatment [Activity]

Phrase: "with DCC suspension,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0038960:Suspension [Biomedical or Dental Material]
   812   C1382107:Suspension [Substance]
   812   C1705537:Suspension [Functional Concept]

Phrase: "which"

Phrase: "removed"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0849355:Removed [Qualitative Concept]
   966 E C1883720:Remove [Activity]
   966 E C3244314:remove [Functional Concept]

Phrase: "endogenous steroids"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0815055:endogenous steroids [Steroid]
   861   C0038317:Steroids [Steroid]

Phrase: "and"

Phrase: "low-molecular-weight substances,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0439861:Substances [Substance]
   708   C0041667:Low weight [Finding]

Phrase: "resulted in a rise of the RBA"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   742   C0080103:Relative [Family Group]
   742   C0205345:Relative [Qualitative Concept]
   742   C0243122:binding [Functional Concept]
   742   C1145667:Binding [Activity]
   742   C1167622:Binding [Molecular Function]
   742   C1510827:Affinity [Natural Phenomenon or Process]
   742   C1547039:*Relative [Quantitative Concept]
   708   C1274040:Result [Functional Concept]
   708   C1546471:Result [Idea or Concept]
   708   C2825142:Result [Finding]

Phrase: "for 17-estradiol"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0014912:Estradiol [Hormone,Pharmacologic Substance,Steroid]
   805 E C0699352:Estrace [Hormone,Pharmacologic Substance,Steroid]
   805 E C0878472:Progynon [Hormone,Pharmacologic Substance,Steroid]

Phrase: "to 65%."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450385:65 [Intellectual Product]
Processing 00000000.tx.132: View larger version (31K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(31K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.133: 4. 

Phrase: "4."
Processing 00000000.tx.134: [3H]17-Estradiol binds to recombinant ERs with an affinity similar to that of [3H]17-estradiol. 

Phrase: "[3H"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1442460:3H [Temporal Concept]

Phrase: "]17-Estradiol"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0014912:Estradiol [Hormone,Pharmacologic Substance,Steroid]
   805 E C0699352:Estrace [Hormone,Pharmacologic Substance,Steroid]
   805 E C0878472:Progynon [Hormone,Pharmacologic Substance,Steroid]

Phrase: "binds to recombinant ERs"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C1145667:Bind [Activity]
   770   C1167622:bind [Molecular Function]
   770   C1514798:recombinant [Organism]
   770   C1704489:ERS [Clinical Attribute]
   770   C2931783:ERS [Disease or Syndrome]

Phrase: "with an affinity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1510827:Affinity [Natural Phenomenon or Process]

Phrase: "similar to that of [3H"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C2348205:Similar [Qualitative Concept]

Phrase: "]17-estradiol."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0014912:Estradiol [Hormone,Pharmacologic Substance,Steroid]
   805 E C0699352:Estrace [Hormone,Pharmacologic Substance,Steroid]
   805 E C0878472:Progynon [Hormone,Pharmacologic Substance,Steroid]
Processing 00000000.tx.135: Scatchard analyses of the data on specific binding of 17-estradiol and 17-estradiol to recombinant human ER, ER, and rat uterine cytosol. 

Phrase: "Scatchard analyses of the data"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   797   C0010992:Data Analyses [Occupational Activity]
   726   C0002778:Analysis [Laboratory Procedure]
   726   C0936012:Analysis [Research Activity]
   726   C1524024:analysis [Functional Concept]

Phrase: "on specific binding"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0205369:Specific [Qualitative Concept]
   861   C0243122:binding [Functional Concept]
   861   C1145667:Binding [Activity]
   861   C1167622:Binding [Molecular Function]
   861   C1552740:specific [Intellectual Product]

Phrase: "of 17-estradiol"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0014912:Estradiol [Hormone,Pharmacologic Substance,Steroid]
   805 E C0699352:Estrace [Hormone,Pharmacologic Substance,Steroid]
   805 E C0878472:Progynon [Hormone,Pharmacologic Substance,Steroid]

Phrase: "and"

Phrase: "17-estradiol to recombinant human ER,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   774   C0034803:Estradiol Receptor [Amino Acid, Peptide, or Protein,Receptor]
   774   C0034804:Estradiol Receptor [Amino Acid, Peptide, or Protein,Receptor]
   774   C1521863:Estradiol Receptor [Amino Acid, Peptide, or Protein,Receptor]
   748   C0014912:Estradiol [Hormone,Pharmacologic Substance,Steroid]

Phrase: "ER,"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0034804:Estrogen receptor [Amino Acid, Peptide, or Protein,Receptor]
  1000   C1414461:ESTROGEN RECEPTOR [Gene or Genome]
  1000   C1521863:Estrogen Receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
   861   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C2936882:Estrogen [Pharmacologic Substance]
   789 E C0720298:Estrogenic [Hormone,Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "rat uterine cytosol."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1383501:Cytosol [Cell Component]
Processing 00000000.tx.136: Each point represents the mean of a duplicate measurement. 

Phrase: "Each point"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1552961:Point [Quantitative Concept]
  1000   C2347617:point [Quantitative Concept]

Phrase: "represents"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "the mean of a duplicate measurement."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0444504:Mean [Quantitative Concept]
   753   C2347634:Mean [Quantitative Concept]
   753   C2348143:Mean [Quantitative Concept]
Processing 00000000.tx.137: Specific binding of 0.25, 0.5, 1.0, 1.3, 2.5, and 5 nM of [3H]17-estradiol or 17-estradiol was measured in three independent experiments for ER and in two independent experiments for ER or rat uterine cytosol.  

Phrase: "Specific binding of 0.25,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0205369:Specific [Qualitative Concept]
   760   C0243122:binding [Functional Concept]
   760   C1145667:Binding [Activity]
   760   C1167622:Binding [Molecular Function]
   760   C1552740:specific [Intellectual Product]

Phrase: "0.5,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0444499:0/5 [Quantitative Concept]

Phrase: "1.0,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: "1.3,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: "2.5,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0450346:2 5 [Quantitative Concept]
   861   C0740116:+2 [Quantitative Concept]
   861   C2827735:2+ [Quantitative Concept]
   861   C2981700:2+ [Classification]

Phrase: "and"

Phrase: "5 nM of [3H"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1442460:3H [Temporal Concept]

Phrase: "]17-estradiol"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0014912:Estradiol [Hormone,Pharmacologic Substance,Steroid]
   805 E C0699352:Estrace [Hormone,Pharmacologic Substance,Steroid]
   805 E C0878472:Progynon [Hormone,Pharmacologic Substance,Steroid]

Phrase: "or"

Phrase: "17-estradiol"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0014912:Estradiol [Hormone,Pharmacologic Substance,Steroid]
   805 E C0699352:Estrace [Hormone,Pharmacologic Substance,Steroid]
   805 E C0878472:Progynon [Hormone,Pharmacologic Substance,Steroid]

Phrase: "was"

Phrase: "measured in three independent experiments"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   760   C0085862:Independent [Idea or Concept]
   760   C0205449:Three [Quantitative Concept]
   760   C0444706:Measured [Qualitative Concept]
   760   C0681814:Experiments [Research Activity]
   760   C1299583:Independent [Finding]
   760   C3541902:MEASURED [Diagnostic Procedure]
   726 E C0079809:Measure [Quantitative Concept]
   726 E C0242485:Measure [Functional Concept]
   726 E C1706386:Experiment [Conceptual Entity]

Phrase: "for ER"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0034804:Estrogen receptor [Amino Acid, Peptide, or Protein,Receptor]
  1000   C1414461:ESTROGEN RECEPTOR [Gene or Genome]
  1000   C1521863:Estrogen Receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
   861   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C2936882:Estrogen [Pharmacologic Substance]
   789 E C0720298:Estrogenic [Hormone,Organic Chemical,Pharmacologic Substance]

Phrase: "and in two independent experiments"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   760   C0085862:Independent [Idea or Concept]
   760   C0205448:Two [Quantitative Concept]
   760   C0681814:Experiments [Research Activity]
   760   C1299583:Independent [Finding]
   760   C1515981:And [Idea or Concept]
   726 E C1706386:Experiment [Conceptual Entity]

Phrase: "for ER or rat uterine cytosol."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C1383501:Cytosol [Cell Component]
Processing 00000000.tx.138: Although estrogen binding studies were attempted with brain tissue, the counts for specific activity were too low, compared with the total binding, and increasing the amount of protein per assay resulted only in higher nonspecific binding activity. 

Phrase: "Although"

Phrase: "estrogen binding studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0947630:studies [Laboratory Procedure]
   793 E C0557651:Study [Manufactured Object]
   793 E C2603343:Study [Research Activity]

Phrase: "were"

Phrase: "attempted with brain tissue,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C0440746:Brain tissue [Tissue]
   833   C0459385:Brain tissue [Body Part, Organ, or Organ Component]
   770   C0006104:Brain [Body Part, Organ, or Organ Component]
   770   C0040300:Tissue [Tissue]
   770   C1269537:Brain [Body Part, Organ, or Organ Component]
   770   C1547928:Tissue [Intellectual Product]
   737   C1516084:Attempt [Event]

Phrase: "the counts for specific activity"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   760   C0439157:counts [Quantitative Concept]
   726 E C0750480:Count [Activity]
   726 E C1705566:Count [Quantitative Concept]

Phrase: "were"

Phrase: "too low,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205251:low [Qualitative Concept]
   861   C1299352:Low [Qualitative Concept]
   861   C1550472:low [Idea or Concept]

Phrase: "compared with the total binding,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0243122:binding [Functional Concept]
   760   C0439175:% total [Quantitative Concept]
   760   C0439810:Total [Qualitative Concept]
   760   C1145667:Binding [Activity]
   760   C1167622:Binding [Molecular Function]
   760   C1707455:Compared [Activity]

Phrase: "and"

Phrase: "increasing"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442808:Increasing [Functional Concept]
   966 E C0442805:Increase [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0205217:Increased [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "the amount of protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1265611:Amount [Quantitative Concept]

Phrase: "per assay"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0005507:Assay [Laboratory Procedure]
  1000   C0243073:assay [Qualitative Concept]
  1000   C1510438:Assay [Laboratory Procedure]

Phrase: "resulted"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "only in higher nonspecific binding activity."
Meta Candidates (Total=15; Excluded=0; Pruned=0; Remaining=15)
   790   C2266866:Binding Activity [Molecular Function]
   753   C0205171:Only [Quantitative Concept]
   753   C0205177:Activity [Functional Concept]
   753   C0205370:Non-specific [Qualitative Concept]
   753   C0243122:binding [Functional Concept]
   753   C0439167:% activity [Quantitative Concept]
   753   C0441655:Activity [Activity]
   753   C0750540:Nonspecific [Idea or Concept]
   753   C1145667:Binding [Activity]
   753   C1167622:Binding [Molecular Function]
   753   C1561536:*Activity [Idea or Concept]
   753   C1720467:Only [Intellectual Product]
   719   C0205250:High [Qualitative Concept]
   719   C1299351:High [Qualitative Concept]
   719   C2700149:HIGH [Intellectual Product]
Processing 00000000.tx.139: The specific activity of the commercially available 17-estradiol is higher than 100 Ci/mmol, but a specific activity of only 34 Ci/mmol was the best we could obtain for our custom tritium-labeled 17-estradiol from the manufacturer. 

Phrase: "The specific activity of the commercially available 17-estradiol"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   742   C0205177:Activity [Functional Concept]
   742   C0205369:Specific [Qualitative Concept]
   742   C0439167:% activity [Quantitative Concept]
   742   C0441655:Activity [Activity]
   742   C1552740:specific [Intellectual Product]
   742   C1561536:*Activity [Idea or Concept]

Phrase: "is"

Phrase: "higher than 100 Ci/mmol,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   726   C0205250:High [Qualitative Concept]
   726   C1299351:High [Qualitative Concept]
   726   C2700149:HIGH [Intellectual Product]

Phrase: "but"

Phrase: "a specific activity of only 34 Ci/mmol"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   744   C0205177:Activity [Functional Concept]
   744   C0205369:Specific [Qualitative Concept]
   744   C0439167:% activity [Quantitative Concept]
   744   C0441655:Activity [Activity]
   744   C1552740:specific [Intellectual Product]
   744   C1561536:*Activity [Idea or Concept]

Phrase: "was"

Phrase: "the best"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1522427:Best [Qualitative Concept]

Phrase: "we"

Phrase: "could"

Phrase: "obtain for our custom tritium-"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   760   C0041119:Tritium [Element, Ion, or Isotope]
   760   C0162343:Custom [Idea or Concept]
   760   C1301820:Obtain [Functional Concept]
   760   C1706701:Obtain [Activity]
   760   C1880202:Custom [Activity]
   704 E C1517378:Gain [Quantitative Concept]

Phrase: "labeled"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C1708632:Labeled [Qualitative Concept]
   966 E C0181496:Label [Manufactured Object]
   966 E C2827499:Label [Governmental or Regulatory Activity]

Phrase: "17-estradiol from the manufacturer."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   760   C0014912:Estradiol [Hormone,Pharmacologic Substance,Steroid]
   704 E C0699352:Estrace [Hormone,Pharmacologic Substance,Steroid]
   704 E C0878472:Progynon [Hormone,Pharmacologic Substance,Steroid]
Processing 00000000.tx.140: In the absence of a 17-estradiol of higher specific activity, we used recombinant ER and ER proteins for our studies and confirmed our results, using uterine ERs. 

Phrase: "In the absence"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332197:absence [Quantitative Concept]
  1000   C1689985:Absence [Anatomical Abnormality]
   928 E C2699517:ABSENT [Finding]

Phrase: "of a 17-estradiol"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0014912:Estradiol [Hormone,Pharmacologic Substance,Steroid]
   805 E C0699352:Estrace [Hormone,Pharmacologic Substance,Steroid]
   805 E C0878472:Progynon [Hormone,Pharmacologic Substance,Steroid]

Phrase: "of higher specific activity,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C0205177:Activity [Functional Concept]
   827   C0205369:Specific [Qualitative Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1552740:specific [Intellectual Product]
   827   C1561536:*Activity [Idea or Concept]

Phrase: "we"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "recombinant ER"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   901   C0034804:Estrogen receptor [Amino Acid, Peptide, or Protein,Receptor]
   901   C1414461:ESTROGEN RECEPTOR [Gene or Genome]
   901   C1521863:Estrogen Receptor [Amino Acid, Peptide, or Protein,Receptor]
   827   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
   827   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   827   C2936882:Estrogen [Pharmacologic Substance]
   755 E C0720298:Estrogenic [Hormone,Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "ER proteins for our studies"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   799   C0059672:estrogen receptor protein [Amino Acid, Peptide, or Protein,Receptor]
   790   C0034804:Estrogen receptor [Amino Acid, Peptide, or Protein,Receptor]
   790   C0597357:receptor proteins [Amino Acid, Peptide, or Protein,Receptor]
           receptor
   790   C1414461:ESTROGEN RECEPTOR [Gene or Genome]
   790   C1521863:Estrogen Receptor [Amino Acid, Peptide, or Protein,Receptor]
   753   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
   753   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C2936882:Estrogen [Pharmacologic Substance]

Phrase: "and"

Phrase: "confirmed"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0521093:confirmed [Qualitative Concept]
  1000   C0750484:Confirmed [Idea or Concept]
   966 E C1456348:Confirm [Qualitative Concept]

Phrase: "our results,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "uterine ERs."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1704489:ERS [Clinical Attribute]
   861   C2931783:ERS [Disease or Syndrome]
Processing 00000000.tx.141: We extrapolated our results from the recombinant ERs and the uterine lysates to the brain because the brain and uterine ERs have the same protein sequence (18). 

Phrase: "We"

Phrase: "extrapolated"

Phrase: "our results from the recombinant ERs"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   719   C1274040:Result [Functional Concept]
   719   C1546471:Result [Idea or Concept]
   719   C2825142:Result [Finding]

Phrase: "and"

Phrase: "the uterine lysates to the brain"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   719   C1881488:Lysate [Physical Object]

Phrase: "because"

Phrase: "the brain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006104:Brain [Body Part, Organ, or Organ Component]
  1000   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "uterine ERs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1704489:ERS [Clinical Attribute]
   861   C2931783:ERS [Disease or Syndrome]

Phrase: "have"

Phrase: "the same protein sequence"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   901   C0002518:Protein Sequence [Amino Acid Sequence]
   827   C0004793:Sequence [Nucleotide Sequence]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0162326:Sequence [Nucleotide Sequence]
   827   C0162327:Sequence [Nucleotide Sequence]
   827   C1519249:Sequence [Functional Concept]
   755 E C1548958:Sequential [Idea or Concept]
   755 E C1705294:Sequential [Qualitative Concept]

Phrase: "(18"

Phrase: ")."
Processing 00000000.tx.142: To complement the binding studies, we tested whether 17-estradiol could activate transfected ER and ER (Fig. 5). 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "complement"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0009498:Complement [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "the binding studies,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "we"

Phrase: "tested"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392366:tested [Intellectual Product]
   966 E C0022885:Test [Laboratory Procedure]
   966 E C0039593:Test [Functional Concept]

Phrase: "whether"

Phrase: "17-estradiol"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0014912:Estradiol [Hormone,Pharmacologic Substance,Steroid]
   805 E C0699352:Estrace [Hormone,Pharmacologic Substance,Steroid]
   805 E C0878472:Progynon [Hormone,Pharmacologic Substance,Steroid]

Phrase: "could"

Phrase: "activate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515877:Activate [Functional Concept]
  1000   C1879547:Activate [Activity]

Phrase: "transfected ER"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   901   C0034804:Estrogen receptor [Amino Acid, Peptide, or Protein,Receptor]
   901   C1414461:ESTROGEN RECEPTOR [Gene or Genome]
   901   C1521863:Estrogen Receptor [Amino Acid, Peptide, or Protein,Receptor]
   827   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
   827   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   827   C2936882:Estrogen [Pharmacologic Substance]
   755 E C0720298:Estrogenic [Hormone,Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "ER"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0034804:Estrogen receptor [Amino Acid, Peptide, or Protein,Receptor]
  1000   C1414461:ESTROGEN RECEPTOR [Gene or Genome]
  1000   C1521863:Estrogen Receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
   861   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C2936882:Estrogen [Pharmacologic Substance]
   789 E C0720298:Estrogenic [Hormone,Organic Chemical,Pharmacologic Substance]

Phrase: "(Fig. 5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.143: Both 17-estradiol and 17-estradiol activated a luciferase reporter gene, containing an ERE in COS-7 cells transfected with ER or ER. 

Phrase: "Both 17-estradiol"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0014912:Estradiol [Hormone,Pharmacologic Substance,Steroid]
   805 E C0699352:Estrace [Hormone,Pharmacologic Substance,Steroid]
   805 E C0878472:Progynon [Hormone,Pharmacologic Substance,Steroid]

Phrase: "and"

Phrase: "17-estradiol"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0014912:Estradiol [Hormone,Pharmacologic Substance,Steroid]
   805 E C0699352:Estrace [Hormone,Pharmacologic Substance,Steroid]
   805 E C0878472:Progynon [Hormone,Pharmacologic Substance,Steroid]

Phrase: "activated"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1879547:Activated [Activity]
   966 E C1515877:Activate [Functional Concept]

Phrase: "a luciferase reporter gene,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C1334435:Luciferase Gene [Gene or Genome]
   901   C0206414:Reporter Gene [Gene or Genome]
   827   C0017337:Gene [Gene or Genome]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "an ERE in COS-7 cells"

Phrase: "transfected with ER"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C0034804:Estrogen receptor [Amino Acid, Peptide, or Protein,Receptor]
   833   C1414461:ESTROGEN RECEPTOR [Gene or Genome]
   833   C1521863:Estrogen Receptor [Amino Acid, Peptide, or Protein,Receptor]
   770   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
   770   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   770   C2936882:Estrogen [Pharmacologic Substance]

Phrase: "or"

Phrase: "ER."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0034804:Estrogen receptor [Amino Acid, Peptide, or Protein,Receptor]
  1000   C1414461:ESTROGEN RECEPTOR [Gene or Genome]
  1000   C1521863:Estrogen Receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
   861   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C2936882:Estrogen [Pharmacologic Substance]
   789 E C0720298:Estrogenic [Hormone,Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.144: Activation of the transfected ERs was blocked by the ER antagonist ICI 182,780. 

Phrase: "Activation of the transfected ERs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1879547:Activation [Activity]

Phrase: "was"

Phrase: "blocked by the ER antagonist ICI 182,780."
Meta Candidates (Total=16; Excluded=3; Pruned=0; Remaining=13)
   790   C1123005:ICI 182,780 [Pharmacologic Substance,Steroid]
   790   C2267020:Estrogen Receptor Antagonist [Pharmacologic Substance]
   764   C0034804:Estrogen receptor [Amino Acid, Peptide, or Protein,Receptor]
   764   C1414461:ESTROGEN RECEPTOR [Gene or Genome]
   764   C1521863:Estrogen Receptor [Amino Acid, Peptide, or Protein,Receptor]
   762   C0014930:Estrogen antagonist [Pharmacologic Substance]
   742   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
   742   C0028778:Blocked [Pathologic Function]
   742   C0231491:Antagonist [Organ or Tissue Function]
   742   C0332206:Blocked [Functional Concept]
   742   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   742   C2936882:Estrogen [Pharmacologic Substance]
   742   C2983591:BLOCKED [Research Activity]
   708 E C1533157:Block [Substance]
   708 E C1706084:Block [Geographic Area]
   708 E C2828370:Block [Quantitative Concept]
Processing 00000000.tx.145: No response to estrogens was observed in the cells transfected with empty vectors. 

Phrase: "No response to estrogens"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0871261:Response [Organism Attribute]
   770   C1704632:Response [Finding]
   770   C1706817:Response [Intellectual Product]
   770   C2911692:Response [Mental Process]

Phrase: "was"

Phrase: "observed in the cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   770   C0007634:Cells [Cell]
   770   C1441672:Observed [Functional Concept]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "transfected with empty vectors."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   770   C0086022:Vectors [Nucleic Acid, Nucleoside, or Nucleotide]
   770   C0442335:Vectors [Spatial Concept]
   770   C1880497:Empty [Qualitative Concept]
   737 E C1705099:Vector [Idea or Concept]
   715 E C0333668:Depleted [Functional Concept]
Processing 00000000.tx.146: View larger version (21K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(21K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.147: 5. 

Phrase: "5."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]
Processing 00000000.tx.148: Both 17-estradiol and 17-estradiol activated a luciferase reporter gene, containing an ERE in COS-7 cells transfected with ER or ER. 

Phrase: "Both 17-estradiol"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0014912:Estradiol [Hormone,Pharmacologic Substance,Steroid]
   805 E C0699352:Estrace [Hormone,Pharmacologic Substance,Steroid]
   805 E C0878472:Progynon [Hormone,Pharmacologic Substance,Steroid]

Phrase: "and"

Phrase: "17-estradiol"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0014912:Estradiol [Hormone,Pharmacologic Substance,Steroid]
   805 E C0699352:Estrace [Hormone,Pharmacologic Substance,Steroid]
   805 E C0878472:Progynon [Hormone,Pharmacologic Substance,Steroid]

Phrase: "activated"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1879547:Activated [Activity]
   966 E C1515877:Activate [Functional Concept]

Phrase: "a luciferase reporter gene,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C1334435:Luciferase Gene [Gene or Genome]
   901   C0206414:Reporter Gene [Gene or Genome]
   827   C0017337:Gene [Gene or Genome]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "an ERE in COS-7 cells"

Phrase: "transfected with ER"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C0034804:Estrogen receptor [Amino Acid, Peptide, or Protein,Receptor]
   833   C1414461:ESTROGEN RECEPTOR [Gene or Genome]
   833   C1521863:Estrogen Receptor [Amino Acid, Peptide, or Protein,Receptor]
   770   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
   770   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   770   C2936882:Estrogen [Pharmacologic Substance]

Phrase: "or"

Phrase: "ER."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0034804:Estrogen receptor [Amino Acid, Peptide, or Protein,Receptor]
  1000   C1414461:ESTROGEN RECEPTOR [Gene or Genome]
  1000   C1521863:Estrogen Receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
   861   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C2936882:Estrogen [Pharmacologic Substance]
   789 E C0720298:Estrogenic [Hormone,Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.149: The ERE-luciferase activity was normalized against Renilla luciferase (Promega) activity. 

Phrase: "The ERE-luciferase activity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1151115:luciferase activity [Molecular Function]
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]

Phrase: "was"

Phrase: "normalized against Renilla luciferase"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0024075:Luciferase [Amino Acid, Peptide, or Protein,Enzyme,Indicator, Reagent, or Diagnostic Aid]
   770   C1093003:Renilla [Eukaryote]
   770   C1882115:Normalized [Research Activity]

Phrase: "(Promega"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0072149:Promega [Lipid]

Phrase: ")"

Phrase: "activity."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0205177:Activity [Functional Concept]
  1000   C0439167:% activity [Quantitative Concept]
  1000   C0441655:Activity [Activity]
  1000   C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.150: Each column represents mean  SEM of three independent experiments done in duplicates.  

Phrase: "Each column"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1185738:Column [Body Part, Organ, or Organ Component]
  1000   C1706132:Column [Idea or Concept]

Phrase: "represents"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "mean  SEM of three independent experiments"

Phrase: "done in duplicates."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0205173:duplicates [Functional Concept]
   790   C1272695:Done [Qualitative Concept]
   790   C2746065:Done [Temporal Concept]
   756 E C3539942:Duplicate [Intellectual Product]
Processing 00000000.tx.151: Because 17-estradiol is known to bind AFP, the principal estrogen-binding plasma protein of the developing rodent, with high affinity (17), we characterized the extent to which 17-estradiol bound AFP. 

Phrase: "Because"

Phrase: "17-estradiol"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0014912:Estradiol [Hormone,Pharmacologic Substance,Steroid]
   805 E C0699352:Estrace [Hormone,Pharmacologic Substance,Steroid]
   805 E C0878472:Progynon [Hormone,Pharmacologic Substance,Steroid]

Phrase: "is"

Phrase: "known"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205309:Known [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "bind"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1145667:Bind [Activity]
  1000   C1167622:bind [Molecular Function]

Phrase: "AFP,"

Phrase: "the principal estrogen-binding plasma protein of the developing rodent,"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   777   C0059672:Estrogen binding protein [Amino Acid, Peptide, or Protein,Receptor]
   760   C0032120:Plasma protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0036825:Plasma Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   757   C0033618:Protein Binding [Molecular Function]
   757   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   757 E C1168405:protein plasma [Laboratory Procedure]
   739   C0032105:Plasma [Body Substance]
   739   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]

Phrase: "with high affinity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0205250:High [Qualitative Concept]
   861   C1299351:High [Qualitative Concept]
   861   C1510827:Affinity [Natural Phenomenon or Process]
   861   C2700149:HIGH [Intellectual Product]

Phrase: "(17"

Phrase: ")"

Phrase: ","

Phrase: "we"

Phrase: "characterized"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1880022:Characterized [Activity]

Phrase: "the extent to which 17-estradiol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0439792:Extent [Spatial Concept]

Phrase: "bound"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0332297:bound [Spatial Concept]
  1000   C1145667:Bound [Activity]
  1000   C1167622:Bound [Molecular Function]
  1000   C1689898:% bound [Quantitative Concept]
  1000   C2349209:Bound [Conceptual Entity]

Phrase: "AFP."
Processing 00000000.tx.152: It had been reported earlier that 17-estradiol has a high affinity for AFP as well (19), and whereas we also obtained some displacement of [3H]17-estradiol from serum AFP by 500-fold molar excess of 17-estradiol, the displacement was minimal. 

Phrase: "It"

Phrase: "had"

Phrase: "been"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "earlier"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1279919:Early [Temporal Concept]

Phrase: "that 17-estradiol"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0014912:Estradiol [Hormone,Pharmacologic Substance,Steroid]
   805 E C0699352:Estrace [Hormone,Pharmacologic Substance,Steroid]
   805 E C0878472:Progynon [Hormone,Pharmacologic Substance,Steroid]

Phrase: "has"

Phrase: "a high affinity for AFP"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0205250:High [Qualitative Concept]
   760   C1299351:High [Qualitative Concept]
   760   C1510827:Affinity [Natural Phenomenon or Process]
   760   C2700149:HIGH [Intellectual Product]

Phrase: "as well"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205170:Well [Qualitative Concept]
  1000   C3146287:Well [Manufactured Object]

Phrase: "(19"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "whereas"

Phrase: "we also"

Phrase: "obtained"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C1301820:Obtained [Functional Concept]
   966 E C1706701:Obtain [Activity]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0205217:Increased [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442805:Increase [Functional Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "some displacement of [3H"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1442460:3H [Temporal Concept]

Phrase: "]17-estradiol from serum AFP"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   797   C0474672:estradiol serum [Laboratory Procedure]
   760   C0014912:Estradiol [Hormone,Pharmacologic Substance,Steroid]
   704 E C0699352:Estrace [Hormone,Pharmacologic Substance,Steroid]
   704 E C0878472:Progynon [Hormone,Pharmacologic Substance,Steroid]

Phrase: "by 500-fold molar excess"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1979886:Excess [Qualitative Concept]

Phrase: "of 17-estradiol,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0014912:Estradiol [Hormone,Pharmacologic Substance,Steroid]
   805 E C0699352:Estrace [Hormone,Pharmacologic Substance,Steroid]
   805 E C0878472:Progynon [Hormone,Pharmacologic Substance,Steroid]

Phrase: "the displacement"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0012725:Displacement [Mental Process]
  1000   C0012727:Displacement [Spatial Concept]
  1000   C0456080:Displacement [Qualitative Concept]
  1000   C2347509:Displacement [Phenomenon or Process]

Phrase: "was"

Phrase: "minimal."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0547040:Minimal [Qualitative Concept]
  1000   C1524031:MINIMAL [Qualitative Concept]
  1000   C2945599:Minimal [Qualitative Concept]
   928 E C1552614:minimum [Idea or Concept]
   928 E C2826545:MINIMUM [Quantitative Concept]
Processing 00000000.tx.153: For a total binding of 2025 x 1000 cpm/sample, 500-fold molar excess of 17-estradiol resulted in 1720 x 1000 cpm, some 20% displacement. 

Phrase: "For a total binding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0243122:binding [Functional Concept]
   861   C1145667:Binding [Activity]
   861   C1167622:Binding [Molecular Function]

Phrase: "of 2025 x 1000 cpm/sample,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0370003:Sample [Substance]
   804   C2347026:Sample [Conceptual Entity]

Phrase: "500-fold molar excess of 17-estradiol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1979886:Excess [Qualitative Concept]

Phrase: "resulted in 1720 x 1000 cpm,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   719   C1274040:Result [Functional Concept]
   719   C1546471:Result [Idea or Concept]
   719   C2825142:Result [Finding]

Phrase: "some 20% displacement."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0012725:Displacement [Mental Process]
   861   C0012727:Displacement [Spatial Concept]
   861   C0456080:Displacement [Qualitative Concept]
   861   C2347509:Displacement [Phenomenon or Process]
Processing 00000000.tx.154: This suggests that 17-estradiol has very low affinity for AFP. 

Phrase: "This"

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that 17-estradiol"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0014912:Estradiol [Hormone,Pharmacologic Substance,Steroid]
   805 E C0699352:Estrace [Hormone,Pharmacologic Substance,Steroid]
   805 E C0878472:Progynon [Hormone,Pharmacologic Substance,Steroid]

Phrase: "has"

Phrase: "very low affinity for AFP."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C0442811:Very low [Finding]
   760   C0205251:low [Qualitative Concept]
   760   C1299352:Low [Qualitative Concept]
   760   C1510827:Affinity [Natural Phenomenon or Process]
   760   C1550472:low [Idea or Concept]
Processing 00000000.tx.155: In fact, the concentration of 17-estradiol used in the displacement studies was in the micromolar range, which could result in some nonspecific suppression of 17-estradiol binding. 

Phrase: "In fact,"

Phrase: "the concentration of 17-estradiol"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0086045:Concentration [Mental Process]
   760   C1446561:Concentration [Quantitative Concept]

Phrase: "used in the displacement studies"
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
   781   C0869040:Use studies [Research Activity]
   760   C0012725:Displacement [Mental Process]
   760   C0012727:Displacement [Spatial Concept]
   760   C0456080:Displacement [Qualitative Concept]
   760   C0947630:studies [Laboratory Procedure]
   760   C1273517:used [Finding]
   760   C2347509:Displacement [Phenomenon or Process]
   726 E C0042153:use [Functional Concept]
   726 E C0457083:Use [Functional Concept]
   726 E C0557651:Study [Manufactured Object]
   726 E C1947944:Use [Intellectual Product]
   726 E C2603343:Study [Research Activity]

Phrase: "was in the micromolar range,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0043194:WAS [Disease or Syndrome]
   760   C0258432:WAS [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0439300:micromolar [Quantitative Concept]
   760   C1421478:WAS [Gene or Genome]
   760   C1514721:Range [Quantitative Concept]
   760   C2348147:Range [Quantitative Concept]
   760   C3542016:Range [Intellectual Product]

Phrase: "which"

Phrase: "could"

Phrase: "result in some nonspecific suppression of 17-estradiol binding."
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   742   C0014912:Estradiol [Hormone,Pharmacologic Substance,Steroid]
   742   C0205370:Non-specific [Qualitative Concept]
   742   C0221103:Suppression [Pathologic Function]
   742   C0243122:binding [Functional Concept]
   742   C0301625:Suppression [Organism Function]
   742   C0439181:% suppression [Quantitative Concept]
   742   C0728721:suppression [Mental Process]
   742   C0750540:Nonspecific [Idea or Concept]
   742   C1145667:Binding [Activity]
   742   C1167622:Binding [Molecular Function]
   742   C1274040:Result [Functional Concept]
   742   C1546471:Result [Idea or Concept]
   742   C2825142:Result [Finding]
Processing 00000000.tx.156: However, when [3H]17-estradiol was used to determine its affinity for AFP, AFP did not bind 17-estradiol at all (Fig. 6). 

Phrase: "However,"

Phrase: "when"

Phrase: "[3H"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1442460:3H [Temporal Concept]

Phrase: "]17-estradiol"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0014912:Estradiol [Hormone,Pharmacologic Substance,Steroid]
   805 E C0699352:Estrace [Hormone,Pharmacologic Substance,Steroid]
   805 E C0878472:Progynon [Hormone,Pharmacologic Substance,Steroid]

Phrase: "was"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "its affinity for AFP,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1510827:Affinity [Natural Phenomenon or Process]

Phrase: "AFP"

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "bind"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1145667:Bind [Activity]
  1000   C1167622:bind [Molecular Function]

Phrase: "17-estradiol at all (Fig. 6"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0014912:Estradiol [Hormone,Pharmacologic Substance,Steroid]

Phrase: ")."
Processing 00000000.tx.157: For example, 17-estradiol may interact very weakly with the AFP ligand binding pocket and may compete with 17-estradiol at very high concentrations. 

Phrase: "For example,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707959:Example [Conceptual Entity]

Phrase: "17-estradiol"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0014912:Estradiol [Hormone,Pharmacologic Substance,Steroid]
   805 E C0699352:Estrace [Hormone,Pharmacologic Substance,Steroid]
   805 E C0878472:Progynon [Hormone,Pharmacologic Substance,Steroid]

Phrase: "may"

Phrase: "interact"

Phrase: "very weakly with the AFP ligand binding pocket"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C1517880:Ligand Binding [Molecular Function]
   744   C0023688:Ligand [Chemical]
   744   C0243122:binding [Functional Concept]
   744   C0442824:Very [Qualitative Concept]
   744   C1145667:Binding [Activity]
   744   C1167622:Binding [Molecular Function]

Phrase: "and"

Phrase: "may"

Phrase: "compete with 17-estradiol"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   770   C0014912:Estradiol [Hormone,Pharmacologic Substance,Steroid]
   715 E C0699352:Estrace [Hormone,Pharmacologic Substance,Steroid]
   715 E C0878472:Progynon [Hormone,Pharmacologic Substance,Steroid]

Phrase: "at very high concentrations."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0086045:Concentrations [Mental Process]
   793 E C1446561:Concentration [Quantitative Concept]
   743 E C1880165:Concentrated [Biomedical or Dental Material]
   734   C0442804:Very high [Finding]
Processing 00000000.tx.158: But no specific binding could be detected, when we used the labeled 17-estradiol at a nanomolar concentration. 

Phrase: "But"

Phrase: "no specific binding"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0205369:Specific [Qualitative Concept]
   861   C0243122:binding [Functional Concept]
   861   C1145667:Binding [Activity]
   861   C1167622:Binding [Molecular Function]
   861   C1552740:specific [Intellectual Product]

Phrase: "could"

Phrase: "be"

Phrase: "detected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442726:Detected [Finding]
  1000   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: ","

Phrase: "when"

Phrase: "we"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the labeled 17-estradiol at a nanomolar concentration."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0014912:Estradiol [Hormone,Pharmacologic Substance,Steroid]
Processing 00000000.tx.159: Similarly, SHBG, the estrogen-binding plasma protein of the developing primate, did not bind 17-estradiol to any extent (data not shown) and was not further evaluated. 

Phrase: "Similarly,"

Phrase: "SHBG,"

Phrase: "the estrogen-binding plasma protein of the developing primate,"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   784   C0059672:Estrogen binding protein [Amino Acid, Peptide, or Protein,Receptor]
   764   C0032120:Plasma protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   764   C0036825:Plasma Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   762   C0033618:Protein Binding [Molecular Function]
   762   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   762 E C1168405:protein plasma [Laboratory Procedure]
   742   C0032105:Plasma [Body Substance]
   742   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "bind"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1145667:Bind [Activity]
  1000   C1167622:bind [Molecular Function]

Phrase: "17-estradiol to any extent"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   760   C0014912:Estradiol [Hormone,Pharmacologic Substance,Steroid]
   704 E C0699352:Estrace [Hormone,Pharmacologic Substance,Steroid]
   704 E C0878472:Progynon [Hormone,Pharmacologic Substance,Steroid]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")"

Phrase: "and"

Phrase: "was"

Phrase: "not further"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C1517331:Further [Spatial Concept]
   861   C1518422:Not [Functional Concept]
   827 E C0205108:far [Spatial Concept]

Phrase: "evaluated."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0220825:Evaluated [Functional Concept]
Processing 00000000.tx.160: On the other hand, no marked differences in specific binding to adult mouse or human serum were found between the two estradiols (Fig. 6). 

Phrase: "On the"

Phrase: "other hand,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0018563:Hand [Body Part, Organ, or Organ Component]
  1000   C1281583:Hand [Body Part, Organ, or Organ Component]
  1000   C1552914:hand [Quantitative Concept]
   944 E C0024763:Manual [Intellectual Product,Manufactured Object]
   944 E C0175674:Manual [Functional Concept]

Phrase: "no marked differences in specific binding"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   719   C1705241:*Difference [Quantitative Concept]
   719   C1705242:Difference [Qualitative Concept]

Phrase: "to adult mouse"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025914:Mouse [Mammal]
   861   C0025929:mouse [Mammal]
   861   C0026809:Mouse [Mammal]

Phrase: "or"

Phrase: "human serum"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0086418:Human [Human]
   861   C0229671:Serum [Body Substance]
   861   C1546774:Serum [Intellectual Product]
   861   C1550100:Serum [Body Substance]

Phrase: "were"

Phrase: "found between the two estradiols"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   760   C0014912:estradiols [Hormone,Pharmacologic Substance,Steroid]
   760   C0150312:Found [Quantitative Concept]
   760   C0205448:Two [Quantitative Concept]
   726 E C0243095:Find [Finding]

Phrase: "(Fig. 6"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.161: View larger version (14K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(14K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.162: 6. 

Phrase: "6."
Processing 00000000.tx.163: Specific binding of [3H]17-estradiol (open triangle) and [3H]17-estradiol (solid triangle) to P7 mouse serum, which is rich in AFP (diluted 2000 times). 

Phrase: "Specific binding of [3H"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1442460:3H [Temporal Concept]

Phrase: "]17-estradiol"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0014912:Estradiol [Hormone,Pharmacologic Substance,Steroid]
   805 E C0699352:Estrace [Hormone,Pharmacologic Substance,Steroid]
   805 E C0878472:Progynon [Hormone,Pharmacologic Substance,Steroid]

Phrase: "(open triangle"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205119:Triangle [Conceptual Entity]

Phrase: ")"

Phrase: "and ["

Phrase: "3H"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1442460:3H [Temporal Concept]

Phrase: "]17-estradiol"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0014912:Estradiol [Hormone,Pharmacologic Substance,Steroid]
   805 E C0699352:Estrace [Hormone,Pharmacologic Substance,Steroid]
   805 E C0878472:Progynon [Hormone,Pharmacologic Substance,Steroid]

Phrase: "(solid triangle"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205119:Triangle [Conceptual Entity]

Phrase: ")"

Phrase: "to P7 mouse serum,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0229671:Serum [Body Substance]
   827   C1546774:Serum [Intellectual Product]
   827   C1550100:Serum [Body Substance]

Phrase: "which"

Phrase: "is"

Phrase: "rich in AFP ("
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0699759:Rich [Qualitative Concept]

Phrase: "diluted"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1720119:Dilute [Functional Concept]
   966   C1948037:Dilute [Functional Concept]

Phrase: "2000 times"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0040223:times [Temporal Concept]
   861   C1632851:Times [Quantitative Concept]
   827 E C3541383:Time [Temporal Concept]
   789 E C0442043:Temporal [Spatial Concept]
   789 E C2362314:Temporal [Temporal Concept]

Phrase: ")."
Processing 00000000.tx.164: The binding isotherm for [3H]17-estradiol represents one assay done in duplicates. 

Phrase: "The binding isotherm for"

Phrase: "[3H"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1442460:3H [Temporal Concept]

Phrase: "]17-estradiol"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0014912:Estradiol [Hormone,Pharmacologic Substance,Steroid]
   805 E C0699352:Estrace [Hormone,Pharmacologic Substance,Steroid]
   805 E C0878472:Progynon [Hormone,Pharmacologic Substance,Steroid]

Phrase: "represents"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "one assay"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0005507:Assay [Laboratory Procedure]
   861   C0243073:assay [Qualitative Concept]
   861   C1510438:Assay [Laboratory Procedure]

Phrase: "done in duplicates."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0205173:duplicates [Functional Concept]
   790   C1272695:Done [Qualitative Concept]
   790   C2746065:Done [Temporal Concept]
   756 E C3539942:Duplicate [Intellectual Product]
Processing 00000000.tx.165: No specific binding to AFP was detectable for [3H]17-estradiol in the range of 1.2510 nM. 

Phrase: "No specific binding to AFP"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   797   C2610645:NO binding [Molecular Function]
   760   C0205369:Specific [Qualitative Concept]
   760   C0243122:binding [Functional Concept]
   760   C1145667:Binding [Activity]
   760   C1167622:Binding [Molecular Function]
   760   C1552740:specific [Intellectual Product]

Phrase: "was"

Phrase: "detectable for"

Phrase: "[3H"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1442460:3H [Temporal Concept]

Phrase: "]17-estradiol in the range of 1.2510 nM."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0014912:Estradiol [Hormone,Pharmacologic Substance,Steroid]
Processing 00000000.tx.166: This was repeated at least five times with 10 nM of [3H]17-estradiol as a positive control, in which high specific binding was seen each time (data not shown). 

Phrase: "This"

Phrase: "was"

Phrase: "repeated at least five times"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   760   C0040223:times [Temporal Concept]
   760   C0205341:Repeated [Functional Concept]
   760   C0205451:Five [Quantitative Concept]
   760   C1632851:Times [Quantitative Concept]
   726 E C1547730:Repeat [Temporal Concept]
   726 E C1705914:Repeat [Conceptual Entity]
   726 E C3541383:Time [Temporal Concept]

Phrase: "with 10 nM of [3H"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1442460:3H [Temporal Concept]

Phrase: "]17-estradiol as a positive control,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0014912:Estradiol [Hormone,Pharmacologic Substance,Steroid]

Phrase: "in which high specific binding"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0205369:Specific [Qualitative Concept]
   827   C0243122:binding [Functional Concept]
   827   C1145667:Binding [Activity]
   827   C1167622:Binding [Molecular Function]
   827   C1552740:specific [Intellectual Product]

Phrase: "was"

Phrase: "seen"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0205397:Seen [Qualitative Concept]
   966 E C0042789:see [Organism Function]
   966 E C1947903:See [Activity]

Phrase: "each time"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0040223:Time [Temporal Concept]
  1000   C3541383:Time [Temporal Concept]
   944 E C0442043:Temporal [Spatial Concept]
   944 E C2362314:Temporal [Temporal Concept]
   916 E C1632851:Times [Quantitative Concept]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.167: Inset, Specific binding of 2 nM of [3H]17-estradiol (open columns) and [3H]17-estradiol (closed columns) to adult mouse and human serum (diluted 200 times) and SHBG (1 nM).   

Phrase: "Inset,"

Phrase: "Specific binding of 2 nM of [3H"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C0205369:Specific [Qualitative Concept]
   748   C0243122:binding [Functional Concept]
   748   C1145667:Binding [Activity]
   748   C1167622:Binding [Molecular Function]
   748   C1552740:specific [Intellectual Product]

Phrase: "]17-estradiol"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0014912:Estradiol [Hormone,Pharmacologic Substance,Steroid]
   805 E C0699352:Estrace [Hormone,Pharmacologic Substance,Steroid]
   805 E C0878472:Progynon [Hormone,Pharmacologic Substance,Steroid]

Phrase: "(open columns"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1185738:Column [Body Part, Organ, or Organ Component]
   827   C1706132:Column [Idea or Concept]

Phrase: ")"

Phrase: "and ["

Phrase: "3H"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1442460:3H [Temporal Concept]

Phrase: "]17-estradiol"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0014912:Estradiol [Hormone,Pharmacologic Substance,Steroid]
   805 E C0699352:Estrace [Hormone,Pharmacologic Substance,Steroid]
   805 E C0878472:Progynon [Hormone,Pharmacologic Substance,Steroid]

Phrase: "(closed columns"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1185738:Column [Body Part, Organ, or Organ Component]
   827   C1706132:Column [Idea or Concept]

Phrase: ")"

Phrase: "to adult mouse"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025914:Mouse [Mammal]
   861   C0025929:mouse [Mammal]
   861   C0026809:Mouse [Mammal]

Phrase: "and"

Phrase: "human serum"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0086418:Human [Human]
   861   C0229671:Serum [Body Substance]
   861   C1546774:Serum [Intellectual Product]
   861   C1550100:Serum [Body Substance]

Phrase: "("

Phrase: "diluted"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1720119:Dilute [Functional Concept]
   966   C1948037:Dilute [Functional Concept]

Phrase: "200 times"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0040223:times [Temporal Concept]
   861   C1632851:Times [Quantitative Concept]
   827 E C3541383:Time [Temporal Concept]
   789 E C0442043:Temporal [Spatial Concept]
   789 E C2362314:Temporal [Temporal Concept]

Phrase: ")"

Phrase: "and"

Phrase: "SHBG"

Phrase: "(1 nM)."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0312860:NM [Cell Function]
Processing 00000000.tx.168: Discussion Top Abstract Introduction Materials and Methods Results Discussion References  We report here the identification of significantly elevated endogenous levels of 17-estradiol and E1 in the brains of postnatal and adult mice of both sexes. 

Phrase: "Discussion Top Abstract Introduction Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "Methods Results Discussion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "We"

Phrase: "report"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0684224:Report [Intellectual Product]
  1000   C0700287:Report [Health Care Activity]
  1000   C3273238:Report [Intellectual Product]

Phrase: "here"

Phrase: "the identification of significantly"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0020792:Identification [Mental Process]
   770   C0205396:Identification [Qualitative Concept]

Phrase: "elevated"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205250:Elevated [Qualitative Concept]
  1000   C3163633:Elevated [Qualitative Concept]

Phrase: "endogenous levels of 17-estradiol"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   781   C0337434:Oestradiol level [Laboratory Procedure]
   760   C0441889:Levels [Qualitative Concept]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]

Phrase: "and"

Phrase: "E1 in the brains of postnatal"

Phrase: "and"

Phrase: "adult mice of both sexes."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0025914:Mice [Mammal]
   760   C0025929:mice [Mammal]
   760   C0026809:Mice [Mammal]
Processing 00000000.tx.169: The presence of such elevated levels was unexpected because the stereo-specificity of the ER for 17-estradiol has been presented for decades as a classical example of the preference of living organisms for only one of two enantiomers. 

Phrase: "The presence of such elevated levels"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "was"

Phrase: "unexpected"

Phrase: "because"

Phrase: "the stereo-specificity of the ER"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0037791:Specificity [Quantitative Concept]
   748   C1511884:Specificity [Quantitative Concept]

Phrase: "for 17-estradiol"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0014912:Estradiol [Hormone,Pharmacologic Substance,Steroid]
   805 E C0699352:Estrace [Hormone,Pharmacologic Substance,Steroid]
   805 E C0878472:Progynon [Hormone,Pharmacologic Substance,Steroid]

Phrase: "has"

Phrase: "been"

Phrase: "presented for decades"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0449450:Presented [Idea or Concept]
   756 E C0150312:Present [Quantitative Concept]
   756   C2981279:Decade [Quantitative Concept]

Phrase: "as a classical example"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439858:classical example [Qualitative Concept]
   861   C1707959:Example [Conceptual Entity]

Phrase: "of the preference"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0558295:preference [Idea or Concept]
  1000   C1549513:Preference [Idea or Concept]

Phrase: "of living organisms"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0029235:LIVING ORGANISMS [Organism]
           Organisms

Phrase: "for only one"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205447:One [Quantitative Concept]

Phrase: "of two enantiomers."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0599473:enantiomers [Chemical Viewed Structurally]
   827 E C3539649:enantiomer [Phenomenon or Process]
Processing 00000000.tx.170: Nonetheless, previous studies (19) have reported that 17-estradiol elicits genomic (classical) estrogenic responses in a human breast cancer cell line, with an estimated Kd of 0.7 nM, which is comparable with that of 17-estradiol (0.2 nM) and with what we found for uterine cytosol (Kd = 0.4 nM). 

Phrase: "Nonetheless,"

Phrase: "previous studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "(19"

Phrase: ")"

Phrase: "have"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "that 17-estradiol"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0014912:Estradiol [Hormone,Pharmacologic Substance,Steroid]
   805 E C0699352:Estrace [Hormone,Pharmacologic Substance,Steroid]
   805 E C0878472:Progynon [Hormone,Pharmacologic Substance,Steroid]

Phrase: "elicits"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449265:elicit [Qualitative Concept]

Phrase: "genomic"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017428:Genomic [Gene or Genome]
  1000   C0887950:genomic [Biomedical Occupation or Discipline]

Phrase: "(classical"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439858:Classical [Qualitative Concept]
  1000   C0443177:Classical [Functional Concept]

Phrase: ")"

Phrase: "estrogenic responses in a human breast cancer cell line,"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   742   C0871261:responses [Organism Attribute]
   708 E C1704632:Response [Finding]
   708 E C1706817:Response [Intellectual Product]
   708 E C2911692:Response [Mental Process]

Phrase: "with an estimated Kd"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0026691:KD [Disease or Syndrome]
   861   C1705240:KD [Gene or Genome]
   861   C1839259:KD [Disease or Syndrome]

Phrase: "of 0.7 nM,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0312860:NM [Cell Function]

Phrase: "which"

Phrase: "is"

Phrase: "comparable with that of 17-estradiol"

Phrase: "(0.2 nM)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0312860:NM [Cell Function]

Phrase: "and with what"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1515981:And [Idea or Concept]

Phrase: "we"

Phrase: "found for uterine cytosol"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0042149:Uterine [Body Part, Organ, or Organ Component]
   770   C0150312:Found [Quantitative Concept]
   770   C1383501:Cytosol [Cell Component]
   737 E C0243095:Find [Finding]

Phrase: "(Kd = 0.4 nM)."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0312860:NM [Cell Function]
Processing 00000000.tx.171: The presence of significantly elevated endogenous levels of 17-estradiol in various brain regions, in association with barely detectable serum levels of this estrogen, strongly suggest that the endogenous levels of 17-estradiol in the brain must be derived from local synthesis. 

Phrase: "The presence of significantly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "elevated"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205250:Elevated [Qualitative Concept]
  1000   C3163633:Elevated [Qualitative Concept]

Phrase: "endogenous levels of 17-estradiol"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   781   C0337434:Oestradiol level [Laboratory Procedure]
   760   C0441889:Levels [Qualitative Concept]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]

Phrase: "in various brain regions,"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   901   C1273723:brain regions [Body Location or Region]
   827   C0006104:Brain [Body Part, Organ, or Organ Component]
   827   C1269537:Brain [Body Part, Organ, or Organ Component]
   793   C0017446:Region [Geographic Area]
   793   C0205147:Region [Spatial Concept]
   743 E C0205276:Regional [Spatial Concept]
   743 E C1947913:Regional [Spatial Concept]

Phrase: "in association"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0004083:Association [Mental Process]
  1000   C0439849:Association [Qualitative Concept]
  1000   C0596306:Association [Phenomenon or Process]
  1000   C0699792:association [Social Behavior]

Phrase: "with barely detectable serum levels"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   812   C0229671:Serum [Body Substance]
   812   C0441889:Levels [Qualitative Concept]
   812   C1546774:Serum [Intellectual Product]
   812   C1550100:Serum [Body Substance]
   779 E C0456079:Level [Classification]
   779 E C1547707:Level [Geographic Area]
   779 E C2946261:Level [Pharmacologic Substance]

Phrase: "of this estrogen,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
  1000   C2936882:Estrogen [Pharmacologic Substance]
   928 E C0720298:Estrogenic [Hormone,Organic Chemical,Pharmacologic Substance]

Phrase: "strongly"

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the endogenous levels of 17-estradiol"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   767   C0337434:Oestradiol level [Laboratory Procedure]
   753   C0441889:Levels [Qualitative Concept]
   719 E C0456079:Level [Classification]
   719 E C1547707:Level [Geographic Area]
   719 E C2946261:Level [Pharmacologic Substance]

Phrase: "in the brain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006104:Brain [Body Part, Organ, or Organ Component]
  1000   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "must"

Phrase: "be"

Phrase: "derived from local synthesis."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0205276:Local [Spatial Concept]
   770   C0220781:synthesis [Biologic Function]
   770   C1441547:Derived [Qualitative Concept]
   770   C1883254:Synthesis [Activity]
   770   C3245521:derived [Idea or Concept]
Processing 00000000.tx.172: To investigate this possibility, we measured the levels of 17-estradiol, 17-estradiol, and E1 in gonadectomized and gonadectomized-adrenalectomized mice, in which we found even more elevated levels of 17-estradiol in all the samples. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "investigate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigate [Functional Concept]

Phrase: "this possibility,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   928   C0332149:Possible [Qualitative Concept]
   928   C1705910:Possible [Qualitative Concept]
   928   C2362652:Possible [Qualitative Concept]

Phrase: "we"

Phrase: "measured"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0444706:Measured [Qualitative Concept]
  1000   C3541902:MEASURED [Diagnostic Procedure]
   966 E C0079809:Measure [Quantitative Concept]
   966 E C0242485:Measure [Functional Concept]

Phrase: "the levels of 17-estradiol,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   781   C0337434:Oestradiol level [Laboratory Procedure]
   760   C0441889:Levels [Qualitative Concept]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]

Phrase: "17-estradiol,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0014912:Estradiol [Hormone,Pharmacologic Substance,Steroid]
   805 E C0699352:Estrace [Hormone,Pharmacologic Substance,Steroid]
   805 E C0878472:Progynon [Hormone,Pharmacologic Substance,Steroid]

Phrase: "and"

Phrase: "E1 in gonadectomized"

Phrase: "and"

Phrase: "gonadectomized-"

Phrase: "adrenalectomized mice,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]

Phrase: "in which"

Phrase: "we"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "even more elevated levels of 17-estradiol"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   757   C0337434:Oestradiol level [Laboratory Procedure]
   748   C0441889:Levels [Qualitative Concept]
   714 E C0456079:Level [Classification]
   714 E C1547707:Level [Geographic Area]
   714 E C2946261:Level [Pharmacologic Substance]

Phrase: "in all"

Phrase: "the samples."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0370003:Sample [Substance]
   966   C2347026:Sample [Conceptual Entity]
Processing 00000000.tx.173: Moreover, whereas 17-estradiol levels were elevated in a few samples, E1 levels were below the limits of detectability, strongly suggesting that 17-estradiol is indeed synthesized locally in the brain (Table 2) and that E1 is of ovarian origin. 

Phrase: "Moreover,"

Phrase: "whereas"

Phrase: "17-estradiol levels"
Meta Candidates (Total=8; Excluded=5; Pruned=0; Remaining=3)
   884   C0337434:Oestradiol level [Laboratory Procedure]
   827   C0014912:Estradiol [Hormone,Pharmacologic Substance,Steroid]
   827   C0441889:Levels [Qualitative Concept]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]
   771 E C0699352:Estrace [Hormone,Pharmacologic Substance,Steroid]
   771 E C0878472:Progynon [Hormone,Pharmacologic Substance,Steroid]

Phrase: "were"

Phrase: "elevated in a few samples,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0205250:Elevated [Qualitative Concept]
   760   C3163633:Elevated [Qualitative Concept]
   726   C0370003:Sample [Substance]
   726   C2347026:Sample [Conceptual Entity]

Phrase: "E1 levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0441889:Levels [Qualitative Concept]
   827 E C0456079:Level [Classification]
   827 E C1547707:Level [Geographic Area]
   827 E C2946261:Level [Pharmacologic Substance]

Phrase: "were below the limits of detectability,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   753   C0439801:limits [Functional Concept]
   719 E C1549649:Limit [Idea or Concept]
   719 E C2349209:Limit [Conceptual Entity]

Phrase: "strongly"

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that 17-estradiol"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0014912:Estradiol [Hormone,Pharmacologic Substance,Steroid]
   805 E C0699352:Estrace [Hormone,Pharmacologic Substance,Steroid]
   805 E C0878472:Progynon [Hormone,Pharmacologic Substance,Steroid]

Phrase: "is"

Phrase: "indeed"

Phrase: "synthesized"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883254:Synthesized [Activity]

Phrase: "locally in the brain"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0006104:Brain [Body Part, Organ, or Organ Component]
   770   C1269537:Brain [Body Part, Organ, or Organ Component]
   770   C1517927:Locally [Spatial Concept]

Phrase: "(Table 2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")"

Phrase: "and"

Phrase: "that E1"

Phrase: "is of ovarian origin."
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   770   C0079946:origin [Classification]
   770   C0205065:Ovarian [Body Part, Organ, or Organ Component]
   770   C0439659:Origin [Temporal Concept]
   770   C1550512:origin [Intellectual Product]
   715 E C0017296:GENETIC [Therapeutic or Preventive Procedure]
   715 E C0314603:Genetic [Functional Concept]
Processing 00000000.tx.174: Although a recent report documented the presence of 17-estradiol in the neonatal rat brain by RIA (20), identification of steroids by LC-MS/MS is considered much more specific. 

Phrase: "Although"

Phrase: "a recent report"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0684224:Report [Intellectual Product]
   861   C0700287:Report [Health Care Activity]
   861   C3273238:Report [Intellectual Product]

Phrase: "documented"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C1301725:Documented [Health Care Activity]
  1000   C1609436:documented [Idea or Concept]
   966 E C1301746:document [Intellectual Product]
   966 E C1547673:Document [Intellectual Product]

Phrase: "the presence of 17-estradiol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "in the neonatal rat brain"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C1882598:Rat Brain [Body Part, Organ, or Organ Component]
   827   C0006104:Brain [Body Part, Organ, or Organ Component]
   827   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "by RIA (20"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0034580:RIA [Laboratory Procedure]

Phrase: ")"

Phrase: ","

Phrase: "identification of steroids"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0020792:Identification [Mental Process]
   790   C0205396:Identification [Qualitative Concept]

Phrase: "by LC-MS/MS"
Meta Candidates (Total=16; Excluded=1; Pruned=0; Remaining=15)
   924   C0872318:Liquid Chromatography Mass Spectrometry [Laboratory Procedure]
   884   C0599748:Tandem Mass Spectrometry [Molecular Biology Research Technique]
   853   C2945612:chromatography mass [Laboratory Procedure]
   840   C0008565:Liquid Chromatography [Laboratory Procedure]
   840   C0037813:Mass Spectrometry [Laboratory Procedure]
   804   C0008550:Chromatography [Laboratory Procedure]
   804   C0075804:TANDEM [Organic Chemical,Pharmacologic Substance]
   804   C0302908:Liquid [Substance]
   804   C0436196:Spectrometry [Laboratory Procedure]
   804   C0577559:Mass [Finding]
   804   C1304698:Liquid [Finding]
   804   C1306372:*Mass [Quantitative Concept]
   804   C1546699:Liquid NOS [Intellectual Product]
   804   C1561501:Liquid NOS [Substance]
   804   C3152252:Mass [Quantitative Concept]
   704 E C0302647:chromatograph [Medical Device]

Phrase: "is"

Phrase: "considered"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750591:considered [Idea or Concept]

Phrase: "much more specific."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0205369:Specific [Qualitative Concept]
   827   C1552740:specific [Intellectual Product]
Processing 00000000.tx.175: LC-MS/MS identifies the different estrogens after they have been separated chromatographically, whereas RIA, which uses antibodies to 17-estradiol, is unable to distinguish the various estrogens because of cross-reactivity. 

Phrase: "LC-MS/MS"
Meta Candidates (Total=16; Excluded=1; Pruned=0; Remaining=15)
   924   C0872318:Liquid Chromatography Mass Spectrometry [Laboratory Procedure]
   884   C0599748:Tandem Mass Spectrometry [Molecular Biology Research Technique]
   853   C2945612:chromatography mass [Laboratory Procedure]
   840   C0008565:Liquid Chromatography [Laboratory Procedure]
   840   C0037813:Mass Spectrometry [Laboratory Procedure]
   804   C0008550:Chromatography [Laboratory Procedure]
   804   C0075804:TANDEM [Organic Chemical,Pharmacologic Substance]
   804   C0302908:Liquid [Substance]
   804   C0436196:Spectrometry [Laboratory Procedure]
   804   C0577559:Mass [Finding]
   804   C1304698:Liquid [Finding]
   804   C1306372:*Mass [Quantitative Concept]
   804   C1546699:Liquid NOS [Intellectual Product]
   804   C1561501:Liquid NOS [Substance]
   804   C3152252:Mass [Quantitative Concept]
   704 E C0302647:chromatograph [Medical Device]

Phrase: "identifies"

Phrase: "the different estrogens"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0014939:Estrogens [Hormone,Pharmacologic Substance,Steroid]
   827 E C2936882:Estrogen [Pharmacologic Substance]
   777 E C0720298:Estrogenic [Hormone,Organic Chemical,Pharmacologic Substance]

Phrase: "after"

Phrase: "they"

Phrase: "have"

Phrase: "been"

Phrase: "separated"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0086972:Separated [Finding]
  1000   C0443299:separated [Spatial Concept]
  1000   C0687118:Separated [Functional Concept]

Phrase: "chromatographically,"

Phrase: "whereas"

Phrase: "RIA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034580:RIA [Laboratory Procedure]

Phrase: "which"

Phrase: "uses"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0042153:use [Functional Concept]
  1000   C0457083:Use [Functional Concept]
  1000   C1947944:Use [Intellectual Product]

Phrase: "antibodies to 17-estradiol,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   737 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "is"

Phrase: "unable to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1299582:Unable [Finding]

Phrase: "distinguish"

Phrase: "the various estrogens because of cross-reactivity."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C0014939:Estrogens [Hormone,Pharmacologic Substance,Steroid]
   714 E C2936882:Estrogen [Pharmacologic Substance]
Processing 00000000.tx.176: Moreover, it has been reported that although there were large differences between the concentration of estradiol measured in the same samples by the different commercially available RIA kits, the apparent changes in concentration that might be regarded as clinically significant were nothing more than the imprecision of the assay (15, 21). 

Phrase: "Moreover,"

Phrase: "it"

Phrase: "has"

Phrase: "been"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "that"

Phrase: "although"

Phrase: "there"

Phrase: "were"

Phrase: "large differences between the concentration of estradiol"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   714   C1705241:*Difference [Quantitative Concept]
   714   C1705242:Difference [Qualitative Concept]

Phrase: "measured in the same samples"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   764   C2348149:Sample Measure [Quantitative Concept]
   760   C0444706:Measured [Qualitative Concept]
   760   C0445247:Same [Qualitative Concept]
   760   C3541902:MEASURED [Diagnostic Procedure]
   726 E C0079809:Measure [Quantitative Concept]
   726 E C0242485:Measure [Functional Concept]
   726   C0370003:Sample [Substance]
   726   C2347026:Sample [Conceptual Entity]

Phrase: "by the different commercially available RIA kits,"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   804   C1690540:Kits [Qualitative Concept]
   771 E C0812225:KIT [Medical Device]
   771 E C1150635:KIT [Molecular Function]
   771 E C1705212:Kit [Medical Device]
   771 E C1705213:KIT [Medical Device]
   771 E C3273202:Kit [Manufactured Object]

Phrase: "the apparent changes in concentration"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   781   C0025320:The change [Physiologic Function]
   760   C0392747:changes [Functional Concept]
   760   C0443172:changes [Quantitative Concept]
   726 E C1705241:Change [Quantitative Concept]

Phrase: "that"

Phrase: "might"

Phrase: "be"

Phrase: "regarded as clinically significant"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0237881:significant [Quantitative Concept]
   770   C0750502:Significant [Idea or Concept]
   770   C1546944:Significant [Qualitative Concept]

Phrase: "were"

Phrase: "nothing more than the imprecision of the assay"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   744   C0005507:Assay [Laboratory Procedure]
   744   C0243073:assay [Qualitative Concept]
   744   C0442735:Nothing [Finding]
   744   C1510438:Assay [Laboratory Procedure]
   744   C1881145:IMPRECISION [Phenomenon or Process]

Phrase: "(15,"

Phrase: "21"

Phrase: ")."
Processing 00000000.tx.177: Although the prevailing view is that 17-estradiol is inactive and does not interact with the classical ERs, ER and ER (22), we found that [3H]17-estradiol bound to and transactivated human recombinant ER and ER with affinities similar to those of 17-estradiol (Kd = 0.4 nM and Kd = 0.5 nM, respectively), a finding confirmed by binding assays performed on adult rat uterine cytosol (Kd = 0.4 nM). 

Phrase: "Although"

Phrase: "the prevailing view"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0449911:View [Spatial Concept]

Phrase: "is"

Phrase: "that 17-estradiol"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0014912:Estradiol [Hormone,Pharmacologic Substance,Steroid]
   805 E C0699352:Estrace [Hormone,Pharmacologic Substance,Steroid]
   805 E C0878472:Progynon [Hormone,Pharmacologic Substance,Steroid]

Phrase: "is"

Phrase: "inactive"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205254:Inactive [Qualitative Concept]

Phrase: "and"

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "interact with the classical ERs,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0439858:Classical [Qualitative Concept]
   760   C0443177:Classical [Functional Concept]
   760   C1704489:ERS [Clinical Attribute]
   760   C2931783:ERS [Disease or Syndrome]

Phrase: "ER"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0034804:Estrogen receptor [Amino Acid, Peptide, or Protein,Receptor]
  1000   C1414461:ESTROGEN RECEPTOR [Gene or Genome]
  1000   C1521863:Estrogen Receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
   861   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C2936882:Estrogen [Pharmacologic Substance]
   789 E C0720298:Estrogenic [Hormone,Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "ER"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0034804:Estrogen receptor [Amino Acid, Peptide, or Protein,Receptor]
  1000   C1414461:ESTROGEN RECEPTOR [Gene or Genome]
  1000   C1521863:Estrogen Receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
   861   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C2936882:Estrogen [Pharmacologic Substance]
   789 E C0720298:Estrogenic [Hormone,Organic Chemical,Pharmacologic Substance]

Phrase: "(22"

Phrase: ")"

Phrase: ","

Phrase: "we"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "that"

Phrase: "[3H"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1442460:3H [Temporal Concept]

Phrase: "]17-estradiol"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0014912:Estradiol [Hormone,Pharmacologic Substance,Steroid]
   805 E C0699352:Estrace [Hormone,Pharmacologic Substance,Steroid]
   805 E C0878472:Progynon [Hormone,Pharmacologic Substance,Steroid]

Phrase: "bound to"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0332297:bound [Spatial Concept]
   833   C1145667:Bound [Activity]
   833   C1167622:Bound [Molecular Function]
   833   C1689898:% bound [Quantitative Concept]
   833   C2349209:Bound [Conceptual Entity]

Phrase: "and"

Phrase: "transactivated human recombinant ER"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   840   C0034804:Estrogen receptor [Amino Acid, Peptide, or Protein,Receptor]
   840   C1414461:ESTROGEN RECEPTOR [Gene or Genome]
   840   C1521863:Estrogen Receptor [Amino Acid, Peptide, or Protein,Receptor]
   804   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
   804   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   804   C2936882:Estrogen [Pharmacologic Substance]
   733 E C0720298:Estrogenic [Hormone,Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "ER with affinities"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C0034804:Estrogen receptor [Amino Acid, Peptide, or Protein,Receptor]
   833   C1414461:ESTROGEN RECEPTOR [Gene or Genome]
   833   C1521863:Estrogen Receptor [Amino Acid, Peptide, or Protein,Receptor]
   770   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
   770   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   770   C2936882:Estrogen [Pharmacologic Substance]

Phrase: "similar to those of 17-estradiol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C2348205:Similar [Qualitative Concept]

Phrase: "(Kd = 0.4 nM"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0312860:NM [Cell Function]

Phrase: "and"

Phrase: "Kd = 0.5 nM,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0312860:NM [Cell Function]

Phrase: "respectively"

Phrase: ")"

Phrase: ","

Phrase: "a finding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0037088:Finding [Sign or Symptom]
  1000   C0243095:Finding [Finding]
  1000   C2825141:Finding [Finding]

Phrase: "confirmed by binding assays"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   833   C0521093:Confirmed by [Qualitative Concept]
           confirmed
   770   C0243122:binding [Functional Concept]
   770   C0750484:Confirmed [Idea or Concept]
   770   C1145667:Binding [Activity]
   770   C1167622:Binding [Molecular Function]
   737   C0005507:Assay [Laboratory Procedure]
   737   C0243073:assay [Qualitative Concept]
   737 E C1456348:Confirm [Qualitative Concept]
   737   C1510438:Assay [Laboratory Procedure]

Phrase: "performed on adult rat uterine cytosol"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   753   C0001675:Adult [Age Group]
   753   C0034693:Rat, NOS [Mammal]
   753   C0034721:Rat [Mammal]
   753   C0042149:Uterine [Body Part, Organ, or Organ Component]
   753   C0884358:Performed [Functional Concept]
   753   C1383501:Cytosol [Cell Component]
   753   C1706450:Adult [Human]
   719 E C2947996:Perform [Pharmacologic Substance]

Phrase: "(Kd = 0.4 nM)."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0312860:NM [Cell Function]
Processing 00000000.tx.178: 17-Estradiol activation of transfected ER and ER has been reported previously (23, 24), and our data are in good agreement with those studies. 

Phrase: "17-Estradiol activation of transfected ER"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   774   C1514758:Receptor Activation [Cell Function]
   748   C1879547:Activation [Activity]

Phrase: "and"

Phrase: "ER"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0034804:Estrogen receptor [Amino Acid, Peptide, or Protein,Receptor]
  1000   C1414461:ESTROGEN RECEPTOR [Gene or Genome]
  1000   C1521863:Estrogen Receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
   861   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C2936882:Estrogen [Pharmacologic Substance]
   789 E C0720298:Estrogenic [Hormone,Organic Chemical,Pharmacologic Substance]

Phrase: "has"

Phrase: "been"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "previously"

Phrase: "(23,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: "24"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "our data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "are in good agreement"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0205170:Good [Qualitative Concept]
   770   C0680240:Agreement [Social Behavior]
   770   C1551058:Are [Quantitative Concept]

Phrase: "with those studies."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0947630:studies [Laboratory Procedure]
   966 E C0557651:Study [Manufactured Object]
   966 E C2603343:Study [Research Activity]
Processing 00000000.tx.179: Whereas our binding results contradict the generally held belief, that 17-estradiol is much less efficient than 17-estradiol in displacing [3H]17-estradiol from ERs, Korenman (25), Edwards and McGuire (26), and Kuiper et al. 

Phrase: "Whereas"

Phrase: "our binding results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]

Phrase: "contradict"

Phrase: "the generally held belief,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0004951:Belief [Idea or Concept]

Phrase: "that 17-estradiol"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0014912:Estradiol [Hormone,Pharmacologic Substance,Steroid]
   805 E C0699352:Estrace [Hormone,Pharmacologic Substance,Steroid]
   805 E C0878472:Progynon [Hormone,Pharmacologic Substance,Steroid]

Phrase: "is"

Phrase: "much less efficient than 17-estradiol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0442799:Efficient [Qualitative Concept]

Phrase: "in displacing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0012727:displacing [Spatial Concept]

Phrase: "[3H"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1442460:3H [Temporal Concept]

Phrase: "]17-estradiol from ERs,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   770   C0014912:Estradiol [Hormone,Pharmacologic Substance,Steroid]
   715 E C0699352:Estrace [Hormone,Pharmacologic Substance,Steroid]
   715 E C0878472:Progynon [Hormone,Pharmacologic Substance,Steroid]

Phrase: "Korenman"

Phrase: "(25"

Phrase: ")"

Phrase: ","

Phrase: "Edwards"

Phrase: "and"

Phrase: "McGuire"

Phrase: "(26"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "Kuiper et al."
Processing 00000000.tx.180: (27) have all reported that 17-estradiol can bind to ERs with an affinity of approximately 50% of the RBA of 17-estradiol. 

Phrase: "(27"

Phrase: ")"

Phrase: "have"

Phrase: "all"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "that 17-estradiol"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0014912:Estradiol [Hormone,Pharmacologic Substance,Steroid]
   805 E C0699352:Estrace [Hormone,Pharmacologic Substance,Steroid]
   805 E C0878472:Progynon [Hormone,Pharmacologic Substance,Steroid]

Phrase: "can"

Phrase: "bind to ERs"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C1145667:Bind [Activity]
   790   C1167622:bind [Molecular Function]
   790   C1704489:ERS [Clinical Attribute]
   790   C2931783:ERS [Disease or Syndrome]

Phrase: "with an affinity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1510827:Affinity [Natural Phenomenon or Process]

Phrase: "of approximately 50%"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0332232:Approximately [Qualitative Concept]

Phrase: "of the RBA"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   827   C0080103:Relative [Family Group]
   827   C0205345:Relative [Qualitative Concept]
   827   C0243122:binding [Functional Concept]
   827   C1145667:Binding [Activity]
   827   C1167622:Binding [Molecular Function]
   827   C1510827:Affinity [Natural Phenomenon or Process]
   827   C1547039:*Relative [Quantitative Concept]

Phrase: "of 17-estradiol."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0014912:Estradiol [Hormone,Pharmacologic Substance,Steroid]
   805 E C0699352:Estrace [Hormone,Pharmacologic Substance,Steroid]
   805 E C0878472:Progynon [Hormone,Pharmacologic Substance,Steroid]
Processing 00000000.tx.181: An RBA of 58% of 17-estradiol has also been reported for 17-estradiol binding to human recombinant ER (27). 

Phrase: "An RBA of 58% of 17-estradiol"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   742   C0080103:Relative [Family Group]
   742   C0205345:Relative [Qualitative Concept]
   742   C0243122:binding [Functional Concept]
   742   C1145667:Binding [Activity]
   742   C1167622:Binding [Molecular Function]
   742   C1510827:Affinity [Natural Phenomenon or Process]
   742   C1547039:*Relative [Quantitative Concept]

Phrase: "has"

Phrase: "also"

Phrase: "been"

Phrase: "reported for 17-estradiol binding"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   760   C0014912:Estradiol [Hormone,Pharmacologic Substance,Steroid]
   760   C0243122:binding [Functional Concept]
   760   C0684224:Reported [Intellectual Product]
   760   C0700287:Reported [Health Care Activity]
   760   C1145667:Binding [Activity]
   760   C1167622:Binding [Molecular Function]
   760   C3496591:Reported [Clinical Attribute]
   726 E C3273238:Report [Intellectual Product]
   704 E C0699352:Estrace [Hormone,Pharmacologic Substance,Steroid]
   704 E C0878472:Progynon [Hormone,Pharmacologic Substance,Steroid]

Phrase: "to human recombinant ER"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   861   C0034804:Estrogen receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C1414461:ESTROGEN RECEPTOR [Gene or Genome]
   861   C1521863:Estrogen Receptor [Amino Acid, Peptide, or Protein,Receptor]
   812   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
   812   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   812   C2936882:Estrogen [Pharmacologic Substance]
   741 E C0720298:Estrogenic [Hormone,Organic Chemical,Pharmacologic Substance]

Phrase: "(27"

Phrase: ")."
Processing 00000000.tx.182: This is consistent with our findings of RBAs of 51 and 64% of 17-estradiol binding to ER and ER, respectively. 

Phrase: "This"

Phrase: "is"

Phrase: "consistent with our findings of RBAs of 51"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0332290:Consistent with [Idea or Concept]
           Consistent
   714   C0332529:Consistency finding [Qualitative Concept]

Phrase: "and"

Phrase: "64% of 17-estradiol binding"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   760   C0014912:Estradiol [Hormone,Pharmacologic Substance,Steroid]
   760   C0243122:binding [Functional Concept]
   760   C1145667:Binding [Activity]
   760   C1167622:Binding [Molecular Function]
   704 E C0699352:Estrace [Hormone,Pharmacologic Substance,Steroid]
   704 E C0878472:Progynon [Hormone,Pharmacologic Substance,Steroid]

Phrase: "to ER"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0034804:Estrogen receptor [Amino Acid, Peptide, or Protein,Receptor]
  1000   C1414461:ESTROGEN RECEPTOR [Gene or Genome]
  1000   C1521863:Estrogen Receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
   861   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C2936882:Estrogen [Pharmacologic Substance]
   789 E C0720298:Estrogenic [Hormone,Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "ER,"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0034804:Estrogen receptor [Amino Acid, Peptide, or Protein,Receptor]
  1000   C1414461:ESTROGEN RECEPTOR [Gene or Genome]
  1000   C1521863:Estrogen Receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
   861   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C2936882:Estrogen [Pharmacologic Substance]
   789 E C0720298:Estrogenic [Hormone,Organic Chemical,Pharmacologic Substance]

Phrase: "respectively."
Processing 00000000.tx.183: The discrepancy with numerous data concerning the lower displacing activity of 17-estradiol may be explained by the presence of other proteins, endogenous substances, or reagents in the assay buffers, which may influence binding. 

Phrase: "The discrepancy with numerous data"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1290905:Discrepancy [Finding]

Phrase: "concerning"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2699424:Concern [Idea or Concept]

Phrase: "the lower displacing activity of 17-estradiol"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0205177:Activity [Functional Concept]
   748   C0439167:% activity [Quantitative Concept]
   748   C0441655:Activity [Activity]
   748   C1561536:*Activity [Idea or Concept]

Phrase: "may"

Phrase: "be"

Phrase: "explained by the presence of other proteins,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "endogenous substances,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439861:Substances [Substance]

Phrase: "or"

Phrase: "reagents in the assay buffers,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0034760:Reagents [Indicator, Reagent, or Diagnostic Aid]

Phrase: "which"

Phrase: "may"

Phrase: "influence"

Phrase: "binding."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0243122:binding [Functional Concept]
  1000   C1145667:Binding [Activity]
  1000   C1167622:Binding [Molecular Function]
Processing 00000000.tx.184: Some DCC-removable low-molecular-weight substances in the uterine cytosol may prevent 17-estradiol from binding to the ERs. 

Phrase: "Some DCC-removable low-molecular-weight substances"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C0439861:Substances [Substance]

Phrase: "in the uterine cytosol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1383501:Cytosol [Cell Component]

Phrase: "may"

Phrase: "prevent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0309872:PREVENT [Pharmacologic Substance]

Phrase: "17-estradiol from binding"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   770   C0014912:Estradiol [Hormone,Pharmacologic Substance,Steroid]
   715 E C0699352:Estrace [Hormone,Pharmacologic Substance,Steroid]
   715 E C0878472:Progynon [Hormone,Pharmacologic Substance,Steroid]

Phrase: "to the ERs."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1704489:ERS [Clinical Attribute]
  1000   C2931783:ERS [Disease or Syndrome]
Processing 00000000.tx.185: For example, free fatty acids are known to influence steroid-protein interactions dramatically (28). 

Phrase: "For example,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707959:Example [Conceptual Entity]

Phrase: "free fatty acids"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C0015688:Free Fatty Acids [Lipid]
   966 E C2698488:Free Fatty Acid [Laboratory Procedure]
   901   C0015684:Fatty Acids [Lipid]
   827   C0001128:Acids [Chemical]
   827   C0332296:free [Functional Concept]
   827   C1880497:Free [Qualitative Concept]
   827   C1996904:Free [Qualitative Concept]
   793 E C0202406:Acid [Laboratory Procedure]

Phrase: "are"

Phrase: "known"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205309:Known [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "influence"

Phrase: "steroid-protein interactions dramatically"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   844   C0872079:protein interaction [Molecular Function]
   779   C1704675:Interaction [Functional Concept]

Phrase: "(28"

Phrase: ")."
Processing 00000000.tx.186: Proteins have also been shown to affect the RBA. 

Phrase: "Proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "have"

Phrase: "also"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "affect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "the RBA."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   827   C0080103:Relative [Family Group]
   827   C0205345:Relative [Qualitative Concept]
   827   C0243122:binding [Functional Concept]
   827   C1145667:Binding [Activity]
   827   C1167622:Binding [Molecular Function]
   827   C1510827:Affinity [Natural Phenomenon or Process]
   827   C1547039:*Relative [Quantitative Concept]
Processing 00000000.tx.187: For example, whereas diethylstilbestrol had an RBA higher than that of 17-estradiol (RBA = 100) in the rat uterine nuclear fraction, the RBA of DES dropped from 245 to 43 in the presence of rat serum and 10-fold in the presence of human serum albumin, with no effect on the RBA of 17-estradiol (29). 

Phrase: "For example,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707959:Example [Conceptual Entity]

Phrase: "whereas"

Phrase: "diethylstilbestrol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0012203:Diethylstilbestrol [Hormone,Organic Chemical,Pharmacologic Substance]

Phrase: "had"

Phrase: "an RBA"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   827   C0080103:Relative [Family Group]
   827   C0205345:Relative [Qualitative Concept]
   827   C0243122:binding [Functional Concept]
   827   C1145667:Binding [Activity]
   827   C1167622:Binding [Molecular Function]
   827   C1510827:Affinity [Natural Phenomenon or Process]
   827   C1547039:*Relative [Quantitative Concept]

Phrase: "higher than that of 17-estradiol"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   767   C0860851:high estradiol [Finding]
   719   C0205250:High [Qualitative Concept]
   719   C1299351:High [Qualitative Concept]
   719   C2700149:HIGH [Intellectual Product]

Phrase: "(RBA"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   827   C0080103:Relative [Family Group]
   827   C0205345:Relative [Qualitative Concept]
   827   C0243122:binding [Functional Concept]
   827   C1145667:Binding [Activity]
   827   C1167622:Binding [Molecular Function]
   827   C1510827:Affinity [Natural Phenomenon or Process]
   827   C1547039:*Relative [Quantitative Concept]

Phrase: "= 100"

Phrase: ")"

Phrase: "in the rat uterine nuclear fraction,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C1264633:Fraction [Quantitative Concept]
   812   C1554103:Fraction [Idea or Concept]

Phrase: "the RBA of DES"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   753   C0080103:Relative [Family Group]
   753   C0205345:Relative [Qualitative Concept]
   753   C0243122:binding [Functional Concept]
   753   C1145667:Binding [Activity]
   753   C1167622:Binding [Molecular Function]
   753   C1510827:Affinity [Natural Phenomenon or Process]
   753   C1547039:*Relative [Quantitative Concept]

Phrase: "dropped from 245"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   790   C1705648:Dropped [Activity]
   756 E C1321095:Drop [Quantitative Concept]
   756 E C2347093:Drop [Quantitative Concept]
   756 E C2348338:Drop [Quantitative Concept]

Phrase: "to 43"

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of rat serum"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0229671:Serum [Body Substance]
   861   C1546774:Serum [Intellectual Product]
   861   C1550100:Serum [Body Substance]

Phrase: "and"

Phrase: "10-fold in the presence of human serum albumin,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0332462:Fold [Spatial Concept]
   742   C1880834:FOLD [Phenomenon or Process]

Phrase: "with no effect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1280500:Effect [Qualitative Concept]
  1000   C2348382:Effect [Qualitative Concept]

Phrase: "on the RBA"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   827   C0080103:Relative [Family Group]
   827   C0205345:Relative [Qualitative Concept]
   827   C0243122:binding [Functional Concept]
   827   C1145667:Binding [Activity]
   827   C1167622:Binding [Molecular Function]
   827   C1510827:Affinity [Natural Phenomenon or Process]
   827   C1547039:*Relative [Quantitative Concept]

Phrase: "of 17-estradiol"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0014912:Estradiol [Hormone,Pharmacologic Substance,Steroid]
   805 E C0699352:Estrace [Hormone,Pharmacologic Substance,Steroid]
   805 E C0878472:Progynon [Hormone,Pharmacologic Substance,Steroid]

Phrase: "(29"

Phrase: ")."
Processing 00000000.tx.188: It is unclear why other workers have failed to detect the high binding affinity of 17-estradiol. 

Phrase: "It"

Phrase: "is"

Phrase: "unclear why"

Phrase: "other workers"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0024752:workers [Functional Concept]
  1000   C1306056:workers [Occupation or Discipline]
  1000   C1527116:Workers [Population Group]

Phrase: "have"

Phrase: "failed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0231175:Failed [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "detect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442726:detect [Finding]

Phrase: "the high binding affinity of 17-estradiol."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1510827:Affinity [Natural Phenomenon or Process]
Processing 00000000.tx.189: We attribute our findings of high affinity to the use of DCC, which removed the endogenous steroids and low-molecular-weight agents, such as free fatty acids, from the cytosol, thereby increasing the affinity of 17-estradiol for the ERs. 

Phrase: "We"

Phrase: "attribute"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0449234:Attribute [Idea or Concept]
  1000   C1704772:Attribute [Conceptual Entity]
  1000   C1882133:Attribute [Qualitative Concept]

Phrase: "our findings of high affinity"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   760   C2607943:findings [Functional Concept]
   760   C2926606:Findings [Clinical Attribute]
   760   C3539655:Findings [Intellectual Product]
   726 E C0037088:Finding [Sign or Symptom]
   726 E C0243095:Finding [Finding]
   726 E C2825141:Finding [Finding]

Phrase: "to the use"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0042153:use [Functional Concept]
  1000   C0457083:Use [Functional Concept]
  1000   C1947944:Use [Intellectual Product]

Phrase: "of DCC,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   827   C0007955:Charcoal [Element, Ion, or Isotope,Pharmacologic Substance]
   827   C0086140:Dextran [Carbohydrate,Pharmacologic Substance]
   827   C1522408:Coated [Qualitative Concept]
   793 E C0453946:Coat [Manufactured Object]
   793 E C2987482:Coat [Body Part, Organ, or Organ Component]

Phrase: "which"

Phrase: "removed"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0849355:Removed [Qualitative Concept]
   966 E C1883720:Remove [Activity]
   966 E C3244314:remove [Functional Concept]

Phrase: "the endogenous steroids"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0815055:endogenous steroids [Steroid]
   861   C0038317:Steroids [Steroid]

Phrase: "and"

Phrase: "low-molecular-weight agents,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   779   C0450442:Agent [Chemical Viewed Functionally]
   779   C1254351:Agent [Pharmacologic Substance]
   779   C1521826:Agent [Intellectual Product]
   708   C0041667:Low weight [Finding]

Phrase: "such as free fatty acids,"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C0015688:Free Fatty Acids [Lipid]
   966 E C2698488:Free Fatty Acid [Laboratory Procedure]
   901   C0015684:Fatty Acids [Lipid]
   827   C0001128:Acids [Chemical]
   827   C0332296:free [Functional Concept]
   827   C1880497:Free [Qualitative Concept]
   827   C1996904:Free [Qualitative Concept]
   793 E C0202406:Acid [Laboratory Procedure]

Phrase: "from the cytosol,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1383501:Cytosol [Cell Component]

Phrase: "thereby"

Phrase: "increasing"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442808:Increasing [Functional Concept]
   966 E C0442805:Increase [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0205217:Increased [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "the affinity of 17-estradiol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1510827:Affinity [Natural Phenomenon or Process]

Phrase: "for the ERs."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1704489:ERS [Clinical Attribute]
  1000   C2931783:ERS [Disease or Syndrome]
Processing 00000000.tx.190: However, removal of low-molecular-weight substances to achieve binding of 17-estradiol to ER and ER may not be physiological. 

Phrase: "However,"

Phrase: "removal of low-molecular-weight substances to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0015252:Removal [Therapeutic or Preventive Procedure]
   748   C0728940:Removal [Therapeutic or Preventive Procedure]

Phrase: "achieve"

Phrase: "binding of 17-estradiol"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0243122:binding [Functional Concept]
   770   C1145667:Binding [Activity]
   770   C1167622:Binding [Molecular Function]

Phrase: "to ER"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0034804:Estrogen receptor [Amino Acid, Peptide, or Protein,Receptor]
  1000   C1414461:ESTROGEN RECEPTOR [Gene or Genome]
  1000   C1521863:Estrogen Receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
   861   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C2936882:Estrogen [Pharmacologic Substance]
   789 E C0720298:Estrogenic [Hormone,Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "ER"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0034804:Estrogen receptor [Amino Acid, Peptide, or Protein,Receptor]
  1000   C1414461:ESTROGEN RECEPTOR [Gene or Genome]
  1000   C1521863:Estrogen Receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
   861   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C2936882:Estrogen [Pharmacologic Substance]
   789 E C0720298:Estrogenic [Hormone,Organic Chemical,Pharmacologic Substance]

Phrase: "may"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "be"

Phrase: "physiological."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0205463:Physiological [Functional Concept]
   928 E C0031842:Physiology [Biomedical Occupation or Discipline]
   928 E C0031843:physiology [Physiologic Function]
Processing 00000000.tx.191: There may be regional brain differences with respect to the presence of proteins, fatty acids, and other molecules that would normally prevent binding of 17-estradiol to these ERs. 

Phrase: "There"

Phrase: "may"

Phrase: "be"

Phrase: "regional brain differences with respect to the presence of proteins,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   757   C0682132:regional differences [Finding]
   706   C1705241:*Difference [Quantitative Concept]
   706   C1705242:Difference [Qualitative Concept]

Phrase: "fatty acids,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0015684:Fatty Acids [Lipid]
   861   C0001128:Acids [Chemical]
   827 E C0202406:Acid [Laboratory Procedure]

Phrase: "and"

Phrase: "other molecules"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0567416:molecules [Substance]
   916 E C1521991:Molecular [Qualitative Concept]

Phrase: "that"

Phrase: "would"

Phrase: "normally"

Phrase: "prevent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0309872:PREVENT [Pharmacologic Substance]

Phrase: "binding of 17-estradiol"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   770   C0014912:Estradiol [Hormone,Pharmacologic Substance,Steroid]
   770   C0243122:binding [Functional Concept]
   770   C1145667:Binding [Activity]
   770   C1167622:Binding [Molecular Function]
   715 E C0699352:Estrace [Hormone,Pharmacologic Substance,Steroid]
   715 E C0878472:Progynon [Hormone,Pharmacologic Substance,Steroid]

Phrase: "to these ERs."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1704489:ERS [Clinical Attribute]
  1000   C2931783:ERS [Disease or Syndrome]
Processing 00000000.tx.192: The potential importance of the elevated endogenous levels of 17-estradiol in the brain is significantly heightened by our observations that 17-estradiol is the preferred ligand of ER-X (30), the novel, plasma membrane-associated, putative ER we recently identified in the developing mouse (13) and baboon (Guan, X., and D. Toran-Allerand, unpublished data) brain. 

Phrase: "The potential importance of the elevated endogenous levels of 17-estradiol"

Phrase: "in the brain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006104:Brain [Body Part, Organ, or Organ Component]
  1000   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "is"

Phrase: "significantly"

Phrase: "heightened by our observations"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   770   C0302523:observations [Research Activity]
   770   C0442803:Heightened [Qualitative Concept]
   770   C0442805:Heightened [Functional Concept]
   770   C0700325:observations [Health Care Activity]
   770   C3244290:observations [Functional Concept]
   737 E C1964257:Observation [Diagnostic Procedure]

Phrase: "that 17-estradiol"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0014912:Estradiol [Hormone,Pharmacologic Substance,Steroid]
   805 E C0699352:Estrace [Hormone,Pharmacologic Substance,Steroid]
   805 E C0878472:Progynon [Hormone,Pharmacologic Substance,Steroid]

Phrase: "is"

Phrase: "the preferred ligand of ER-X (30"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   767   C1621296:receptor ligand [Molecular Function]
   744   C0023688:Ligand [Chemical]

Phrase: ")"

Phrase: ","

Phrase: "the novel, plasma membrane-associated, putative ER"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   861   C0230664:Membrane receptor [Receptor]
   818   C0034804:Estrogen receptor [Amino Acid, Peptide, or Protein,Receptor]
   818   C1414461:ESTROGEN RECEPTOR [Gene or Genome]
   818   C1521863:Estrogen Receptor [Amino Acid, Peptide, or Protein,Receptor]
   795   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
   795   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   795   C2936882:Estrogen [Pharmacologic Substance]
   724 E C0720298:Estrogenic [Hormone,Organic Chemical,Pharmacologic Substance]

Phrase: "we recently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332185:Recently [Temporal Concept]

Phrase: "identified in the developing mouse"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0025914:Mouse [Mammal]
   760   C0025929:mouse [Mammal]
   760   C0026809:Mouse [Mammal]
   760   C0205396:Identified [Qualitative Concept]
   760   C1550043:Identified [Finding]
   760   C1551388:Identified [Functional Concept]

Phrase: "(13"

Phrase: ")"

Phrase: "and"

Phrase: "baboon"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0030362:Baboon [Mammal]
  1000   C0324820:baboon [Mammal]

Phrase: "(Guan,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325602:Guan [Bird]

Phrase: "X.,"

Phrase: "and"

Phrase: "D. Toran-Allerand,"

Phrase: "unpublished data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1511726:Data [Idea or Concept]
   861   C3245479:data [Medical Device]

Phrase: ")"

Phrase: "brain."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006104:Brain [Body Part, Organ, or Organ Component]
  1000   C1269537:Brain [Body Part, Organ, or Organ Component]
Processing 00000000.tx.193: ER-X is considered the preferred putative receptor for 17-estradiol because 17-estradiol activates MAPK/ERK at a dose level of 1 pM, whereas 17-estradiol requires a level 100-fold higher to achieve the same degree of activation (13), presumably because 17-estradiol has a greater affinity for ER and ER than for ER-X and would activate those receptors before ER-X. 

Phrase: "ER-X"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   734   C0034804:Estrogen receptor [Amino Acid, Peptide, or Protein,Receptor]
   734   C1414461:ESTROGEN RECEPTOR [Gene or Genome]
   734   C1521863:Estrogen Receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "is"

Phrase: "considered"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750591:considered [Idea or Concept]

Phrase: "the preferred putative receptor for 17-estradiol"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   774   C0034803:Estradiol Receptor [Amino Acid, Peptide, or Protein,Receptor]
   774   C0034804:Estradiol Receptor [Amino Acid, Peptide, or Protein,Receptor]
   774   C1521863:Estradiol Receptor [Amino Acid, Peptide, or Protein,Receptor]
   748   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "because"

Phrase: "17-estradiol"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0014912:Estradiol [Hormone,Pharmacologic Substance,Steroid]
   805 E C0699352:Estrace [Hormone,Pharmacologic Substance,Steroid]
   805 E C0878472:Progynon [Hormone,Pharmacologic Substance,Steroid]

Phrase: "activates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515877:Activate [Functional Concept]
  1000   C1879547:Activate [Activity]

Phrase: "MAPK/ERK at a dose level of 1 pM,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   762   C0082529:ERK-1 [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "whereas"

Phrase: "17-estradiol"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0014912:Estradiol [Hormone,Pharmacologic Substance,Steroid]
   805 E C0699352:Estrace [Hormone,Pharmacologic Substance,Steroid]
   805 E C0878472:Progynon [Hormone,Pharmacologic Substance,Steroid]

Phrase: "requires"

Phrase: "a level 100-fold higher to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0332462:Fold [Spatial Concept]
   804   C1880834:FOLD [Phenomenon or Process]

Phrase: "achieve"

Phrase: "the same degree of activation"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0441889:Degree [Qualitative Concept]
   760   C0449286:Degree [Quantitative Concept]
   760   C0542560:Degree [Intellectual Product]
   760   C1561545:degree [Quantitative Concept]
   760   C2348088:Degree [Quantitative Concept]

Phrase: "(13"

Phrase: ")"

Phrase: ","

Phrase: "presumably"

Phrase: "because"

Phrase: "17-estradiol"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0014912:Estradiol [Hormone,Pharmacologic Substance,Steroid]
   805 E C0699352:Estrace [Hormone,Pharmacologic Substance,Steroid]
   805 E C0878472:Progynon [Hormone,Pharmacologic Substance,Steroid]

Phrase: "has"

Phrase: "a greater affinity for ER"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1510827:Affinity [Natural Phenomenon or Process]

Phrase: "and"

Phrase: "ER than"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   882   C0034804:Estrogen receptor [Amino Acid, Peptide, or Protein,Receptor]
   882   C1414461:ESTROGEN RECEPTOR [Gene or Genome]
   882   C1521863:Estrogen Receptor [Amino Acid, Peptide, or Protein,Receptor]
   790   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
   790   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   790   C2936882:Estrogen [Pharmacologic Substance]
   718 E C0720298:Estrogenic [Hormone,Organic Chemical,Pharmacologic Substance]

Phrase: "for ER-X"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   734   C0034804:Estrogen receptor [Amino Acid, Peptide, or Protein,Receptor]
   734   C1414461:ESTROGEN RECEPTOR [Gene or Genome]
   734   C1521863:Estrogen Receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "and"

Phrase: "would"

Phrase: "activate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515877:Activate [Functional Concept]
  1000   C1879547:Activate [Activity]

Phrase: "those receptors before ER-X."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   783   C0034804:Estrogen Receptors [Amino Acid, Peptide, or Protein,Receptor]
   767   C1421546:X RECEPTOR [Gene or Genome]
   753   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]
Processing 00000000.tx.194: Moreover, whereas activation of ER-X by 17-estradiol elicits activation of MAPK/ERK, activation of ER by ER-selective ligands inhibits MAPK/ERK dramatically (13, 31) and exposure of ER to ER-selective ligands is without effect on MAPK activation (31). 

Phrase: "Moreover,"

Phrase: "whereas"

Phrase: "activation of ER-X"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   797   C1514758:Receptor Activation [Cell Function]
   760   C1879547:Activation [Activity]

Phrase: "by 17-estradiol"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0014912:Estradiol [Hormone,Pharmacologic Substance,Steroid]
   805 E C0699352:Estrace [Hormone,Pharmacologic Substance,Steroid]
   805 E C0878472:Progynon [Hormone,Pharmacologic Substance,Steroid]

Phrase: "elicits"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449265:elicit [Qualitative Concept]

Phrase: "activation of MAPK/ERK,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   819   C1155551:MAPK activation [Molecular Function]
   770   C1879547:Activation [Activity]

Phrase: "activation of ER"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   819   C1514758:Receptor Activation [Cell Function]
   770   C1879547:Activation [Activity]

Phrase: "by ER-selective ligands"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   858   C1621296:receptor ligand [Molecular Function]
   812   C0023688:Ligands [Chemical]

Phrase: "inhibits"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "MAPK/ERK dramatically"

Phrase: "(13,"

Phrase: "31"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]

Phrase: ")"

Phrase: "and"

Phrase: "exposure of ER"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0274281:Exposure, NOS [Injury or Poisoning]
   770   C0332157:Exposure [Clinical Attribute]

Phrase: "to ER-selective ligands"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   858   C1621296:receptor ligand [Molecular Function]
   812   C0023688:Ligands [Chemical]

Phrase: "is without effect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1280500:Effect [Qualitative Concept]
   790   C2348382:Effect [Qualitative Concept]

Phrase: "on MAPK activation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1155551:MAPK activation [Molecular Function]
   861   C1879547:Activation [Activity]

Phrase: "(31"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.195: Thus, the high levels of 17-estradiol may be more relevant for neural functions mediated by ER-X than ER and ER. 

Phrase: "Thus,"

Phrase: "the high levels of 17-estradiol"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   767   C0337434:Oestradiol level [Laboratory Procedure]
   753   C0441889:Levels [Qualitative Concept]
   719 E C0456079:Level [Classification]
   719 E C1547707:Level [Geographic Area]
   719 E C2946261:Level [Pharmacologic Substance]

Phrase: "may"

Phrase: "be"

Phrase: "more relevant for neural functions"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C2347946:Relevant [Qualitative Concept]

Phrase: "mediated by ER-X"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   806   C0034804:Estrogen receptor [Amino Acid, Peptide, or Protein,Receptor]
   806   C1414461:ESTROGEN RECEPTOR [Gene or Genome]
   806   C1521863:Estrogen Receptor [Amino Acid, Peptide, or Protein,Receptor]
   797   C1421546:X RECEPTOR [Gene or Genome]
   760   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
   760   C0086597:mediated [Social Behavior]
   760   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   760   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   760   C2936882:Estrogen [Pharmacologic Substance]

Phrase: "than ER"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0034804:Estrogen receptor [Amino Acid, Peptide, or Protein,Receptor]
  1000   C1414461:ESTROGEN RECEPTOR [Gene or Genome]
  1000   C1521863:Estrogen Receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
   861   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C2936882:Estrogen [Pharmacologic Substance]
   789 E C0720298:Estrogenic [Hormone,Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "ER."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0034804:Estrogen receptor [Amino Acid, Peptide, or Protein,Receptor]
  1000   C1414461:ESTROGEN RECEPTOR [Gene or Genome]
  1000   C1521863:Estrogen Receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
   861   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C2936882:Estrogen [Pharmacologic Substance]
   789 E C0720298:Estrogenic [Hormone,Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.196: The 17-estradiol/ER-X association may be particularly relevant because, although ER-X is developmentally regulated, it is reexpressed in the adult brain after an ischemic brain injury (13) and in a transgenic mouse model (J20) of Alzheimers disease (Nethrapalli, I. S., and D. Toran-Allerand, unpublished data). 

Phrase: "The 17-estradiol/ER-X association"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   799   C0004083:Association [Mental Process]
   799   C0439849:Association [Qualitative Concept]
   799   C0596306:Association [Phenomenon or Process]
   799   C0699792:association [Social Behavior]

Phrase: "may"

Phrase: "be"

Phrase: "particularly relevant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347946:Relevant [Qualitative Concept]

Phrase: "because"

Phrase: ","

Phrase: "although"

Phrase: "ER-X"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   734   C0034804:Estrogen receptor [Amino Acid, Peptide, or Protein,Receptor]
   734   C1414461:ESTROGEN RECEPTOR [Gene or Genome]
   734   C1521863:Estrogen Receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "is"

Phrase: "developmentally"

Phrase: "regulated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0851285:Regulated [Governmental or Regulatory Activity]

Phrase: ","

Phrase: "it"

Phrase: "is"

Phrase: "reexpressed in the adult brain"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0001675:Adult [Age Group]
   760   C0006104:Brain [Body Part, Organ, or Organ Component]
   760   C1269537:Brain [Body Part, Organ, or Organ Component]
   760   C1706450:Adult [Human]

Phrase: "after an ischemic brain injury"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C2945681:ischemic brain injury [Injury or Poisoning]
   901   C0270611:Brain Injury [Injury or Poisoning]
   827   C3263722:Injury [Injury or Poisoning]
   827   C3263723:Injury [Injury or Poisoning]

Phrase: "(13"

Phrase: ")"

Phrase: "and in a transgenic mouse model"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   790   C0025936:Mouse, Transgenic [Mammal]
   790   C2986594:Mouse Model [Experimental Model of Disease]
   783   C1519606:Transgenic Model [Experimental Model of Disease]
   753   C0003069:Transgenic [Animal]
   753   C0025914:Mouse [Mammal]
   753   C0025929:mouse [Mammal]
   753   C0026809:Mouse [Mammal]
   753   C1515981:And [Idea or Concept]
   753   C3161035:Model [Intellectual Product]

Phrase: "(J20"

Phrase: ")"

Phrase: "of Alzheimers disease"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0002395:Alzheimers disease [Disease or Syndrome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "(Nethrapalli,"

Phrase: "I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "S."

Phrase: ","

Phrase: "and"

Phrase: "D. Toran-Allerand,"

Phrase: "unpublished data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1511726:Data [Idea or Concept]
   861   C3245479:data [Medical Device]

Phrase: ")."
Processing 00000000.tx.197: Thus, the likely target of 17-estradiol in the brain is ER-X and not the classical intranuclear ERs, ER and ER. 

Phrase: "Thus,"

Phrase: "the likely target of 17-estradiol"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1521840:Target [Functional Concept]
   753   C2986546:TARGET [Diagnostic Procedure]

Phrase: "in the brain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006104:Brain [Body Part, Organ, or Organ Component]
  1000   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "is"

Phrase: "ER-X"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   734   C0034804:Estrogen receptor [Amino Acid, Peptide, or Protein,Receptor]
   734   C1414461:ESTROGEN RECEPTOR [Gene or Genome]
   734   C1521863:Estrogen Receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "and"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "the classical intranuclear ERs,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1704489:ERS [Clinical Attribute]
   827   C2931783:ERS [Disease or Syndrome]

Phrase: "ER"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0034804:Estrogen receptor [Amino Acid, Peptide, or Protein,Receptor]
  1000   C1414461:ESTROGEN RECEPTOR [Gene or Genome]
  1000   C1521863:Estrogen Receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
   861   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C2936882:Estrogen [Pharmacologic Substance]
   789 E C0720298:Estrogenic [Hormone,Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "ER."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0034804:Estrogen receptor [Amino Acid, Peptide, or Protein,Receptor]
  1000   C1414461:ESTROGEN RECEPTOR [Gene or Genome]
  1000   C1521863:Estrogen Receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
   861   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C2936882:Estrogen [Pharmacologic Substance]
   789 E C0720298:Estrogenic [Hormone,Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.198: The presence of significantly elevated endogenous levels of 17-estradiol and E1 in the brains of postnatal and adult mice raises questions regarding their possible biological roles. 

Phrase: "The presence of significantly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "elevated"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205250:Elevated [Qualitative Concept]
  1000   C3163633:Elevated [Qualitative Concept]

Phrase: "endogenous levels of 17-estradiol"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   781   C0337434:Oestradiol level [Laboratory Procedure]
   760   C0441889:Levels [Qualitative Concept]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]

Phrase: "and"

Phrase: "E1 in the brains of postnatal"

Phrase: "and"

Phrase: "adult mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]

Phrase: "raises"

Phrase: "questions"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1522634:Question [Intellectual Product]

Phrase: "regarding"

Phrase: "their possible biological roles."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0035820:Roles [Social Behavior]
   793 E C1705810:Role [Conceptual Entity]
Processing 00000000.tx.199: 17-Estradiol and/or 17-estradiol have been shown to have differentiative effects in the developing brain (17) and neuroprotective effects in the adult with respect to damage from age-associated, neurodegenerative states such as Alzheimers (9, 32) and Parkinsons (33) diseases as well as multiple sclerosis (34), schizophrenia (35), and ischemic stroke (8, 36, 37). 

Phrase: "17-Estradiol"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0014912:Estradiol [Hormone,Pharmacologic Substance,Steroid]
   805 E C0699352:Estrace [Hormone,Pharmacologic Substance,Steroid]
   805 E C0878472:Progynon [Hormone,Pharmacologic Substance,Steroid]

Phrase: "and/or"

Phrase: "17-estradiol"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0014912:Estradiol [Hormone,Pharmacologic Substance,Steroid]
   805 E C0699352:Estrace [Hormone,Pharmacologic Substance,Steroid]
   805 E C0878472:Progynon [Hormone,Pharmacologic Substance,Steroid]

Phrase: "have"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "have"

Phrase: "differentiative effects in the developing brain"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C1280500:effects [Qualitative Concept]
   719 E C2348382:Effect [Qualitative Concept]

Phrase: "(17"

Phrase: ")"

Phrase: "and"

Phrase: "neuroprotective effects in the adult"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   806   C0815279:Neuroprotective Effects [Functional Concept]
   760   C1280500:effects [Qualitative Concept]
   726 E C2348382:Effect [Qualitative Concept]

Phrase: "with respect to"

Phrase: "damage from age-associated, neurodegenerative states"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   753   C0001779:Age [Organism Attribute]
   753   C0010957:Damage [Injury or Poisoning]
   753   C0332281:Associated [Qualitative Concept]
   753   C1301808:states [Geographic Area]
   753   C1883709:Damage [Functional Concept]
   719 E C0750490:Associate [Idea or Concept]
   719 E C1442792:State [Functional Concept]
   719 E C1706221:Associate [Professional or Occupational Group]
   719 E C3148680:State [Geographic Area]

Phrase: "such as Alzheimers (9,"

Phrase: "32"

Phrase: ")"

Phrase: "and"

Phrase: "Parkinsons"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   893   C1021144:Parkinsonia [Plant]

Phrase: "(33"

Phrase: ")"

Phrase: "diseases"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0012634:Diseases [Disease or Syndrome]
   928 E C1836721:MALS [Finding]
   928 E C3538764:MALS [Gene or Genome]
   928 E C3540595:MAL [Gene or Genome]

Phrase: "as well as"

Phrase: "multiple sclerosis"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0026769:Multiple Sclerosis [Disease or Syndrome]
  1000   C1417325:multiple sclerosis [Gene or Genome]
   861   C0036429:Sclerosis [Pathologic Function]
   861   C0439064:Multiple [Quantitative Concept]
   789 E C0334135:Sclerotic [Functional Concept]

Phrase: "(34"

Phrase: ")"

Phrase: ","

Phrase: "schizophrenia"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0036341:Schizophrenia [Mental or Behavioral Dysfunction]

Phrase: "(35"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "ischemic stroke"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0948008:Ischaemic stroke [Disease or Syndrome]
  1000   C3272363:Ischemic Stroke [Disease or Syndrome]
   861   C0038454:Stroke [Disease or Syndrome]
   861   C0475224:Ischaemic [Functional Concept]

Phrase: "(8,"

Phrase: "36,"

Phrase: "37"

Phrase: ")."
Processing 00000000.tx.200: 17-Estradiol and ER-X thus form an estrogen/receptor system that would be readily available for neuroprotection during development and in the adult. 

Phrase: "17-Estradiol"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0014912:Estradiol [Hormone,Pharmacologic Substance,Steroid]
   805 E C0699352:Estrace [Hormone,Pharmacologic Substance,Steroid]
   805 E C0878472:Progynon [Hormone,Pharmacologic Substance,Steroid]

Phrase: "and"

Phrase: "ER-X thus"

Phrase: "form"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0348078:Form [Qualitative Concept]
  1000   C0376315:Form [Manufactured Object]
  1000   C1522492:Form [Functional Concept]

Phrase: "an estrogen/receptor system"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   827   C0449913:System [Functional Concept]
   827   C1553451:System [Manufactured Object]
   827   C1704459:System [Medical Device]
   755 E C0205373:Systemic [Functional Concept]
   734   C0034804:Estrogen receptor [Amino Acid, Peptide, or Protein,Receptor]
   734   C1414461:ESTROGEN RECEPTOR [Gene or Genome]
   734   C1521863:Estrogen Receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "that"

Phrase: "would"

Phrase: "be"

Phrase: "readily available for neuroprotection"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0470187:Available [Functional Concept]

Phrase: "during development"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0243107:development [Physiologic Function]
  1000   C0678723:Development [Organism Function]
  1000   C1527148:Development [Functional Concept]
   928 E C0458003:Developmental [Qualitative Concept]

Phrase: "and in the adult."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0001675:Adult [Age Group]
   770   C1515981:And [Idea or Concept]
   770   C1706450:Adult [Human]
Processing 00000000.tx.201: The importance of 17-estradiol for the adult brain in particular is further emphasized by noting that, although endogenous levels of 17-estradiol were elevated in the adult uterus, the classical estrogen (17-estradiol) target tissue, 17-estradiol, but not 17-estradiol, levels were significantly elevated in the adult brain of both sexes. 

Phrase: "The importance of 17-estradiol"

Phrase: "for the adult brain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0006104:Brain [Body Part, Organ, or Organ Component]
   861   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "in particular"

Phrase: "is"

Phrase: "further"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "emphasized by noting"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   756   C1316572:Note [Clinical Attribute]
   756   C1317574:Note [Intellectual Product]
   756   C1369612:Note [Clinical Attribute]

Phrase: "that,"

Phrase: "although"

Phrase: "endogenous levels of 17-estradiol"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   781   C0337434:Oestradiol level [Laboratory Procedure]
   760   C0441889:Levels [Qualitative Concept]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]

Phrase: "were"

Phrase: "elevated in the adult uterus,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0001675:Adult [Age Group]
   760   C0042149:Uterus [Body Part, Organ, or Organ Component]
   760   C0205250:Elevated [Qualitative Concept]
   760   C1269032:Uterus [Body Part, Organ, or Organ Component]
   760   C1706450:Adult [Human]
   760   C3163633:Elevated [Qualitative Concept]

Phrase: "the classical estrogen"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
   861   C2936882:Estrogen [Pharmacologic Substance]
   789 E C0720298:Estrogenic [Hormone,Organic Chemical,Pharmacologic Substance]

Phrase: "(17-estradiol"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0014912:Estradiol [Hormone,Pharmacologic Substance,Steroid]
   805 E C0699352:Estrace [Hormone,Pharmacologic Substance,Steroid]
   805 E C0878472:Progynon [Hormone,Pharmacologic Substance,Steroid]

Phrase: ")"

Phrase: "target tissue,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0040300:Tissue [Tissue]
   861   C1521840:Target [Functional Concept]
   861   C1547928:Tissue [Intellectual Product]
   861   C2986546:TARGET [Diagnostic Procedure]

Phrase: "17-estradiol,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0014912:Estradiol [Hormone,Pharmacologic Substance,Steroid]
   805 E C0699352:Estrace [Hormone,Pharmacologic Substance,Steroid]
   805 E C0878472:Progynon [Hormone,Pharmacologic Substance,Steroid]

Phrase: "but"

Phrase: "not 17-estradiol,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0014912:Estradiol [Hormone,Pharmacologic Substance,Steroid]
   771 E C0699352:Estrace [Hormone,Pharmacologic Substance,Steroid]
   771 E C0878472:Progynon [Hormone,Pharmacologic Substance,Steroid]

Phrase: "levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0441889:Levels [Qualitative Concept]
   966 E C0456079:Level [Classification]
   966 E C1547707:Level [Geographic Area]
   966 E C2946261:Level [Pharmacologic Substance]

Phrase: "were"

Phrase: "significantly"

Phrase: "elevated in the adult brain of both sexes."
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   744   C0001675:Adult [Age Group]
   744   C0006104:Brain [Body Part, Organ, or Organ Component]
   744   C0205250:Elevated [Qualitative Concept]
   744   C1269537:Brain [Body Part, Organ, or Organ Component]
   744   C1706450:Adult [Human]
   744   C3163633:Elevated [Qualitative Concept]
   711   C0009253:Sex [Organism Function]
   711   C0036864:Sex [Behavior]
   711   C0079399:sex [Organism Attribute]
   711   C1314687:Sex [Finding]
   711   C1522384:sex [Organism Attribute]
Processing 00000000.tx.202: The uterotrophic activity of 17 -estradiol has also been reported (38). 

Phrase: "The uterotrophic activity of 17 -estradiol"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0205177:Activity [Functional Concept]
   753   C0439167:% activity [Quantitative Concept]
   753   C0441655:Activity [Activity]
   753   C1561536:*Activity [Idea or Concept]

Phrase: "has"

Phrase: "also"

Phrase: "been"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "(38"

Phrase: ")."
Processing 00000000.tx.203: However, it was not possible in these studies to determine whether the uterotrophic stimulation was due to the direct effects of 17-estradiol because this enantiomer was partially metabolized to 17-estradiol, and both enantiomers were found in uterine nuclei after an implant of 17-estradiol (38). 

Phrase: "However,"

Phrase: "it"

Phrase: "was"

Phrase: "not possible in these studies to"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0332149:Possible [Qualitative Concept]
   753   C1705910:Possible [Qualitative Concept]
   753   C2362652:Possible [Qualitative Concept]

Phrase: "determine"

Phrase: "whether"

Phrase: "the uterotrophic stimulation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   861   C1948023:Stimulation [Natural Phenomenon or Process]

Phrase: "was due to the direct effects of 17-estradiol"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   764   C0678226:Due to [Functional Concept]
           due
   742   C0014912:Estradiol [Hormone,Pharmacologic Substance,Steroid]
   742   C0043194:WAS [Disease or Syndrome]
   742   C0258432:WAS [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0439851:Direct [Qualitative Concept]
   742   C1280500:effects [Qualitative Concept]
   742   C1421478:WAS [Gene or Genome]
   742   C1947931:Direct [Qualitative Concept]
   742   C3146286:Due [Idea or Concept]
   708 E C2348382:Effect [Qualitative Concept]

Phrase: "because"

Phrase: "this enantiomer"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0599473:enantiomer [Chemical Viewed Structurally]
  1000   C3539649:enantiomer [Phenomenon or Process]

Phrase: "was"

Phrase: "partially"

Phrase: "metabolized to 17-estradiol,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   770   C0014912:Estradiol [Hormone,Pharmacologic Substance,Steroid]
   770   C1524026:Metabolized [Cell Function]
   715 E C0699352:Estrace [Hormone,Pharmacologic Substance,Steroid]
   715 E C0878472:Progynon [Hormone,Pharmacologic Substance,Steroid]

Phrase: "and"

Phrase: "both enantiomers"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0599473:enantiomers [Chemical Viewed Structurally]
   966 E C3539649:enantiomer [Phenomenon or Process]

Phrase: "were"

Phrase: "found in uterine nuclei"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0042149:Uterine [Body Part, Organ, or Organ Component]
   770   C0150312:Found [Quantitative Concept]
   737   C0007610:Nucleus [Cell Component]
   737 E C0243095:Find [Finding]

Phrase: "after an implant"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021102:Implant [Medical Device]
  1000   C0021107:implant [Therapeutic or Preventive Procedure]
  1000   C0332837:Implant [Injury or Poisoning]
  1000   C1711357:Implant [Functional Concept]

Phrase: "of 17-estradiol"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0014912:Estradiol [Hormone,Pharmacologic Substance,Steroid]
   805 E C0699352:Estrace [Hormone,Pharmacologic Substance,Steroid]
   805 E C0878472:Progynon [Hormone,Pharmacologic Substance,Steroid]

Phrase: "(38"

Phrase: ")."
Processing 00000000.tx.204: The importance of age-specific functions of 17-estradiol is suggested by our findings of its lack of binding to plasma AFP, the major estrogen binding plasma protein of the developing rodent, whose circulating postnatal levels are very high (2 mg/ml) (17). 

Phrase: "The importance of age-specific functions of 17-estradiol"

Phrase: "is"

Phrase: "suggested by our findings of its lack of binding"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   742   C0243122:binding [Functional Concept]
   742   C0332268:lack [Qualitative Concept]
   742   C1145667:Binding [Activity]
   742   C1167622:Binding [Molecular Function]
   742   C2607943:findings [Functional Concept]
   742   C2926606:Findings [Clinical Attribute]
   742   C3539655:Findings [Intellectual Product]
   708 E C0037088:Finding [Sign or Symptom]
   708 E C0243095:Finding [Finding]
   708   C1705535:Suggest [Idea or Concept]
   708 E C2825141:Finding [Finding]

Phrase: "to plasma AFP,"

Phrase: "the major estrogen binding plasma protein of the developing rodent,"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   777   C0059672:Estrogen binding protein [Amino Acid, Peptide, or Protein,Receptor]
   760   C0032120:Plasma protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0036825:Plasma Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   757   C0033618:Protein Binding [Molecular Function]
   757   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   757 E C1168405:protein plasma [Laboratory Procedure]
   739   C0032105:Plasma [Body Substance]
   739   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]

Phrase: "whose"

Phrase: "circulating"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0175630:Circulating [Functional Concept]

Phrase: "postnatal levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0441889:Levels [Qualitative Concept]
   827 E C0456079:Level [Classification]
   827 E C1547707:Level [Geographic Area]
   827 E C2946261:Level [Pharmacologic Substance]

Phrase: "are"

Phrase: "very high"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0442804:Very high [Finding]
   861   C0205250:High [Qualitative Concept]
   861   C1299351:High [Qualitative Concept]
   861   C2700149:HIGH [Intellectual Product]

Phrase: "(2 mg/ml) (17"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   861   C0439294:mg ml [Quantitative Concept]
   812   C0439269:mg% [Quantitative Concept]
   812   C0439526:/mL [Quantitative Concept]
   812   C0740116:+2 [Quantitative Concept]
   812   C1960952:mg % [Quantitative Concept]
   812   C2346927:Mg++ [Element, Ion, or Isotope,Pharmacologic Substance]
   812   C2827735:2+ [Quantitative Concept]
   812   C2981700:2+ [Classification]

Phrase: ")."
Processing 00000000.tx.205: AFP has generally been considered the principal barrier that protects tissues of the perinatal rodent, particularly the brain, from excessive exposure to circulating estrogens (17). 

Phrase: "AFP"

Phrase: "has"

Phrase: "generally"

Phrase: "been"

Phrase: "considered"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750591:considered [Idea or Concept]

Phrase: "the principal barrier"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1706912:BARRIER [Medical Device]

Phrase: "that"

Phrase: "protects"

Phrase: "tissues of the perinatal rodent,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0040300:Tissues [Tissue]
   726 E C1547928:Tissue [Intellectual Product]

Phrase: "particularly"

Phrase: "the brain,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006104:Brain [Body Part, Organ, or Organ Component]
  1000   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "from excessive exposure"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0274281:Exposure, NOS [Injury or Poisoning]
   861   C0332157:Exposure [Clinical Attribute]

Phrase: "to circulating estrogens"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0014939:Estrogens [Hormone,Pharmacologic Substance,Steroid]
   827 E C2936882:Estrogen [Pharmacologic Substance]
   777 E C0720298:Estrogenic [Hormone,Organic Chemical,Pharmacologic Substance]

Phrase: "(17"

Phrase: ")."
Processing 00000000.tx.206: The dramatic difference in the bioavailability of the two E2 enantiomers for the ERs in the postnatal brain suggests that, during the developmental period, 17-estradiol may have important age-specific functions that are distinct from sexual differentiation of the brain (39) as, for example, influences on neurogenesis and neuronal survival. 

Phrase: "The dramatic difference in the bioavailability of the two E2 enantiomers"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   738   C1705241:*Difference [Quantitative Concept]
   738   C1705242:Difference [Qualitative Concept]

Phrase: "for the ERs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1704489:ERS [Clinical Attribute]
  1000   C2931783:ERS [Disease or Syndrome]

Phrase: "in the postnatal brain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0006104:Brain [Body Part, Organ, or Organ Component]
   861   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that,"

Phrase: "during the developmental period,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0439531:/period [Temporal Concept]
   861   C1948053:Period [Temporal Concept]
   789 E C0332182:Periodic [Temporal Concept]
   789 E C1706381:PERIODIC [Intellectual Product]
   761 E C0031084:Periodicities [Temporal Concept]

Phrase: "17-estradiol"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0014912:Estradiol [Hormone,Pharmacologic Substance,Steroid]
   805 E C0699352:Estrace [Hormone,Pharmacologic Substance,Steroid]
   805 E C0878472:Progynon [Hormone,Pharmacologic Substance,Steroid]

Phrase: "may"

Phrase: "have"

Phrase: "important age-specific functions"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   812   C0542341:Functions [Functional Concept]
   779 E C0031843:function [Physiologic Function]
   779 E C0700205:FUNCTION [Classification]
   779 E C1705273:Function [Intellectual Product]
   729 E C0205245:Functional [Functional Concept]
   729 E C2700217:Functional [Conceptual Entity]

Phrase: "that"

Phrase: "are"

Phrase: "distinct from sexual differentiation of the brain"

Phrase: "(39"

Phrase: ")"

Phrase: "as"

Phrase: ","

Phrase: "for example,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707959:Example [Conceptual Entity]

Phrase: "influences on neurogenesis"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0814002:Neurogenesis [Cell Function,Organism Function]
   718 E C0597047:neurogenetic [Biomedical Occupation or Discipline]

Phrase: "and"

Phrase: "neuronal survival."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   964   C1819944:neuron survival [Cell Function]
   861   C0038952:Survival [Activity]
   861   C0220921:survival [Functional Concept]
Processing 00000000.tx.207: Although immunoreactivity for AFP and other plasma proteins has been found within neurons of the neonatal rodent brain (17), the binding of 17-estradiol to its intraneuronal ERs (ER-X) would not be modulated or regulated by AFP, as 17-estradiol binding to ER and ER would be, thus enabling 17-estradiol to exert its actions freely. 

Phrase: "Although"

Phrase: "immunoreactivity for AFP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0597879:immunoreactivity [Molecular Function]

Phrase: "and"

Phrase: "other plasma proteins"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0032120:Plasma Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   966 E C0036825:Plasma Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0032105:Plasma [Body Substance]
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]

Phrase: "has"

Phrase: "been"

Phrase: "found within neurons of the neonatal rodent brain"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   744   C0006104:Brain [Body Part, Organ, or Organ Component]
   744   C0027882:Neurons [Cell]
   744   C0035804:Rodent [Mammal]
   744   C0150312:Found [Quantitative Concept]
   744   C1269537:Brain [Body Part, Organ, or Organ Component]
   744   C1552240:Neonatal [Professional or Occupational Group]
   744   C1552264:Neonatal [Professional or Occupational Group]
   744   C2939425:Neonatal [Temporal Concept]
   711 E C0243095:Find [Finding]

Phrase: "(17"

Phrase: ")"

Phrase: ","

Phrase: "the binding of 17-estradiol"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0243122:binding [Functional Concept]
   760   C1145667:Binding [Activity]
   760   C1167622:Binding [Molecular Function]

Phrase: "to its intraneuronal ERs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1704489:ERS [Clinical Attribute]
   861   C2931783:ERS [Disease or Syndrome]

Phrase: "(ER-X)"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   734   C0034804:Estrogen receptor [Amino Acid, Peptide, or Protein,Receptor]
   734   C1414461:ESTROGEN RECEPTOR [Gene or Genome]
   734   C1521863:Estrogen Receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "would"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "be"

Phrase: "modulated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443264:Modulated [Spatial Concept]

Phrase: "or"

Phrase: "regulated by AFP,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0851285:Regulated [Governmental or Regulatory Activity]

Phrase: "as"

Phrase: "17-estradiol binding to ER"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   820   C1149369:estrogen receptor binding [Molecular Function]
   783   C0597358:Receptor Binding [Molecular Function]
   753   C0243122:binding [Functional Concept]
   753   C1145667:Binding [Activity]
   753   C1167622:Binding [Molecular Function]

Phrase: "and"

Phrase: "ER"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0034804:Estrogen receptor [Amino Acid, Peptide, or Protein,Receptor]
  1000   C1414461:ESTROGEN RECEPTOR [Gene or Genome]
  1000   C1521863:Estrogen Receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
   861   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C2936882:Estrogen [Pharmacologic Substance]
   789 E C0720298:Estrogenic [Hormone,Organic Chemical,Pharmacologic Substance]

Phrase: "would"

Phrase: "be"

Phrase: ","

Phrase: "thus"

Phrase: "enabling"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1171285:Enabling [Mental Process]
   966 E C0562342:enable [Mental Process]

Phrase: "17-estradiol to"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0014912:Estradiol [Hormone,Pharmacologic Substance,Steroid]
   771 E C0699352:Estrace [Hormone,Pharmacologic Substance,Steroid]
   771 E C0878472:Progynon [Hormone,Pharmacologic Substance,Steroid]

Phrase: "exert"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015264:exert [Organism Function]

Phrase: "its actions freely."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0441472:actions [Functional Concept]
   827 E C3266814:Action [Activity]
Processing 00000000.tx.208: Treatment with exogenous 17-estradiol may have unpredictable consequences. 

Phrase: "Treatment with exogenous 17-estradiol"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0039798:treatment [Functional Concept]
   760   C0087111:Treatment [Therapeutic or Preventive Procedure]
   760   C1522326:Treatment [Functional Concept]
   760   C1533734:Treatment [Therapeutic or Preventive Procedure]
   760   C1705169:Treatment [Conceptual Entity]
   760   C3538994:TREATMENT [Research Activity]

Phrase: "may"

Phrase: "have"

Phrase: "unpredictable consequences."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0686907:consequences [Functional Concept]
Processing 00000000.tx.209: For example, Hajek et al. 

Phrase: "For example,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707959:Example [Conceptual Entity]

Phrase: "Hajek et al."
Processing 00000000.tx.210: (40) reported that exogenous 17-estradiol was carcinogenic in the reproductive tract of neonatal BALB/c mice but not in the adult. 

Phrase: "(40"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439509:/40 [Temporal Concept]

Phrase: ")"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "that exogenous 17-estradiol"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0014912:Estradiol [Hormone,Pharmacologic Substance,Steroid]
   771 E C0699352:Estrace [Hormone,Pharmacologic Substance,Steroid]
   771 E C0878472:Progynon [Hormone,Pharmacologic Substance,Steroid]

Phrase: "was"

Phrase: "carcinogenic in the reproductive tract of neonatal BALB/c mice"

Phrase: "but"

Phrase: "not in the adult."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0001675:Adult [Age Group]
   770   C1518422:Not [Functional Concept]
   770   C1706450:Adult [Human]
Processing 00000000.tx.211: They proposed that the biological effects of 17-estradiol may be age dependent, which may explain why this estrogen has been considered inactive in the adult. 

Phrase: "They"

Phrase: "proposed"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1441414:PROPOSED [Idea or Concept]
  1000   C1553874:Proposed [Qualitative Concept]
  1000   C1578820:Proposed [Idea or Concept]

Phrase: "that"

Phrase: "the biological effects of 17-estradiol"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   753   C0005532:Biological [Biomedical Occupation or Discipline]
   753   C0205460:biological [Qualitative Concept]
   753   C1280500:effects [Qualitative Concept]
   719 E C2348382:Effect [Qualitative Concept]

Phrase: "may"

Phrase: "be"

Phrase: "age"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001779:Age [Organism Attribute]

Phrase: "dependent,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0851827:Dependent [Qualitative Concept]
  1000   C1701901:Dependent [Qualitative Concept]
  1000   C3244310:dependent [Functional Concept]

Phrase: "which"

Phrase: "may"

Phrase: "explain"

Phrase: "why"

Phrase: "this estrogen"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
  1000   C2936882:Estrogen [Pharmacologic Substance]
   928 E C0720298:Estrogenic [Hormone,Organic Chemical,Pharmacologic Substance]

Phrase: "has"

Phrase: "been"

Phrase: "considered inactive in the adult."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0205254:Inactive [Qualitative Concept]
Processing 00000000.tx.212: Moreover, because 17-estradiol does not bind to AFP, its bioavailability, as compared with 17-estradiol, is much higher in perinatal animals, which may explain its reported carcinogenic effects at this age (40). 

Phrase: "Moreover,"

Phrase: "because"

Phrase: "17-estradiol"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0014912:Estradiol [Hormone,Pharmacologic Substance,Steroid]
   805 E C0699352:Estrace [Hormone,Pharmacologic Substance,Steroid]
   805 E C0878472:Progynon [Hormone,Pharmacologic Substance,Steroid]

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "bind to AFP,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1145667:Bind [Activity]
   790   C1167622:bind [Molecular Function]

Phrase: "its bioavailability,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0005508:Bioavailability [Quantitative Concept]
  1000   C1706947:BIO-AVAILABILITY [Research Activity]
   928 E C0935763:Bioavailable [Qualitative Concept]

Phrase: "as"

Phrase: "compared with 17-estradiol,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   770   C0014912:Estradiol [Hormone,Pharmacologic Substance,Steroid]
   770   C1707455:Compared [Activity]
   715 E C0699352:Estrace [Hormone,Pharmacologic Substance,Steroid]
   715 E C0878472:Progynon [Hormone,Pharmacologic Substance,Steroid]

Phrase: "is"

Phrase: "much higher in perinatal animals,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   797   C0684068:higher animals [Animal]
   726   C0205250:High [Qualitative Concept]
   726   C1299351:High [Qualitative Concept]
   726   C2700149:HIGH [Intellectual Product]

Phrase: "which"

Phrase: "may"

Phrase: "explain"

Phrase: "its reported carcinogenic effects at this age (40"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   744   C1280500:effects [Qualitative Concept]
   718   C0520759:Carcinogen effect [Injury or Poisoning]
   711 E C2348382:Effect [Qualitative Concept]

Phrase: ")."
Processing 00000000.tx.213: Here we show, for the first time to our knowledge, that high endogenous levels of 17-estradiol are present in the postnatal and adult male and female brain. 

Phrase: "Here"

Phrase: "we"

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: ","

Phrase: "for the first time"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0040223:Time [Temporal Concept]
   861   C3541383:Time [Temporal Concept]
   805 E C0442043:Temporal [Spatial Concept]
   805 E C2362314:Temporal [Temporal Concept]
   777 E C1632851:Times [Quantitative Concept]

Phrase: "to our knowledge,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0376554:Knowledge [Intellectual Product]

Phrase: "that high endogenous levels of 17-estradiol"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   757   C0337434:Oestradiol level [Laboratory Procedure]
   748   C0441889:Levels [Qualitative Concept]
   714 E C0456079:Level [Classification]
   714 E C1547707:Level [Geographic Area]
   714 E C2946261:Level [Pharmacologic Substance]

Phrase: "are"

Phrase: "present in the postnatal"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0150312:Present [Quantitative Concept]
   770   C0449450:Present [Idea or Concept]

Phrase: "and"

Phrase: "adult male"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   861   C0001675:Adult [Age Group]
   861   C0024554:Male [Finding]
   861   C0086582:male [Population Group]
   861   C1706180:Male [Qualitative Concept]
   861   C1706428:Male [Qualitative Concept]
   861   C1706429:Male [Organism Attribute]
   861   C1706450:Adult [Human]

Phrase: "and"

Phrase: "female brain."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0006104:Brain [Body Part, Organ, or Organ Component]
   861   C1269537:Brain [Body Part, Organ, or Organ Component]
Processing 00000000.tx.214: Our findings suggest that because 17-estradiol is not present in the circulation and is unaffected by ovariectomy, castration, and/or adrenalectomy, it is likely to be made in the brain. 

Phrase: "Our findings"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2607943:findings [Functional Concept]
  1000   C2926606:Findings [Clinical Attribute]
  1000   C3539655:Findings [Intellectual Product]
   966 E C0037088:Finding [Sign or Symptom]
   966 E C0243095:Finding [Finding]
   966 E C2825141:Finding [Finding]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "because"

Phrase: "17-estradiol"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0014912:Estradiol [Hormone,Pharmacologic Substance,Steroid]
   805 E C0699352:Estrace [Hormone,Pharmacologic Substance,Steroid]
   805 E C0878472:Progynon [Hormone,Pharmacologic Substance,Steroid]

Phrase: "is"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "present in the circulation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0005775:Circulation [Physiologic Function]
   770   C0150312:Present [Quantitative Concept]
   770   C0449450:Present [Idea or Concept]
   770   C1516559:Circulation [Organism Function]

Phrase: "and"

Phrase: "is"

Phrase: "unaffected by ovariectomy,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C2986417:Unaffected [Conceptual Entity]

Phrase: "castration,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0007344:Castration [Therapeutic or Preventive Procedure]
  1000   C0029189:Castration [Therapeutic or Preventive Procedure]

Phrase: "and/or"

Phrase: "adrenalectomy,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001632:Adrenalectomy [Therapeutic or Preventive Procedure]

Phrase: "it"

Phrase: "is"

Phrase: "likely to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332148:Likely [Qualitative Concept]
   861   C0750492:Likely [Idea or Concept]

Phrase: "be"

Phrase: "made in the brain."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0006104:Brain [Body Part, Organ, or Organ Component]
   770   C1269537:Brain [Body Part, Organ, or Organ Component]
   737   C1881534:Make [Functional Concept]
Processing 00000000.tx.215: Moreover, that the endogenous levels of 17-estradiol are significantly elevated in the brain, after gonadectomy and/or adrenalectomy, suggests that the gonads and adrenals may normally exert some sort of regulatory influence on the endogenous brain content of 17-estradiol, which disappears after their removal. 

Phrase: "Moreover,"

Phrase: "that"

Phrase: "the endogenous levels of 17-estradiol"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   767   C0337434:Oestradiol level [Laboratory Procedure]
   753   C0441889:Levels [Qualitative Concept]
   719 E C0456079:Level [Classification]
   719 E C1547707:Level [Geographic Area]
   719 E C2946261:Level [Pharmacologic Substance]

Phrase: "are"

Phrase: "significantly"

Phrase: "elevated in the brain,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0006104:Brain [Body Part, Organ, or Organ Component]
   770   C0205250:Elevated [Qualitative Concept]
   770   C1269537:Brain [Body Part, Organ, or Organ Component]
   770   C3163633:Elevated [Qualitative Concept]

Phrase: "after"

Phrase: "gonadectomy"

Phrase: "and/or"

Phrase: "adrenalectomy,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001632:Adrenalectomy [Therapeutic or Preventive Procedure]

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the gonads"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0018067:Gonads [Body Part, Organ, or Organ Component]
   966 E C1281670:Gonad [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "adrenals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001625:Adrenals [Body Part, Organ, or Organ Component]

Phrase: "may"

Phrase: "normally"

Phrase: "exert"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015264:exert [Organism Function]

Phrase: "some sort of regulatory influence"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0237886:sort [Mental Process]
   760   C0700314:sort [Cell Function]
   760   C1947906:Sort [Activity]

Phrase: "on the endogenous brain content"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C1555325:endogenous content [Intellectual Product]
   827   C0423896:Content [Mental Process]
   827   C0456205:Content [Conceptual Entity]

Phrase: "of 17-estradiol,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0014912:Estradiol [Hormone,Pharmacologic Substance,Steroid]
   805 E C0699352:Estrace [Hormone,Pharmacologic Substance,Steroid]
   805 E C0878472:Progynon [Hormone,Pharmacologic Substance,Steroid]

Phrase: "which"

Phrase: "disappears after their removal."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0015252:Removal [Therapeutic or Preventive Procedure]
   770   C0728940:Removal [Therapeutic or Preventive Procedure]
Processing 00000000.tx.216: Because 17-estradiol elicits both MAPK/ERK and phosphatidylinositol 3-kinase and Akt phosphorylation (11, 12, 13), its presence in the brain makes it uniquely positioned to activate the entire subsequent range of differentiative and neuroprotective signaling pathways. 

Phrase: "Because"

Phrase: "17-estradiol"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0014912:Estradiol [Hormone,Pharmacologic Substance,Steroid]
   805 E C0699352:Estrace [Hormone,Pharmacologic Substance,Steroid]
   805 E C0878472:Progynon [Hormone,Pharmacologic Substance,Steroid]

Phrase: "elicits"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449265:elicit [Qualitative Concept]

Phrase: "both MAPK/ERK"

Phrase: "and"

Phrase: "phosphatidylinositol 3-kinase"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0044602:Phosphatidylinositol 3-Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   972 E C2936824:Phosphatidylinositol 3-Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "Akt phosphorylation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0031715:Phosphorylation [Molecular Function]
   861   C1158886:Phosphorylation [Molecular Function]

Phrase: "(11,"

Phrase: "12,"

Phrase: "13"

Phrase: ")"

Phrase: ","

Phrase: "its presence in the brain"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "makes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1881534:Make [Functional Concept]

Phrase: "it uniquely"

Phrase: "positioned"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0733755:Position [Spatial Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "activate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515877:Activate [Functional Concept]
  1000   C1879547:Activate [Activity]

Phrase: "the entire subsequent range of differentiative"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C1514721:Range [Quantitative Concept]
   753   C2348147:Range [Quantitative Concept]
   753   C3542016:Range [Intellectual Product]

Phrase: "and"

Phrase: "neuroprotective signaling pathways."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   884   C0037080:Signal Pathways [Molecular Function]
   884   C0037083:signaling pathway [Cell Function]
   884   C0086982:Signaling Pathway [Molecular Function]
   827   C1704259:Pathways [Molecular Function]
   827   C1705987:Pathways [Conceptual Entity]
Processing 00000000.tx.217: Moreover, because 17-estradiol is capable of both binding and activating ER-X, these findings challenge the view that 17-estradiol is without biological significance. 

Phrase: "Moreover,"

Phrase: "because"

Phrase: "17-estradiol"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0014912:Estradiol [Hormone,Pharmacologic Substance,Steroid]
   805 E C0699352:Estrace [Hormone,Pharmacologic Substance,Steroid]
   805 E C0878472:Progynon [Hormone,Pharmacologic Substance,Steroid]

Phrase: "is"

Phrase: "capable of both binding"

Phrase: "and"

Phrase: "activating ER-X,"

Phrase: "these findings challenge"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0798503:Challenge [Clinical Attribute]
   861   C0805586:Challenge [Health Care Activity]
   861   C3274764:Challenge [Conceptual Entity]

Phrase: "the view"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "that 17-estradiol"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0014912:Estradiol [Hormone,Pharmacologic Substance,Steroid]
   805 E C0699352:Estrace [Hormone,Pharmacologic Substance,Steroid]
   805 E C0878472:Progynon [Hormone,Pharmacologic Substance,Steroid]

Phrase: "is without biological significance."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0005532:Biological [Biomedical Occupation or Discipline]
   770   C0205460:biological [Qualitative Concept]
   770   C0237881:Significance [Quantitative Concept]
   770   C0750502:Significance [Idea or Concept]
Processing 00000000.tx.218: 17-Estradiol and its specific receptor ER-X do not constitute a classical endocrine hormone/receptor system but, rather, a novel system with important local autocrine and paracrine functions in both the developing and adult brain of both sexes. 

Phrase: "17-Estradiol"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0014912:Estradiol [Hormone,Pharmacologic Substance,Steroid]
   805 E C0699352:Estrace [Hormone,Pharmacologic Substance,Steroid]
   805 E C0878472:Progynon [Hormone,Pharmacologic Substance,Steroid]

Phrase: "and"

Phrase: "its specific receptor ER-X"

Phrase: "do"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "constitute"

Phrase: "a classical endocrine hormone/receptor system"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   875   C0014136:Endocrine system [Body System]
           Hormonal System
   875   C0559306:ENDOCRINE SYSTEM [Finding]
   875   C1280975:Endocrine system [Body System]
   804   C0449913:System [Functional Concept]
   804   C1553451:System [Manufactured Object]
   804   C1704459:System [Medical Device]
   733 E C0205373:Systemic [Functional Concept]

Phrase: "but"

Phrase: ","

Phrase: "rather,"

Phrase: "a novel system with important local autocrine"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0449913:System [Functional Concept]
   748   C1553451:System [Manufactured Object]
   748   C1704459:System [Medical Device]

Phrase: "and"

Phrase: "paracrine functions in both"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   770   C0542341:Functions [Functional Concept]
   737 E C0031843:function [Physiologic Function]
   737 E C0700205:FUNCTION [Classification]
   737 E C1705273:Function [Intellectual Product]

Phrase: "the developing"

Phrase: "and"

Phrase: "adult brain of both sexes."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0006104:Brain [Body Part, Organ, or Organ Component]
   760   C1269537:Brain [Body Part, Organ, or Organ Component]
Processing 00000000.tx.219: Far from being a biologically inactive estrogen, as is generally believed, 17-estradiol may have very important neural functions throughout life, with enormous implications for hormone replacement strategies at the menopause and in the treatment of various neurodegenerative disorders, including Alzheimers disease and ischemic stroke.  

Phrase: "Far from"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C0205108:far [Spatial Concept]

Phrase: "being"

Phrase: "a biologically inactive estrogen,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
   827   C2936882:Estrogen [Pharmacologic Substance]
   755 E C0720298:Estrogenic [Hormone,Organic Chemical,Pharmacologic Substance]

Phrase: "as is generally"

Phrase: "believed"

Phrase: ","

Phrase: "17-estradiol"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0014912:Estradiol [Hormone,Pharmacologic Substance,Steroid]
   805 E C0699352:Estrace [Hormone,Pharmacologic Substance,Steroid]
   805 E C0878472:Progynon [Hormone,Pharmacologic Substance,Steroid]

Phrase: "may"

Phrase: "have"

Phrase: "very important neural functions throughout life,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   773   C0700630:neural function [Physiologic Function]
   753   C0542341:Functions [Functional Concept]
   719 E C0031843:function [Physiologic Function]
   719 E C0700205:FUNCTION [Classification]
   719 E C1705273:Function [Intellectual Product]

Phrase: "with enormous implications"

Phrase: "for hormone replacement strategies"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0679199:strategies [Mental Process]
   734   C0282402:hormone replacement [Therapeutic or Preventive Procedure]

Phrase: "at the menopause"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0025320:Menopause [Physiologic Function]
  1000   C0567312:Menopause [Finding]

Phrase: "and in the treatment of various neurodegenerative disorders,"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   770   C0524851:Neurodegenerative Disorders [Disease or Syndrome]
   770   C1522560:Neurodegenerative Disorders [Functional Concept]
   744   C0012634:Disorders [Disease or Syndrome]
   744   C0039798:treatment [Functional Concept]
   744   C0087111:Treatment [Therapeutic or Preventive Procedure]
   744   C0440102:Various [Indicator, Reagent, or Diagnostic Aid]
   744   C1515981:And [Idea or Concept]
   744   C1522326:Treatment [Functional Concept]
   744   C1533734:Treatment [Therapeutic or Preventive Procedure]
   744   C1705169:Treatment [Conceptual Entity]
   744   C3538994:TREATMENT [Research Activity]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "Alzheimers disease"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0002395:Alzheimers disease [Disease or Syndrome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "and"

Phrase: "ischemic stroke."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0948008:Ischaemic stroke [Disease or Syndrome]
  1000   C3272363:Ischemic Stroke [Disease or Syndrome]
   861   C0038454:Stroke [Disease or Syndrome]
   861   C0475224:Ischaemic [Functional Concept]
Processing 00000000.tx.220: Acknowledgments  We thank Drs. 

Phrase: "Acknowledgments"

Phrase: "We"

Phrase: "thank"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986676:THANK [Gene or Genome]

Phrase: "Drs."
Processing 00000000.tx.221: Carol A. 

Phrase: "Carol A."
Processing 00000000.tx.222: Mason (Columbia University) for the generous gift of the C57BL/6J mice; 

Phrase: "Mason"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0331857:Mason [Health Care Related Organization]

Phrase: "(Columbia University"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0041740:University [Manufactured Object,Organization]
   861   C1551442:Columbia [Population Group]
   861   C3245499:Columbia [Health Care Related Organization]
   789 E C1551955:Columbian [Language]

Phrase: ")"

Phrase: "for the generous gift"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   789   C0423899:Gifted [Finding]

Phrase: "of the C57BL/6J mice"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   913   C0025921:Mice, C57BL [Mammal]
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]

Phrase: ";"
Processing 00000000.tx.223: Maria Sjoberg (Karolinska Institute) for providing expression plasmids for ER-, ER-, and ERE-luciferase; 

Phrase: "Maria Sjoberg"

Phrase: "(Karolinska Institute"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021622:institute [Organization]
   861   C1272753:Institute [Idea or Concept]

Phrase: ")"

Phrase: "for providing expression plasmids"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0032136:Plasmids [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "for ER-,"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0034804:Estrogen receptor [Amino Acid, Peptide, or Protein,Receptor]
  1000   C1414461:ESTROGEN RECEPTOR [Gene or Genome]
  1000   C1521863:Estrogen Receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
   861   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C2936882:Estrogen [Pharmacologic Substance]
   789 E C0720298:Estrogenic [Hormone,Organic Chemical,Pharmacologic Substance]

Phrase: "ER-,"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0034804:Estrogen receptor [Amino Acid, Peptide, or Protein,Receptor]
  1000   C1414461:ESTROGEN RECEPTOR [Gene or Genome]
  1000   C1521863:Estrogen Receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
   861   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C2936882:Estrogen [Pharmacologic Substance]
   789 E C0720298:Estrogenic [Hormone,Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "ERE-luciferase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0024075:Luciferase [Amino Acid, Peptide, or Protein,Enzyme,Indicator, Reagent, or Diagnostic Aid]

Phrase: ";"
Processing 00000000.tx.224: Meharvan Singh (University of North Texas) for constructive criticisms of the manuscript; 

Phrase: "Meharvan Singh"

Phrase: "(University of North Texas"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0039711:Texas [Geographic Area]
   812   C0041740:University [Manufactured Object,Organization]
   812   C1709269:North [Spatial Concept]

Phrase: ")"

Phrase: "for constructive criticisms"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0870379:criticisms [Social Behavior]

Phrase: "of the manuscript"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0600659:Manuscript [Intellectual Product,Manufactured Object]

Phrase: ";"
Processing 00000000.tx.225: and Ms. 

Phrase: "and"

Phrase: "Ms."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039676:MS [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C2349943:Ms. [Conceptual Entity]
  1000   C3539704:MS [Gene or Genome]
Processing 00000000.tx.226: Hranush Melikyan for expert technical assistance in the care of the mice. 

Phrase: "Hranush Melikyan for expert technical assistance"

Phrase: "in the care"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1947933:Care [Activity]

Phrase: "of the mice."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]
Processing 00000000.tx.227: We also thank Dr. 

Phrase: "We also"

Phrase: "thank"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986676:THANK [Gene or Genome]

Phrase: "Dr."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0031831:DR [Professional or Occupational Group]
  1000   C1707664:DR [Biomedical or Dental Material]
  1000   C2348314:Dr. [Conceptual Entity]
  1000   C3540849:DR [Idea or Concept]
Processing 00000000.tx.228: Michel Ferin (Columbia University) for allowing us to use his nitrogen evaporation facility.  

Phrase: "Michel Ferin"

Phrase: "(Columbia University"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0041740:University [Manufactured Object,Organization]
   861   C1551442:Columbia [Population Group]
   861   C3245499:Columbia [Health Care Related Organization]
   789 E C1551955:Columbian [Language]

Phrase: ")"

Phrase: "for allowing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683607:allowing [Social Behavior]

Phrase: "us to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "use"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0042153:use [Functional Concept]
  1000   C0457083:Use [Functional Concept]
  1000   C1947944:Use [Intellectual Product]

Phrase: "his nitrogen evaporation facility."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1547538:Facility [Idea or Concept]
Processing 00000000.tx.229: Footnotes  This work was supported in part by grants from National Institutes of Health (National Institute on Aging) and National Institute of Mental Health/Office of Research in Womens Health and the Maffei Gift for Brain Research (all to C.D.T.-A.). 

Phrase: "Footnotes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2825232:Footnote [Intellectual Product]

Phrase: "This work"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043227:Work [Occupational Activity]

Phrase: "was"

Phrase: "supported in part"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0449719:Part [Spatial Concept]
   790   C1521721:Supported [Conceptual Entity]
   790   C1709471:Part [Quantitative Concept]
   756 E C0183683:Support [Medical Device]

Phrase: "by grants"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0018173:Grants [Quantitative Concept]
   966 E C1548284:Grant [Idea or Concept]

Phrase: "from National Institutes of Health"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027468:National Institutes of Health [Health Care Related Organization]
           national institute health
   812   C0018684:Health [Idea or Concept]
   812   C0021622:Institutes [Organization]
   812   C3245503:national [Intellectual Product]
   779 E C1272753:Institute [Idea or Concept]
   712 E C0031206:healthiness [Finding]

Phrase: "(National Institute on Aging"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C1955974:National Institute on Aging [Health Care Related Organization]
   812   C0001811:Ageing [Organism Function]
   812   C0021622:institute [Organization]
   812   C1272753:Institute [Idea or Concept]
   812   C3245503:national [Intellectual Product]
   779 E C0001779:Age [Organism Attribute]

Phrase: ")"

Phrase: "and"

Phrase: "National Institute of Mental Health/Office of Research"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0442603:Office [Manufactured Object]
   703   C0027466:National Institute of Mental Health [Health Care Related Organization]

Phrase: "in Womens Health"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0080339:Womens Health [Biomedical Occupation or Discipline]
   861   C0018684:Health [Idea or Concept]
   761 E C0031206:healthiness [Finding]

Phrase: "and"

Phrase: "the Maffei Gift for Brain Research"

Phrase: "("

Phrase: "all to C.D.T.-A."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0444868:All [Quantitative Concept]
   753   C3539085:All [Idea or Concept]

Phrase: ")."
Processing 00000000.tx.230: First Published Online June 9, 2005 1 A.A.T. and I.S.N. contributed equally to this work. 

Phrase: "First"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205435:First [Quantitative Concept]
  1000   C1279901:First [Qualitative Concept]

Phrase: "Published"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034037:Published [Occupational Activity]
  1000   C1704324:Published [Intellectual Product]

Phrase: "Online June 9,"

Phrase: "2005 1 A.A.T."

Phrase: "and"

Phrase: "I.S.N."

Phrase: "contributed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1880177:Contribute [Activity]

Phrase: "equally to this work."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0043227:Work [Occupational Activity]
Processing 00000000.tx.231: Abbreviations: AFP, -Fetoprotein; 

Phrase: "Abbreviations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0000723:Abbreviations [Intellectual Product]

Phrase: ":"

Phrase: "AFP, -"

Phrase: "Fetoprotein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015950:Fetoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ";"
Processing 00000000.tx.232: DCC, dextran-coated charcoal; 

Phrase: "DCC,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   827   C0007955:Charcoal [Element, Ion, or Isotope,Pharmacologic Substance]
   827   C0086140:Dextran [Carbohydrate,Pharmacologic Substance]
   827   C1522408:Coated [Qualitative Concept]
   793 E C0453946:Coat [Manufactured Object]
   793 E C2987482:Coat [Body Part, Organ, or Organ Component]

Phrase: "dextran-coated charcoal"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   827   C0007955:Charcoal [Element, Ion, or Isotope,Pharmacologic Substance]
   827   C0086140:Dextran [Carbohydrate,Pharmacologic Substance]
   827   C1522408:Coated [Qualitative Concept]
   793 E C0453946:Coat [Manufactured Object]
   793 E C2987482:Coat [Body Part, Organ, or Organ Component]

Phrase: ";"
Processing 00000000.tx.233: E1, estrone; 

Phrase: "E1,"

Phrase: "estrone"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0014942:Estrone [Hormone,Pharmacologic Substance,Steroid]
   944 E C0700903:Folliculin [Hormone,Pharmacologic Substance,Steroid]
   944 E C1123064:Theelin [Hormone,Pharmacologic Substance,Steroid]
   944 E C1539518:FOLLICULIN [Gene or Genome]

Phrase: ";"
Processing 00000000.tx.234: E2, estradiol; 

Phrase: "E2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3539520:E2 [Gene or Genome]

Phrase: "estradiol"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0014912:Estradiol [Hormone,Pharmacologic Substance,Steroid]
   944 E C0699352:Estrace [Hormone,Pharmacologic Substance,Steroid]
   944 E C0878472:Progynon [Hormone,Pharmacologic Substance,Steroid]

Phrase: ";"
Processing 00000000.tx.235: ER, estrogen receptor; 

Phrase: "ER,"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0034804:Estrogen receptor [Amino Acid, Peptide, or Protein,Receptor]
  1000   C1414461:ESTROGEN RECEPTOR [Gene or Genome]
  1000   C1521863:Estrogen Receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
   861   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C2936882:Estrogen [Pharmacologic Substance]
   789 E C0720298:Estrogenic [Hormone,Organic Chemical,Pharmacologic Substance]

Phrase: "estrogen receptor"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0034804:Estrogen receptor [Amino Acid, Peptide, or Protein,Receptor]
  1000   C1414461:ESTROGEN RECEPTOR [Gene or Genome]
  1000   C1521863:Estrogen Receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
   861   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C2936882:Estrogen [Pharmacologic Substance]
   789 E C0720298:Estrogenic [Hormone,Organic Chemical,Pharmacologic Substance]

Phrase: ";"
Processing 00000000.tx.236: ERE, estrogen response element; 

Phrase: "ERE,"

Phrase: "estrogen response element"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   901   C0600508:Response Element [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0013879:Element [Element, Ion, or Isotope]
   827   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
   827   C0871261:Response [Organism Attribute]
   827   C1704632:Response [Finding]
   827   C1705248:Element [Conceptual Entity]
   827   C1706817:Response [Intellectual Product]
   827   C2911692:Response [Mental Process]
   827   C2936882:Estrogen [Pharmacologic Substance]
   755 E C0720298:Estrogenic [Hormone,Organic Chemical,Pharmacologic Substance]

Phrase: ";"
Processing 00000000.tx.237: Kd, affinity constant; 

Phrase: "Kd,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0026691:KD [Disease or Syndrome]
  1000   C1705240:KD [Gene or Genome]
  1000   C1839259:KD [Disease or Syndrome]

Phrase: "affinity constant"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1510827:Affinity [Natural Phenomenon or Process]
   861   C1547014:*Constant [Quantitative Concept]
   861   C1948059:Constant [Qualitative Concept]

Phrase: ";"
Processing 00000000.tx.238: LC-MS/MS, liquid chromatography/tandem mass spectrometry; 

Phrase: "LC-MS/MS,"
Meta Candidates (Total=16; Excluded=1; Pruned=0; Remaining=15)
   924   C0872318:Liquid Chromatography Mass Spectrometry [Laboratory Procedure]
   884   C0599748:Tandem Mass Spectrometry [Molecular Biology Research Technique]
   853   C2945612:chromatography mass [Laboratory Procedure]
   840   C0008565:Liquid Chromatography [Laboratory Procedure]
   840   C0037813:Mass Spectrometry [Laboratory Procedure]
   804   C0008550:Chromatography [Laboratory Procedure]
   804   C0075804:TANDEM [Organic Chemical,Pharmacologic Substance]
   804   C0302908:Liquid [Substance]
   804   C0436196:Spectrometry [Laboratory Procedure]
   804   C0577559:Mass [Finding]
   804   C1304698:Liquid [Finding]
   804   C1306372:*Mass [Quantitative Concept]
   804   C1546699:Liquid NOS [Intellectual Product]
   804   C1561501:Liquid NOS [Substance]
   804   C3152252:Mass [Quantitative Concept]
   704 E C0302647:chromatograph [Medical Device]

Phrase: "liquid chromatography/tandem mass spectrometry"
Meta Candidates (Total=16; Excluded=1; Pruned=0; Remaining=15)
   924   C0872318:Liquid Chromatography Mass Spectrometry [Laboratory Procedure]
   884   C0599748:Tandem Mass Spectrometry [Molecular Biology Research Technique]
   853   C2945612:chromatography mass [Laboratory Procedure]
   840   C0008565:Liquid Chromatography [Laboratory Procedure]
   840   C0037813:Mass Spectrometry [Laboratory Procedure]
   804   C0008550:Chromatography [Laboratory Procedure]
   804   C0075804:TANDEM [Organic Chemical,Pharmacologic Substance]
   804   C0302908:Liquid [Substance]
   804   C0436196:Spectrometry [Laboratory Procedure]
   804   C0577559:Mass [Finding]
   804   C1304698:Liquid [Finding]
   804   C1306372:*Mass [Quantitative Concept]
   804   C1546699:Liquid NOS [Intellectual Product]
   804   C1561501:Liquid NOS [Substance]
   804   C3152252:Mass [Quantitative Concept]
   704 E C0302647:chromatograph [Medical Device]

Phrase: ";"
Processing 00000000.tx.239: P, postnatal day; 

Phrase: "P,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0332173:/day [Temporal Concept]
   861   C0439228:day [Temporal Concept]
   861   C0439505:/day [Temporal Concept]
   861   C0443281:Postnatal [Temporal Concept]

Phrase: "postnatal day"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0332173:/day [Temporal Concept]
   861   C0439228:day [Temporal Concept]
   861   C0439505:/day [Temporal Concept]
   861   C0443281:Postnatal [Temporal Concept]

Phrase: ";"
Processing 00000000.tx.240: RBA, relative binding affinity. 

Phrase: "RBA,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   827   C0080103:Relative [Family Group]
   827   C0205345:Relative [Qualitative Concept]
   827   C0243122:binding [Functional Concept]
   827   C1145667:Binding [Activity]
   827   C1167622:Binding [Molecular Function]
   827   C1510827:Affinity [Natural Phenomenon or Process]
   827   C1547039:*Relative [Quantitative Concept]

Phrase: "relative binding affinity."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   827   C0080103:Relative [Family Group]
   827   C0205345:Relative [Qualitative Concept]
   827   C0243122:binding [Functional Concept]
   827   C1145667:Binding [Activity]
   827   C1167622:Binding [Molecular Function]
   827   C1510827:Affinity [Natural Phenomenon or Process]
   827   C1547039:*Relative [Quantitative Concept]
Processing 00000000.tx.241: Received December 15, 2004. 

Phrase: "Received December 15,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1514756:Received [Qualitative Concept]

Phrase: "2004."
Processing 00000000.tx.242: Accepted for publication May 27, 2005.  

Phrase: "Accepted for publication May 27,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   760   C0034036:Publication [Intellectual Product,Manufactured Object]
   760   C0034037:Publication [Occupational Activity]
   760   C1272684:Accepted [Qualitative Concept]
   760   C1548435:Accepted [Idea or Concept]
   760   C1704324:Publication [Intellectual Product]
   726 E C1548601:Accept [Idea or Concept]

Phrase: "2005."
Processing 00000000.tx.243: References Top Abstract Introduction Materials and Methods Results Discussion References  Weisz J, Gunsalus P 1973 Estrogen levels in immature female rats: true or spurious-ovarian or adrenal? 

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Top Abstract Introduction Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "Methods Results Discussion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Weisz J,"

Phrase: "Gunsalus P 1973 Estrogen levels in immature female rats"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   739   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
   739   C0441889:Levels [Qualitative Concept]
   739   C2936882:Estrogen [Pharmacologic Substance]
   706 E C0456079:Level [Classification]
   706 E C1547707:Level [Geographic Area]
   706 E C2946261:Level [Pharmacologic Substance]

Phrase: ":"

Phrase: "true"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205238:True [Qualitative Concept]

Phrase: "or"

Phrase: "spurious-ovarian"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205065:Ovarian [Body Part, Organ, or Organ Component]

Phrase: "or"

Phrase: "adrenal?"
Processing 00000000.tx.244: Endocrinology 93:10571065[Medline] Blaquier J, Dorfman RI, Forchielli E 1967 Formation of epitestosterone by human blood and adrenal tissue. 

Phrase: "Endocrinology 93"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0014137:Endocrinology [Biomedical Occupation or Discipline]
   789 E C0694557:endocrinologic [Functional Concept]

Phrase: ":"

Phrase: "10571065"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Blaquier J,"

Phrase: "Dorfman RI,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0035487:RI [Geographic Area]

Phrase: "Forchielli E 1967 Formation of epitestosterone"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0220781:formation [Biologic Function]
   753   C0439634:formation [Spatial Concept]
   753   C1522492:Formation [Functional Concept]

Phrase: "by human blood"
Meta Candidates (Total=10; Excluded=7; Pruned=0; Remaining=3)
   861   C0005767:Blood [Tissue]
   861   C0005768:blood [Body Substance]
   861   C0229664:Blood [Body Substance]
   789 E C0333275:Bloody [Qualitative Concept]
   777 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   777 E C0392895:Bloods [Population Group]
   777 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   777 E C1511228:VESSEL, BLOOD [Tissue]
   761 E C1558950:VASCULAR [Finding]
   761 E C1801960:Vascular [Qualitative Concept]

Phrase: "and"

Phrase: "adrenal tissue."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0586608:Adrenal tissue [Tissue]
   861   C0040300:Tissue [Tissue]
   861   C1547928:Tissue [Intellectual Product]
Processing 00000000.tx.245: Acta Endocrinol (Copenh) 54:208214[Medline] Budavari S, ed 1996 The Merck index. 

Phrase: "Acta Endocrinol"

Phrase: "(Copenh"

Phrase: ")"

Phrase: "54"

Phrase: ":"

Phrase: "208214"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Budavari S,"

Phrase: "ed 1996"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3538926:ED [Idea or Concept]

Phrase: "The Merck index."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0918012:Index [Intellectual Product]
   861   C1552854:index [Idea or Concept]
   861   C1637833:% index [Quantitative Concept]
Processing 00000000.tx.246: 12th ed. 

Phrase: "12th ed."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3538926:ED [Idea or Concept]
Processing 00000000.tx.247: Whitehouse Station, NJ: Merck Research Laboratories Finkelstein M, Weidenfeld J, Neeman Y, Samuni A, Mizrachi Y, Ben-Uzilio R 1981 Comparative studies of the aromatization of testosterone and epitestosterone by human placental aromatase. 

Phrase: "Whitehouse Station,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1883167:Station [Manufactured Object]
   789 E C0439835:Stationary [Qualitative Concept]

Phrase: "NJ"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0027971:NJ [Geographic Area]

Phrase: ":"

Phrase: "Merck Research Laboratories Finkelstein M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   804   C0441923:M+ [Intellectual Product]

Phrase: "Weidenfeld J,"

Phrase: "Neeman Y,"

Phrase: "Samuni A,"

Phrase: "Mizrachi Y,"

Phrase: "Ben-Uzilio R 1981 Comparative studies of the aromatization of testosterone"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   756   C0009491:Comparative Studies [Intellectual Product]
   738   C0947630:studies [Laboratory Procedure]
   722 E C1579762:comparative study [Research Activity]
   704 E C0557651:Study [Manufactured Object]
   704 E C2603343:Study [Research Activity]

Phrase: "and"

Phrase: "epitestosterone by human placental aromatase."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0014594:Epitestosterone [Hormone,Steroid]
Processing 00000000.tx.248: Endocrinology 108:943947[Abstract] MacLusky NJ, Walters MJ, Clark AS, Toran-Allerand CD 1994 Aromatase in the cerebral cortex, hippocampus, and mid-brain: ontogeny and developmental implications. 

Phrase: "Endocrinology 108"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0014137:Endocrinology [Biomedical Occupation or Discipline]
   789 E C0694557:endocrinologic [Functional Concept]

Phrase: ":"

Phrase: "943947"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] MacLusky NJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0027971:NJ [Geographic Area]

Phrase: "Walters MJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439254:MJ [Medical Device]

Phrase: "Clark AS,"

Phrase: "Toran-Allerand CD 1994 Aromatase in the cerebral cortex,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0003805:Aromatase [Amino Acid, Peptide, or Protein,Enzyme]
   742   C1366496:AROMATASE [Gene or Genome]

Phrase: "hippocampus,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0019564:Hippocampus [Body Part, Organ, or Organ Component]
  1000   C0949582:Hippocampus [Fish]
  1000   C1029104:Hippocampus [Fish]
  1000   C1284077:Hippocampus [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "mid-brain"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0025462:Mid-brain [Body Part, Organ, or Organ Component]
   861   C0006104:Brain [Body Part, Organ, or Organ Component]
   861   C0444598:Mid [Spatial Concept]
   861   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: ":"

Phrase: "ontogeny"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0018270:ontogeny [Organism Function]
  1000   C1621967:Ontogeny [Organism Function]

Phrase: "and"

Phrase: "developmental implications."
Processing 00000000.tx.249: Mol Cell Neurosci 5:691698[CrossRef][Medline] Steckelbroeck S, Watzka M, Reissinger A, Wegener-Toper P, Bidlingmaier F, Bliesener N, Hans VH, Clusmann H, Ludwig, M, Siekmann L, Klingmuller DJ 2003 Characterization of estrogenic 17-hydroxysteroid dehydrogenase (17-HSD) activity in the human brain. 

Phrase: "Mol Cell Neurosci 5"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   812   C0007634:Cell [Cell]
   812   C0027960:Mole [Neoplastic Process]
   812   C0324740:Mole [Mammal]
   812   C0439189:Mole [Quantitative Concept]
   812   C1269647:Cell [Cell]
   812   C1456781:mole [Neoplastic Process]
   812   C1704653:Cell [Medical Device]
   812   C1824986:mol [Gene or Genome]
   812   C1948049:Cell [Spatial Concept]
   729 E C0026367:Molar [Body Part, Organ, or Organ Component]
   712 E C0027962:moles [Neoplastic Process]

Phrase: ":"

Phrase: "691698"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Steckelbroeck S,"

Phrase: "Watzka M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Reissinger A,"

Phrase: "Wegener-Toper P,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0332173:/day [Temporal Concept]
   812   C0439228:day [Temporal Concept]
   812   C0439505:/day [Temporal Concept]
   812   C0443281:Postnatal [Temporal Concept]

Phrase: "Bidlingmaier F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Bliesener N,"

Phrase: "Hans VH,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1420224:VH [Gene or Genome]

Phrase: "Clusmann H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Ludwig,"

Phrase: "M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]

Phrase: "Siekmann L,"

Phrase: "Klingmuller DJ 2003 Characterization of estrogenic 17-hydroxysteroid dehydrogenase (17-HSD) activity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C1880022:Characterization [Activity]

Phrase: "in the human brain."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0006104:Brain [Body Part, Organ, or Organ Component]
   861   C1269537:Brain [Body Part, Organ, or Organ Component]
Processing 00000000.tx.250: Steroid Biochem Mol Biol 86:7992[CrossRef] Callard GV, Petro Z, Ryan KJ 1978 Phylogenetic distribution of aromatase and other androgen-converting enzymes in the central nervous system. 

Phrase: "Steroid Biochem Mol Biol 86"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   804   C0027960:Mole [Neoplastic Process]
   804   C0038317:Steroid [Steroid]
   804   C0324740:Mole [Mammal]
   804   C0439189:Mole [Quantitative Concept]
   804   C1456781:mole [Neoplastic Process]
   804   C1824986:mol [Gene or Genome]
   721 E C0026367:Molar [Body Part, Organ, or Organ Component]
   704 E C0027962:moles [Neoplastic Process]

Phrase: ":"

Phrase: "7992"

Phrase: "[CrossRef"

Phrase: "] Callard GV,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0376406:gv [Virus]

Phrase: "Petro Z,"

Phrase: "Ryan KJ 1978 Phylogenetic distribution of aromatase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0520511:distribution [Idea or Concept]
   748   C1704711:Distribution [Functional Concept]

Phrase: "and"

Phrase: "other androgen-converting enzymes in the central nervous system."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0014442:Enzymes [Enzyme,Organic Chemical]
   742   C0014445:enzymes [Functional Concept]
Processing 00000000.tx.251: Endocrinology 103:22832290[Abstract] Simpkins JW, Rajakumar G, Zhang YQ, Simpkins CE, Greenwald D, Yu CJ, Bodor N, Day AL 1997 Estrogens may reduce mortality and ischemic damage caused by middle cerebral artery occlusion in the female rat. 

Phrase: "Endocrinology 103"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0014137:Endocrinology [Biomedical Occupation or Discipline]
   789 E C0694557:endocrinologic [Functional Concept]

Phrase: ":"

Phrase: "22832290"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Simpkins JW,"

Phrase: "Rajakumar G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Zhang YQ,"

Phrase: "Simpkins CE,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2827664:CE [Idea or Concept]

Phrase: "Greenwald D,"

Phrase: "Yu CJ,"

Phrase: "Bodor N,"

Phrase: "Day AL 1997 Estrogens"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   812   C0014939:Estrogens [Hormone,Pharmacologic Substance,Steroid]
   779 E C2936882:Estrogen [Pharmacologic Substance]
   729 E C0720298:Estrogenic [Hormone,Organic Chemical,Pharmacologic Substance]

Phrase: "may"

Phrase: "reduce"

Phrase: "mortality"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0026565:Mortality [Quantitative Concept]
  1000   C0026566:mortality [Quantitative Concept]

Phrase: "and"

Phrase: "ischemic damage"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0010957:Damage [Injury or Poisoning]
   861   C1883709:Damage [Functional Concept]

Phrase: "caused by middle cerebral artery occlusion"
Meta Candidates (Total=21; Excluded=0; Pruned=0; Remaining=21)
   882   C0740391:Middle Cerebral Artery Occlusion [Acquired Abnormality]
   833   C0028790:Cerebral artery occlusion [Acquired Abnormality]
   833   C0149566:Middle Cerebral Artery [Body Part, Organ, or Organ Component]
   833   C1269012:Middle cerebral artery [Body Part, Organ, or Organ Component]
   790   C0007770:Cerebral artery [Body Part, Organ, or Organ Component]
   790   C0264995:artery occlusion [Pathologic Function]
   790   C1278936:Cerebral artery [Body Part, Organ, or Organ Component]
   783   C0596298:cerebral occlusion [Disease or Syndrome]
   753   C0003842:Artery [Body Part, Organ, or Organ Component]
   753   C0011382:Occlusion [Organ or Tissue Function]
   753   C0028778:Occlusion [Pathologic Function]
   753   C0226004:artery [Body System]
   753   C0441597:Occlusion [Functional Concept]
   753   C0444598:Middle [Spatial Concept]
   753   C0549183:middle [Spatial Concept]
   753   C1110554:OCCLUSION [Pathologic Function]
   753   C1552826:middle [Idea or Concept]
   753   C1882137:OCCLUSION [Phenomenon or Process]
   753   C1947917:Occlusion, NOS [Functional Concept]
   719   C0015127:cause [Functional Concept]
   719   C1524003:Cause [Conceptual Entity]

Phrase: "in the female rat."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0034693:Rat, NOS [Mammal]
   861   C0034721:Rat [Mammal]
Processing 00000000.tx.252: J Neurosurg 87:724730[Medline] Levin-Allerhand JA, Lominska CE, Wang J, Smith JD 2002 17-estradiol and 17-estradiol treatments are effective in lowering cerebral amyloid- levels in APPSWE transgenic mice. 

Phrase: "J Neurosurg 87"

Phrase: ":"

Phrase: "724730"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Levin-Allerhand JA,"

Phrase: "Lominska CE,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2827664:CE [Idea or Concept]

Phrase: "Wang J,"

Phrase: "Smith JD 2002 17-estradiol"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   804   C0014912:Estradiol [Hormone,Pharmacologic Substance,Steroid]
   748 E C0699352:Estrace [Hormone,Pharmacologic Substance,Steroid]
   748 E C0878472:Progynon [Hormone,Pharmacologic Substance,Steroid]

Phrase: "and"

Phrase: "17-estradiol treatments"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   827   C0087111:Treatments [Therapeutic or Preventive Procedure]
   793 E C0039798:treatment [Functional Concept]
   793 E C1522326:Treatment [Functional Concept]
   793 E C1533734:Treatment [Therapeutic or Preventive Procedure]
   793 E C1705169:Treatment [Conceptual Entity]
   793 E C3538994:TREATMENT [Research Activity]

Phrase: "are"

Phrase: "effective in lowering cerebral amyloid- levels"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1280519:effective [Qualitative Concept]
   753   C1704419:Effective [Qualitative Concept]

Phrase: "in APPSWE transgenic mice."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0025936:Mice, Transgenic [Mammal]
   827   C0003069:Transgenic [Animal]
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]
Processing 00000000.tx.253: J Alzheimers Dis 4:449457[Medline] Gelinas S, Bureau G, Valsatro B, Massicotte G, Cicchetti F, Chiasson K, Gagne B, Blanchet J, Matinoli MG 2004 - And -estradiol protect neuronal but not native PC12 cells from paraquat-induced oxidative stress. 

Phrase: "J Alzheimers Dis 4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0451119:DIS [Intellectual Product]
   812   C1444662:DIS [Finding]

Phrase: ":"

Phrase: "449457"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Gelinas S,"

Phrase: "Bureau G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Valsatro B,"

Phrase: "Massicotte G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Cicchetti F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Chiasson K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Gagne B,"

Phrase: "Blanchet J,"

Phrase: "Matinoli MG 2004 -"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0439269:mg% [Quantitative Concept]
   827   C1960952:mg % [Quantitative Concept]
   827   C2346927:Mg++ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "And -"

Phrase: "estradiol"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0014912:Estradiol [Hormone,Pharmacologic Substance,Steroid]
   944 E C0699352:Estrace [Hormone,Pharmacologic Substance,Steroid]
   944 E C0878472:Progynon [Hormone,Pharmacologic Substance,Steroid]

Phrase: "protect"

Phrase: "neuronal"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0521390:Neuronal [Immunologic Factor]
   928 E C0027882:Neuron [Cell]

Phrase: "but"

Phrase: "not native PC12 cells from paraquat-induced oxidative stress."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   764   C0085262:PC12 Cells [Cell]
   742   C0007634:Cells [Cell]
   742   C3282337:Cells [Cell]
   708 E C1269647:Cell [Cell]
   708 E C1704653:Cell [Medical Device]
   708 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.254: Neurotox Res 6:141148[Medline] Singh M, Stl Jr G, Guan X, Warren M, Toran-Allerand CD 1999 Estrogen-induced activation of mitogen-activated protein kinase in cerebral cortical explants: convergence of estrogen and neurotrophin signaling pathways. 

Phrase: "Neurotox Res 6"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2347379:RES [Finding]

Phrase: ":"

Phrase: "141148"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Singh M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Stl Jr G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439267:g% [Quantitative Concept]

Phrase: "Guan X,"

Phrase: "Warren M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Toran-Allerand CD 1999 Estrogen-induced activation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C1879547:Activation [Activity]

Phrase: "of mitogen-activated protein kinase"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
  1000   C0752312:Mitogen-Activated Protein Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   923   C1979930:Mitogen-activated protein [Amino Acid, Peptide, or Protein]
   861   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0018284:Mitogen [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0026249:Mitogen [Pharmacologic Substance]
   812   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1879547:Activated [Activity]
   779 E C1515877:Activate [Functional Concept]

Phrase: "in cerebral cortical explants"

Phrase: ":"

Phrase: "convergence of estrogen"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0443193:Convergence [Spatial Concept]
   790   C1446614:Convergence [Finding]
   790   C2700387:Convergence [Activity]

Phrase: "and"

Phrase: "neurotrophin signaling pathways."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   988   C2984256:Neurotrophin Signaling Pathway [Molecular Function]
   884   C0037080:Signal Pathways [Molecular Function]
   884   C0037083:signaling pathway [Cell Function]
   884   C0086982:Signaling Pathway [Molecular Function]
   827   C1704259:Pathways [Molecular Function]
   827   C1705987:Pathways [Conceptual Entity]
Processing 00000000.tx.255: J Neurosci 19:11791188[Abstract/Free FullText] Singh M 2001 Ovarian hormones elicit phosphorylation of Akt and extracellular-signal regulated kinase in explants of the cerebral cortex. 

Phrase: "J Neurosci 19"

Phrase: ":"

Phrase: "11791188"

Phrase: "[Abstract/Free FullText"

Phrase: "] Singh M 2001 Ovarian hormones"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   806   C0729511:Ovarian hormone [Hormone,Organic Chemical,Pharmacologic Substance]
   804   C0019932:Hormones [Hormone]
   804   C0205065:Ovarian [Body Part, Organ, or Organ Component]
   721 E C0458083:Hormonal [Qualitative Concept]

Phrase: "elicit"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449265:elicit [Qualitative Concept]

Phrase: "phosphorylation of Akt"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0031715:Phosphorylation [Molecular Function]
   790   C1158886:Phosphorylation [Molecular Function]

Phrase: "and"

Phrase: "extracellular-signal regulated kinase in explants of the cerebral cortex."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   785   C0600388:Extracellular Signal Regulated Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   785   C0752312:Extracellular Signal-Regulated Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   739   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   739   C0521119:Extracellular [Cell Component]
   739   C0851285:Regulated [Governmental or Regulatory Activity]
   739   C1710082:Signal [Phenomenon or Process]
Processing 00000000.tx.256: Endocrine 14:407415[CrossRef][Medline] Toran-Allerand CD, Guan X, MacLusky NJ, Horvath TL, Diano S, Singh M, Connolly Jr ES, Nethrapalli IS, Tinnikov AA 2002 "ER-X": a novel, plasma membrane-associated, putative estrogen receptor that is regulated during development and after ischemic brain injury. 

Phrase: "Endocrine 14"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0014136:Endocrine [Body System]
   861   C0521425:Endocrine [Functional Concept]

Phrase: ":"

Phrase: "407415"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Toran-Allerand CD,"

Phrase: "Guan X,"

Phrase: "MacLusky NJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0027971:NJ [Geographic Area]

Phrase: "Horvath TL,"

Phrase: "Diano S,"

Phrase: "Singh M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Connolly Jr ES,"

Phrase: "Nethrapalli"

Phrase: "IS"

Phrase: ","

Phrase: "Tinnikov AA 2002 ""ER-X"""

Phrase: ":"

Phrase: "a novel, plasma membrane-associated, putative estrogen receptor"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   861   C0230664:Membrane receptor [Receptor]
   818   C0034804:Estrogen receptor [Amino Acid, Peptide, or Protein,Receptor]
   818   C1414461:ESTROGEN RECEPTOR [Gene or Genome]
   818   C1521863:Estrogen Receptor [Amino Acid, Peptide, or Protein,Receptor]
   795   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
   795   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   795   C2936882:Estrogen [Pharmacologic Substance]
   724 E C0720298:Estrogenic [Hormone,Organic Chemical,Pharmacologic Substance]

Phrase: "that"

Phrase: "is"

Phrase: "regulated during development"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   790   C0243107:development [Physiologic Function]
   790   C0678723:Development [Organism Function]
   790   C0851285:Regulated [Governmental or Regulatory Activity]
   790   C1527148:Development [Functional Concept]
   718 E C0458003:Developmental [Qualitative Concept]

Phrase: "and after ischemic brain injury."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   862   C2945681:ischemic brain injury [Injury or Poisoning]
   806   C0270611:Brain Injury [Injury or Poisoning]
   760   C0006104:Brain [Body Part, Organ, or Organ Component]
   760   C0475224:Ischaemic [Functional Concept]
   760   C1269537:Brain [Body Part, Organ, or Organ Component]
   760   C1515981:And [Idea or Concept]
   760   C3263722:Injury [Injury or Poisoning]
   760   C3263723:Injury [Injury or Poisoning]
Processing 00000000.tx.257: J Neurosci 22:83918401[Abstract/Free FullText] MacLusky NJ, Luine VN, Hajszan T, Leranth C 2004 The 17 and 17 isomers of estradiol both induce rapid spine synapse formation in the CA1 hippocampal subfield of ovariectomized female rats. 

Phrase: "J Neurosci 22"

Phrase: ":"

Phrase: "83918401"

Phrase: "[Abstract/Free FullText"

Phrase: "] MacLusky NJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0027971:NJ [Geographic Area]

Phrase: "Luine VN,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0042658:VN [Geographic Area]
   861   C1336937:VN [Gene or Genome]

Phrase: "Hajszan T,"

Phrase: "Leranth C 2004"

Phrase: "The 17"

Phrase: "and"

Phrase: "17 isomers of estradiol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0022203:isomers [Natural Phenomenon or Process]

Phrase: "both"

Phrase: "induce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "rapid spine synapse formation in the CA1 hippocampal subfield of ovariectomized female rats."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   750   C0597545:synapse formation [Organ or Tissue Function]
   749   C0175202:Hippocampal Formation [Body Part, Organ, or Organ Component]
   735   C0220781:formation [Biologic Function]
   735   C0439634:formation [Spatial Concept]
   735   C1522492:Formation [Functional Concept]
Processing 00000000.tx.258: Endocrinology 146:287293[CrossRef][Medline] Nelson RE, Grebe SK, OKane DJ, Singh RJ 2004 Liquid chromatography-tandem mass spectrometry assay for simultaneous measurement of estradiol and estrone in human plasma. 

Phrase: "Endocrinology 146"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0014137:Endocrinology [Biomedical Occupation or Discipline]
   789 E C0694557:endocrinologic [Functional Concept]

Phrase: ":"

Phrase: "287293"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Nelson RE,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2986904:RE [Idea or Concept]

Phrase: "Grebe SK,"

Phrase: "OKane DJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0012836:DJ [Geographic Area]

Phrase: "Singh RJ 2004 Liquid chromatography-tandem mass spectrometry assay for simultaneous measurement"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   736   C0005507:Assay [Laboratory Procedure]
   736   C0243073:assay [Qualitative Concept]
   736   C1510438:Assay [Laboratory Procedure]

Phrase: "of estradiol"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0014912:Estradiol [Hormone,Pharmacologic Substance,Steroid]
   944 E C0699352:Estrace [Hormone,Pharmacologic Substance,Steroid]
   944 E C0878472:Progynon [Hormone,Pharmacologic Substance,Steroid]

Phrase: "and"

Phrase: "estrone in human plasma."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   770   C0014942:Estrone [Hormone,Pharmacologic Substance,Steroid]
   715 E C0700903:Folliculin [Hormone,Pharmacologic Substance,Steroid]
   715 E C1123064:Theelin [Hormone,Pharmacologic Substance,Steroid]
   715 E C1539518:FOLLICULIN [Gene or Genome]
Processing 00000000.tx.259: Clin Chem 50:373384[Abstract/Free FullText] Bjornstrom L, Sjoberg M 2002 Mutations in the estrogen receptor DNA-binding domain discriminate between the classical mechanism of action and cross-talk with Stat5b and activating protein 1 (AP-1). 

Phrase: "Clin Chem 50"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0201682:CHEM [Laboratory Procedure]
   827   C1315013:CLIN [Intellectual Product]

Phrase: ":"

Phrase: "373384"

Phrase: "[Abstract/Free FullText"

Phrase: "] Bjornstrom L,"

Phrase: "Sjoberg M 2002 Mutations in the estrogen receptor DNA-binding domain"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   738   C0026882:Mutations [Genetic Function]
   704 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "discriminate between the classical mechanism of action"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   814   C0031327:mechanism of action [Physiologic Function]
   814   C1524059:mechanism of action [Functional Concept]
   748   C0205235:Discriminate [Qualitative Concept]
   748   C0439858:Classical [Qualitative Concept]
   748   C0441472:Action [Functional Concept]
   748   C0441712:Mechanism [Functional Concept]
   748   C0443177:Classical [Functional Concept]
   748   C1706376:Mechanism [Manufactured Object]
   748   C3266814:Action [Activity]

Phrase: "and"

Phrase: "cross-talk with Stat5b"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C0010357:Crosstalk [Molecular Function]
   833   C2986468:Cross-talk [Cell Function]
   770   C0037817:Talk [Organism Function]
   770   C0234856:talk [Daily or Recreational Activity]
   770   C0600118:talk [Finding]
   770   C2828360:Cross [Conceptual Entity]

Phrase: "and"

Phrase: "activating protein 1 (AP-1)."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   901   C0087044:protein i [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C0103404:Protein I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1879547:activating [Activity]
   793 E C1515877:Activate [Functional Concept]
Processing 00000000.tx.260: J Biol Chem 277:4847948483[Abstract/Free FullText] Toran-Allerand CD 1984 On the genesis of sexual differentiation of the general nervous system: morphogenetic consequences of steroidal exposure and possible role of -fetoprotein. 

Phrase: "J Biol Chem 277"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0201682:CHEM [Laboratory Procedure]

Phrase: ":"

Phrase: "4847948483"

Phrase: "[Abstract/Free FullText"

Phrase: "] Toran-Allerand CD 1984 On the genesis of sexual differentiation"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0036874:Sexual Differentiation [Organ or Tissue Function]
   739   C0007589:Differentiation [Cell Function]
   739   C0036864:Sexual [Behavior]
   739   C1414672:Genesis [Gene or Genome]
   739   C1511938:Differentiation [Clinical Attribute]
   739   C2945687:Differentiation [Functional Concept]
   739   C2984892:Genesis [Gene or Genome]

Phrase: "of the general nervous system"
Meta Candidates (Total=15; Excluded=7; Pruned=0; Remaining=8)
   901   C0027763:Nervous System [Body System]
   901   C0422837:NERVOUS SYSTEM [Finding]
   901   C1269560:Nervous system [Body System]
   845 E C0205494:Neurologic [Qualitative Concept]
   827   C0027769:Nervous [Sign or Symptom]
   827   C0449913:System [Functional Concept]
   827   C0599851:Nervous [Functional Concept]
   827   C1553451:System [Manufactured Object]
   827   C1704459:System [Medical Device]
   808 E C0027855:Neurology [Biomedical Occupation or Discipline]
   790 E C2707261:Neurological [Clinical Attribute]
   755 E C0205373:Systemic [Functional Concept]
   711 E C0027740:Nerve [Tissue]
   711 E C0027757:NERVE [Tissue]
   711 E C1280541:Nerve [Body Part, Organ, or Organ Component]

Phrase: ":"

Phrase: "morphogenetic consequences of steroidal exposure"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0686907:Consequence of [Functional Concept]
           consequences

Phrase: "and"

Phrase: "possible role of -fetoprotein."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0015950:Fetoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.261: Prog Brain Res 61:6398[Medline] Bettini E, Pollio G, Santagati S, Maggi A 1992 Estrogen receptor in rat brain: presence in the hippocampal formation. 

Phrase: "Prog Brain Res 61"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0006104:Brain [Body Part, Organ, or Organ Component]
   812   C1269537:Brain [Body Part, Organ, or Organ Component]
   812   C2347379:RES [Finding]

Phrase: ":"

Phrase: "6398"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Bettini E,"

Phrase: "Pollio G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Santagati S,"

Phrase: "Maggi"

Phrase: "A 1992 Estrogen receptor in rat brain"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   778   C0034804:Estrogen receptor [Amino Acid, Peptide, or Protein,Receptor]
   778   C1414461:ESTROGEN RECEPTOR [Gene or Genome]
   778   C1521863:Estrogen Receptor [Amino Acid, Peptide, or Protein,Receptor]
   748   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
   748   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   748   C2936882:Estrogen [Pharmacologic Substance]

Phrase: ":"

Phrase: "presence in the hippocampal formation."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0392148:Presence [Therapeutic or Preventive Procedure]
Processing 00000000.tx.262: Neuroendocrinology 56:502508[Medline] Laurant C, de Lauzon SD, Cittanova N, Nunez E, Jayle MF 1975 The comparative specificity of 3 estradiol-binding proteins. 

Phrase: "Neuroendocrinology 56"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0027827:Neuroendocrinology [Biomedical Occupation or Discipline]

Phrase: ":"

Phrase: "502508"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Laurant C,"

Phrase: "de Lauzon SD,"

Phrase: "Cittanova N,"

Phrase: "Nunez E,"

Phrase: "Jayle MF 1975"

Phrase: "The comparative specificity of 3 estradiol-binding proteins."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   778   C0172659:Specificity Protein 3 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0037791:Specificity [Quantitative Concept]
   744   C1511884:Specificity [Quantitative Concept]
Processing 00000000.tx.263: Rat -foetoprotein, rat liver 17-hydroxy steroid dehydrogenase and anti-(estradiol-6-carboxymethyloxime-bovine serum albumin) antiserum. 

Phrase: "Rat -foetoprotein,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0015950:Fetoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "rat liver 17-hydroxy steroid dehydrogenase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0030016:Dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "anti-(estradiol-6-carboxymethyloxime-bovine serum albumin"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   895   C0059640:estradiol-bovine serum albumin [Amino Acid, Peptide, or Protein,Steroid]
   861   C0474672:estradiol serum [Laboratory Procedure]
   845   C0036774:Serum Albumin, Bovine [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   818   C0036773:Serum Albumin [Amino Acid, Peptide, or Protein]
   818   C0728877:serum albumin [Laboratory or Test Result]
   795   C0001924:Albumin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   795   C0007452:Bovine [Mammal]
   795   C0229671:Serum [Body Substance]
   795   C1140701:bovine [Mammal]
   795   C1546774:Serum [Intellectual Product]
   795   C1550100:Serum [Body Substance]

Phrase: ")"

Phrase: "antiserum."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020960:Antiserum [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.264: Biochem J 151:513518[Medline] Amateau SK, Alt JJ, Stamps CL, McCarthy MM 2004 Brain estradiol content in newborn rats: sex differences, regional heterogeneity, and possible de novo synthesis by the female telencephalon. 

Phrase: "Biochem J 151"

Phrase: ":"

Phrase: "513518"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Amateau SK,"

Phrase: "Alt JJ,"

Phrase: "Stamps CL,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0596019:Cl - [Element, Ion, or Isotope]

Phrase: "McCarthy MM 2004 Brain estradiol content in newborn rats"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0423896:Content [Mental Process]
   742   C0456205:Content [Conceptual Entity]

Phrase: ":"

Phrase: "sex differences,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0036866:Sex Differences [Organism Attribute]
   827   C1705241:*Difference [Quantitative Concept]
   827   C1705242:Difference [Qualitative Concept]
   777 E C0443199:Differential [Qualitative Concept]

Phrase: "regional heterogeneity,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0019409:Heterogeneity [Qualitative Concept]
   777 E C1512426:Heterogenous [Idea or Concept]

Phrase: "and"

Phrase: "possible de novo synthesis by the female telencephalon."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0220781:synthesis [Biologic Function]
   744   C1883254:Synthesis [Activity]
Processing 00000000.tx.265: Endocrinology 145:29062917[Abstract/Free FullText] Lee CS, Smith NM, Kahn SN 1991 Analytic variability and clinical significance of different assays for serum estradiol. 

Phrase: "Endocrinology 145"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0014137:Endocrinology [Biomedical Occupation or Discipline]
   789 E C0694557:endocrinologic [Functional Concept]

Phrase: ":"

Phrase: "29062917"

Phrase: "[Abstract/Free FullText"

Phrase: "] Lee CS,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3540510:cs [Quantitative Concept]

Phrase: "Smith NM,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0312860:NM [Cell Function]

Phrase: "Kahn SN 1991 Analytic variability"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   804   C2827666:Variability [Conceptual Entity]
   733 E C0439828:Variable [Qualitative Concept]

Phrase: "and"

Phrase: "clinical significance of different assays"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C2826293:Clinical Significance [Finding]
   760   C0237881:Significance [Quantitative Concept]
   760   C0750502:Significance [Idea or Concept]

Phrase: "for serum estradiol."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0474672:serum estradiol [Laboratory Procedure]
   861   C0014912:Estradiol [Hormone,Pharmacologic Substance,Steroid]
   805 E C0699352:Estrace [Hormone,Pharmacologic Substance,Steroid]
   805 E C0878472:Progynon [Hormone,Pharmacologic Substance,Steroid]
Processing 00000000.tx.266: J Reprod Med. 

Phrase: "J Reprod Med."
Processing 00000000.tx.267: 36:156160 Anstead GM, Carlson KE, Katzenellenbogen JA 1997 The estradiol pharmacophore: ligand structure-estrogen receptor binding affinity relationships and a model for the receptor binding site. 

Phrase: "36"

Phrase: ":"

Phrase: "156160 Anstead GM,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0546866:GM [Antibiotic,Carbohydrate]

Phrase: "Carlson KE,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0022558:KE [Geographic Area]

Phrase: "Katzenellenbogen JA 1997"

Phrase: "The estradiol pharmacophore"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0599740:pharmacophore [Receptor]

Phrase: ":"

Phrase: "ligand structure-estrogen receptor binding affinity relationships"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   825   C0923800:Structural relationship [Conceptual Entity]
   795   C0439849:Relationships [Qualitative Concept]
   762 E C1705630:Relationship [Idea or Concept]
   762 E C1706279:Relationship [Idea or Concept]
   762 E C3540605:Relationship [Intellectual Product]

Phrase: "and"

Phrase: "a model for the receptor binding site."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C3161035:Model [Intellectual Product]
Processing 00000000.tx.268: Steroids 62:268303[CrossRef][Medline] Preisler-Mashek MT, Solodin N, Stark BL, Tyriver MK, Alarid ET 2002 Ligand-specific regulation of proteasome-mediated proteolysis of estrogen receptor-. 

Phrase: "Steroids 62"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0038317:Steroids [Steroid]

Phrase: ":"

Phrase: "268303"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Preisler-Mashek MT,"

Phrase: "Solodin N,"

Phrase: "Stark BL,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0006413:BL [Neoplastic Process]
   861   C1552663:BL [Idea or Concept]
   861   C2827109:BL [Geographic Area]

Phrase: "Tyriver MK,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3539059:MK [Idea or Concept]

Phrase: "Alarid ET 2002 Ligand-specific regulation of proteasome-mediated proteolysis"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   777   C1514825:Regulation of Proteolysis [Molecular Function]
           Proteolytic Regulation
   739   C0851285:Regulation [Governmental or Regulatory Activity]
   739   C1327622:Regulation [Biologic Function]

Phrase: "of estrogen receptor-."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0034804:Estrogen receptor [Amino Acid, Peptide, or Protein,Receptor]
  1000   C1414461:ESTROGEN RECEPTOR [Gene or Genome]
  1000   C1521863:Estrogen Receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
   861   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C2936882:Estrogen [Pharmacologic Substance]
   789 E C0720298:Estrogenic [Hormone,Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.269: Am J Physiol Endocrinol Metab 282:E891E898 Wade CB, Robinson S, Shapiro RA, Dorsa DM 2001 Estrogen receptor (ER) and ER exhibit unique pharmacologic properties when coupled to activation of the mitogen-activated protein kinase pathway. 

Phrase: "Am"

Phrase: "J Physiol Endocrinol Metab 282"

Phrase: ":"

Phrase: "E891E898"

Phrase: "Wade"

Phrase: "CB,"

Phrase: "Robinson S,"

Phrase: "Shapiro RA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3538806:Ra [Spatial Concept]

Phrase: "Dorsa DM 2001 Estrogen receptor"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   840   C0034804:Estrogen receptor [Amino Acid, Peptide, or Protein,Receptor]
   840   C1414461:ESTROGEN RECEPTOR [Gene or Genome]
   840   C1521863:Estrogen Receptor [Amino Acid, Peptide, or Protein,Receptor]
   804   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
   804   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   804   C2936882:Estrogen [Pharmacologic Substance]
   733 E C0720298:Estrogenic [Hormone,Organic Chemical,Pharmacologic Substance]

Phrase: "(ER"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0034804:Estrogen receptor [Amino Acid, Peptide, or Protein,Receptor]
  1000   C1414461:ESTROGEN RECEPTOR [Gene or Genome]
  1000   C1521863:Estrogen Receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
   861   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C2936882:Estrogen [Pharmacologic Substance]
   789 E C0720298:Estrogenic [Hormone,Organic Chemical,Pharmacologic Substance]

Phrase: ")"

Phrase: "and"

Phrase: "ER"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0034804:Estrogen receptor [Amino Acid, Peptide, or Protein,Receptor]
  1000   C1414461:ESTROGEN RECEPTOR [Gene or Genome]
  1000   C1521863:Estrogen Receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
   861   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C2936882:Estrogen [Pharmacologic Substance]
   789 E C0720298:Estrogenic [Hormone,Organic Chemical,Pharmacologic Substance]

Phrase: "exhibit"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015272:Exhibit [Intellectual Product]

Phrase: "unique pharmacologic properties"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0871161:properties [Qualitative Concept]
   827   C1292721:properties [Functional Concept]
   793 E C1882134:Property [Conceptual Entity]
   793 E C2347695:Property [Entity]

Phrase: "when"

Phrase: "coupled to activation of the mitogen-activated protein kinase pathway."
Meta Candidates (Total=18; Excluded=2; Pruned=0; Remaining=16)
   806   C0752312:Mitogen-Activated Protein Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   782   C1979930:Mitogen-activated protein [Amino Acid, Peptide, or Protein]
   777   C1819041:protein kinase activation [Cell Function]
   775   C1514528:Protein Activation Pathway [Functional Concept]
   775   C3156336:protein activation pathway [Molecular Function]
   760   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   757   C0599177:protein activation [Genetic Function]
   739   C0018284:Mitogen [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0026249:Mitogen [Pharmacologic Substance]
   739   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   739   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C1704259:Pathway [Molecular Function]
   739   C1705987:Pathway [Conceptual Entity]
   739   C1879547:Activated [Activity]
           Activation
   739   C1948027:Coupled [Functional Concept]
   706 E C0010222:couple [Family Group]
   706 E C1515877:Activate [Functional Concept]
Processing 00000000.tx.270: Endocrinology 142:23362342[Abstract/Free FullText] Korenman SG 1969 Comparative binding affinity of estrogens and its relation to estrogenic potency. 

Phrase: "Endocrinology 142"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0014137:Endocrinology [Biomedical Occupation or Discipline]
   789 E C0694557:endocrinologic [Functional Concept]

Phrase: ":"

Phrase: "23362342"

Phrase: "[Abstract/Free FullText"

Phrase: "] Korenman SG 1969 Comparative binding affinity of estrogens"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1510827:Affinity [Natural Phenomenon or Process]

Phrase: "and"

Phrase: "its relation to estrogenic potency."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0080103:Relation [Family Group]
   760   C0869014:relation [Social Behavior]
Processing 00000000.tx.271: Steroids 13:163177[CrossRef][Medline] Edwards DP, McGuire WL 1980 17-Estradiol is a biologically active estrogen in human breast cancer cells in tissue culture. 

Phrase: "Steroids 13"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0038317:Steroids [Steroid]

Phrase: ":"

Phrase: "163177"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Edwards DP,"

Phrase: "McGuire WL 1980 17-Estradiol"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   804   C0014912:Estradiol [Hormone,Pharmacologic Substance,Steroid]
   748 E C0699352:Estrace [Hormone,Pharmacologic Substance,Steroid]
   748 E C0878472:Progynon [Hormone,Pharmacologic Substance,Steroid]

Phrase: "is"

Phrase: "a biologically active estrogen in human breast cancer cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
   742   C2936882:Estrogen [Pharmacologic Substance]

Phrase: "in tissue culture."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0040284:Tissue culture [Laboratory Procedure]
   861   C0010453:Culture [Idea or Concept]
   861   C0040300:Tissue [Tissue]
   861   C0220814:culture [Functional Concept]
   861   C0430400:Culture [Laboratory Procedure]
   861   C1547928:Tissue [Intellectual Product]
   861   C2242979:Culture [Laboratory Procedure]
Processing 00000000.tx.272: Endocrinology 107:884891[Abstract] Kuiper GG, Carlsson B, Grandien K, Enmark E, Haggblad J, Nilsson S, Gustafsson JA 1997 Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors and . Endocrinology 138:863870[Abstract/Free FullText] Boonstra R, Tinnikov AA 1998 Increased corticosteroid binding capacity of plasma albumin but not of corticosteroid-binding globulin caused by ACTH-induced changes in free fatty acid concentrations in snowshoe hares and rabbits. 

Phrase: "Endocrinology 107"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0014137:Endocrinology [Biomedical Occupation or Discipline]
   789 E C0694557:endocrinologic [Functional Concept]

Phrase: ":"

Phrase: "884891"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Kuiper GG,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0018370:GG [Geographic Area]

Phrase: "Carlsson B,"

Phrase: "Grandien K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Enmark E,"

Phrase: "Haggblad J,"

Phrase: "Nilsson S,"

Phrase: "Gustafsson JA 1997 Comparison of the ligand binding specificity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C1707455:Comparison [Activity]

Phrase: "and"

Phrase: "transcript tissue distribution of estrogen receptors"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0040287:Tissue Distribution [Quantitative Concept]
   790   C0220927:tissue distribution [Functional Concept]
   753   C0040300:Tissue [Tissue]
   753   C0520511:distribution [Idea or Concept]
   753   C1547928:Tissue [Intellectual Product]
   753   C1704711:Distribution [Functional Concept]

Phrase: "and . Endocrinology 138"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0014137:Endocrinology [Biomedical Occupation or Discipline]
   789 E C0694557:endocrinologic [Functional Concept]

Phrase: ":"

Phrase: "863870"

Phrase: "[Abstract/Free FullText"

Phrase: "] Boonstra R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Tinnikov AA 1998 Increased corticosteroid binding capacity of plasma albumin"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0439155:Binding capacity [Quantitative Concept]
   739   C0243122:binding [Functional Concept]
   739   C1145667:Binding [Activity]
   739   C1167622:Binding [Molecular Function]
   739   C1516240:Capacity [Quantitative Concept]

Phrase: "but"

Phrase: "not of corticosteroid-binding globulin"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   862   C0040643:Corticosteroid-Binding Globulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   862   C1413150:CORTICOSTEROID-BINDING GLOBULIN [Gene or Genome]
   760   C0001617:corticosteroid [Hormone,Pharmacologic Substance,Steroid]
   760   C0017649:Globulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0243122:binding [Functional Concept]
   760   C1145667:Binding [Activity]
   760   C1167622:Binding [Molecular Function]
   760   C1518422:Not [Functional Concept]
   760   C3536709:Corticosteroid [Pharmacologic Substance]

Phrase: "caused by ACTH-induced changes"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   760   C0205263:Induced [Functional Concept]
   760   C0392747:changes [Functional Concept]
   760   C0443172:changes [Quantitative Concept]
   726   C0015127:cause [Functional Concept]
   726   C1524003:Cause [Conceptual Entity]
   726 E C1705241:Change [Quantitative Concept]

Phrase: "in free fatty acid concentrations"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   812   C0086045:Concentrations [Mental Process]
   779 E C1446561:Concentration [Quantitative Concept]
   756   C0015688:free fatty acid [Lipid]
   756   C2698488:Free Fatty Acid [Laboratory Procedure]
   729 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "in snowshoe hares"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1013735:Snowshoe hare [Mammal]
   861   C0242372:Hare [Mammal]
   861   C1425660:HARE [Gene or Genome]

Phrase: "and"

Phrase: "rabbits."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034493:Rabbit [Mammal]
Processing 00000000.tx.273: J Endocrinol 156:205212[Abstract/Free FullText] Okulicz WC, Johnson LD 1987 The relative binding affinity of diethylstilbestrol to uterine nuclear estrogen receptor: effect of serum and serum albumin. 

Phrase: "J Endocrinol 156"

Phrase: ":"

Phrase: "205212"

Phrase: "[Abstract/Free FullText"

Phrase: "] Okulicz WC,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0013123:WC [Organism Function]
   861   C2825512:WC [Quantitative Concept]

Phrase: "Johnson LD 1987"

Phrase: "The relative binding affinity of diethylstilbestrol"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   753   C0080103:Relative [Family Group]
   753   C0205345:Relative [Qualitative Concept]
   753   C0243122:binding [Functional Concept]
   753   C1145667:Binding [Activity]
   753   C1167622:Binding [Molecular Function]
   753   C1510827:Affinity [Natural Phenomenon or Process]
   753   C1547039:*Relative [Quantitative Concept]

Phrase: "to uterine nuclear estrogen receptor"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   875   C0206588:Nuclear Receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C0034804:Estrogen receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C1414461:ESTROGEN RECEPTOR [Gene or Genome]
   861   C1521863:Estrogen Receptor [Amino Acid, Peptide, or Protein,Receptor]
   812   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
   812   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   812   C2936882:Estrogen [Pharmacologic Substance]
   741 E C0720298:Estrogenic [Hormone,Organic Chemical,Pharmacologic Substance]

Phrase: ":"

Phrase: "effect of serum"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1280500:Effect [Qualitative Concept]
   790   C2348382:Effect [Qualitative Concept]

Phrase: "and"

Phrase: "serum albumin."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0036773:Serum Albumin [Amino Acid, Peptide, or Protein]
  1000   C0728877:serum albumin [Laboratory or Test Result]
   861   C0001924:Albumin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0229671:Serum [Body Substance]
   861   C1546774:Serum [Intellectual Product]
   861   C1550100:Serum [Body Substance]
Processing 00000000.tx.274: Proc Soc Exp Biol Med 185:478483[Abstract] Toran-Allerand CD 2004 Novel mechanisms of estrogen action in the developing brain: beyond ER- and ER-. 

Phrase: "Proc Soc Exp Biol Med 185"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C1417055:EXP [Gene or Genome]
   799   C1418943:PROC [Gene or Genome]

Phrase: ":"

Phrase: "478483"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Toran-Allerand CD 2004 Novel mechanisms of estrogen action"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   773   C0031327:mechanism of action [Physiologic Function]
   773   C1524059:mechanism of action [Functional Concept]
   742   C0441712:Mechanisms [Functional Concept]
   708 E C1706376:Mechanism [Manufactured Object]

Phrase: "in the developing brain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0006104:Brain [Body Part, Organ, or Organ Component]
   861   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: ":"

Phrase: "beyond ER-"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0034804:Estrogen receptor [Amino Acid, Peptide, or Protein,Receptor]
  1000   C1414461:ESTROGEN RECEPTOR [Gene or Genome]
  1000   C1521863:Estrogen Receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
   861   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C2936882:Estrogen [Pharmacologic Substance]
   789 E C0720298:Estrogenic [Hormone,Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "ER-."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0034804:Estrogen receptor [Amino Acid, Peptide, or Protein,Receptor]
  1000   C1414461:ESTROGEN RECEPTOR [Gene or Genome]
  1000   C1521863:Estrogen Receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
   861   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C2936882:Estrogen [Pharmacologic Substance]
   789 E C0720298:Estrogenic [Hormone,Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.275: Exp Gerontol 39:15791586[CrossRef][Medline] Singh M, Stl Jr G, Guan X, Frail DF, Toran-Allerand CD 2000 Estrogen-induced activation of the MAP kinase cascade in the cerebral cortex of estrogen receptor- knock-out mice. 

Phrase: "Exp Gerontol 39"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1417055:EXP [Gene or Genome]

Phrase: ":"

Phrase: "15791586"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Singh M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Stl Jr G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439267:g% [Quantitative Concept]

Phrase: "Guan X,"

Phrase: "Frail DF,"

Phrase: "Toran-Allerand CD 2000 Estrogen-induced activation of the MAP kinase cascade"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   783   C1155551:activation of MAP kinase [Molecular Function]
   736   C1879547:Activation [Activity]

Phrase: "in the cerebral cortex"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007776:Cerebral cortex [Body Part, Organ, or Organ Component]
           Cortex
   861   C1176472:Cortex [Body Part, Organ, or Organ Component]
   861   C2700441:Cortex [Plant]

Phrase: "of estrogen receptor- knock-out mice."
Meta Candidates (Total=15; Excluded=1; Pruned=0; Remaining=14)
   884   C0206745:Knock-out Mice [Mammal]
   840   C0034804:Estrogen receptor [Amino Acid, Peptide, or Protein,Receptor]
   840   C0560617:knock out [Injury or Poisoning]
   840   C1414461:ESTROGEN RECEPTOR [Gene or Genome]
   840   C1521863:Estrogen Receptor [Amino Acid, Peptide, or Protein,Receptor]
   840   C1522225:Knock-out [Experimental Model of Disease]
   804   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
   804   C0025914:Mice [Mammal]
   804   C0025929:mice [Mammal]
   804   C0026809:Mice [Mammal]
   804   C0439787:Out [Spatial Concept]
   804   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   804   C0849355:Out [Qualitative Concept]
   804   C2936882:Estrogen [Pharmacologic Substance]
   733 E C0720298:Estrogenic [Hormone,Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.276: J Neurosci 20:16941700[Abstract/Free FullText] Green PS, Simpkins JW 2000 Estrogens and estrogen-like non-feminizing compounds. 

Phrase: "J Neurosci 20"

Phrase: ":"

Phrase: "16941700"

Phrase: "[Abstract/Free FullText"

Phrase: "] Green PS,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1418867:Ps [Gene or Genome]
   861   C1518860:PS [Geographic Area]
   861   C1552158:Ps [Body Part, Organ, or Organ Component]

Phrase: "Simpkins JW 2000 Estrogens"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   812   C0014939:Estrogens [Hormone,Pharmacologic Substance,Steroid]
   779 E C2936882:Estrogen [Pharmacologic Substance]
   729 E C0720298:Estrogenic [Hormone,Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "estrogen-like non-feminizing compounds."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   862   C0014939:Estrogenic Compounds [Hormone,Pharmacologic Substance,Steroid]
   771   C0205198:Compound [Qualitative Concept]
   771   C1706082:Compound [Chemical]
Processing 00000000.tx.277: Their role in the prevention and treatment of Alzheimers disease. 

Phrase: "Their role in the prevention"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0035820:Role [Social Behavior]
   760   C1705810:Role [Conceptual Entity]

Phrase: "and"

Phrase: "treatment of Alzheimers disease."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0039798:treatment [Functional Concept]
   770   C0087111:Treatment [Therapeutic or Preventive Procedure]
   770   C1522326:Treatment [Functional Concept]
   770   C1533734:Treatment [Therapeutic or Preventive Procedure]
   770   C1705169:Treatment [Conceptual Entity]
   770   C3538994:TREATMENT [Research Activity]
Processing 00000000.tx.278: Ann NY Acad Sci 924:9398[Abstract/Free FullText] Currie LJ, Harrison MB, Trugman JM, Bennett JP, Wooten GF 2004 Postmenopausal estrogen use affects risk for Parkinson disease. 

Phrase: "Ann NY Acad Sci 924"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   804   C0027976:NY [Geographic Area]
   804   C0268596:ACAD [Disease or Syndrome]
   804   C1879958:NY [Intellectual Product]
   804   C2700624:ACAD [Cell Function]
   804   C3642273:SCI [Professional or Occupational Group]

Phrase: ":"

Phrase: "9398"

Phrase: "[Abstract/Free FullText"

Phrase: "] Currie LJ,"

Phrase: "Harrison MB,"

Phrase: "Trugman JM,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0022337:JM [Geographic Area]

Phrase: "Bennett JP,"

Phrase: "Wooten GF 2004 Postmenopausal estrogen use"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0239301:ESTROGEN USE [Finding]
   799   C0042153:use [Functional Concept]
   799   C0457083:Use [Functional Concept]
   799   C1947944:Use [Intellectual Product]

Phrase: "affects"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "risk for Parkinson disease."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   819   C1281905:disease risk [Finding]
   770   C0035647:Risk [Qualitative Concept]
Processing 00000000.tx.279: Arch Neurol 61:886888[Abstract/Free FullText] Voskuhl RR 2003 Hormone-based therapies in MS. 

Phrase: "Arch Neurol 61"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0230467:arch [Body Location or Region]
   827   C0741204:ARCH [Body Space or Junction]

Phrase: ":"

Phrase: "886888"

Phrase: "[Abstract/Free FullText"

Phrase: "] Voskuhl RR 2003 Hormone-based therapies in MS."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   767   C0279025:hormone therapies [Therapeutic or Preventive Procedure]
   744   C0087111:therapies [Therapeutic or Preventive Procedure]
   711 E C0039798:therapy [Functional Concept]
   711 E C1363945:Therapy [Finding]
Processing 00000000.tx.280: Int MS J 10:6066[Medline] Akhondzadeh S, Nejatisafa AA, Amini H, Mohammadi MR, Larijani B, Kashani L, Raisi F, Kamalipour A 2003 Adjunctive estrogen treatment in women with chronic schizophrenia: a double-blind, randomized, and placebo-controlled trial. 

Phrase: "Int MS J 10"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   812   C0039676:MS [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0063789:INT [Organic Chemical]
   812   C2349943:Ms. [Conceptual Entity]
   812   C3272375:INT [Intellectual Product]
   812   C3539704:MS [Gene or Genome]

Phrase: ":"

Phrase: "6066"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Akhondzadeh S,"

Phrase: "Nejatisafa AA,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1235746:Aa [Plant]
   861   C1882141:aa [Qualitative Concept]

Phrase: "Amini H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Mohammadi MR,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347167:Mr. [Conceptual Entity]

Phrase: "Larijani B,"

Phrase: "Kashani L,"

Phrase: "Raisi F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Kamalipour"

Phrase: "A 2003 Adjunctive estrogen treatment in women"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   748   C0039798:treatment [Functional Concept]
   748   C0087111:Treatment [Therapeutic or Preventive Procedure]
   748   C1522326:Treatment [Functional Concept]
   748   C1533734:Treatment [Therapeutic or Preventive Procedure]
   748   C1705169:Treatment [Conceptual Entity]
   748   C3538994:TREATMENT [Research Activity]

Phrase: "with chronic schizophrenia"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0221765:Chronic schizophrenia [Mental or Behavioral Dysfunction]
   861   C0036341:Schizophrenia [Mental or Behavioral Dysfunction]

Phrase: ":"

Phrase: "a double-blind,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0013072:DOUBLE BLIND [Research Activity]
   861   C0150108:Blind [Research Activity]
   861   C0205173:Double [Functional Concept]
   861   C0456909:Blind [Disease or Syndrome]
   861   C0525065:blind [Patient or Disabled Group]
   861   C1705764:Double [Activity]
   861   C1705765:Double [Qualitative Concept]

Phrase: "randomized"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034656:randomized [Research Activity]

Phrase: ","

Phrase: "and"

Phrase: "placebo-controlled trial."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0008976:Trial [Research Activity]
   734   C1706408:placebo-controlled [Research Activity]
Processing 00000000.tx.281: Prog Neuropsychopharmacol Biol Psychiatry 27:10071012[CrossRef][Medline] Yang SH, Liu R, Wu SS, Simpkins JW 2003 The use of estrogens and related compounds in the treatment of damage from cerebral ischemia. 

Phrase: "Prog Neuropsychopharmacol Biol Psychiatry 27"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   804   C0033872:Psychiatry [Professional or Occupational Group]
   804   C0033873:Psychiatry [Biomedical Occupation or Discipline]
   733 E C0205487:Psychiatric [Functional Concept]

Phrase: ":"

Phrase: "10071012"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Yang SH,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0038108:SH [Geographic Area]

Phrase: "Liu R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Wu SS,"

Phrase: "Simpkins JW 2003"

Phrase: "The use of estrogens"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C1524063:Use of [Functional Concept]
   802   C0239301:ESTROGEN USE [Finding]
   770   C0042153:use [Functional Concept]
   770   C0457083:Use [Functional Concept]
   770   C1947944:Use [Intellectual Product]

Phrase: "and"

Phrase: "related compounds in the treatment of damage"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   778   C0600686:related compounds [Chemical Viewed Structurally]
   714   C0205198:Compound [Qualitative Concept]
   714   C1706082:Compound [Chemical]

Phrase: "from cerebral ischemia."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0007785:Cerebral Ischemia [Disease or Syndrome]
  1000   C0917798:Cerebral Ischemia [Disease or Syndrome]
   861   C0022116:Ischaemia [Disease or Syndrome]
   789 E C0475224:Ischaemic [Functional Concept]
Processing 00000000.tx.282: Ann NY Acad Sci 1007:101107[Abstract/Free FullText] Rau SW, Dubal DB, Bottner M, Gerhold LM, Wise PM 2003 Estradiol attenuates programmed cell death after stroke-like injury. 

Phrase: "Ann NY Acad Sci 1007"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   804   C0027976:NY [Geographic Area]
   804   C0268596:ACAD [Disease or Syndrome]
   804   C1879958:NY [Intellectual Product]
   804   C2700624:ACAD [Cell Function]
   804   C3642273:SCI [Professional or Occupational Group]

Phrase: ":"

Phrase: "101107"

Phrase: "[Abstract/Free FullText"

Phrase: "] Rau SW,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1420193:SW [Gene or Genome]
   861   C1832169:SW [Body System]
   861   C3538902:SW [Gene or Genome]

Phrase: "Dubal DB,"

Phrase: "Bottner M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Gerhold LM,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1261082:LM [Body Part, Organ, or Organ Component]
   861   C1551056:lm [Quantitative Concept]
   861   C2981682:LM [Quantitative Concept]

Phrase: "Wise PM 2003 Estradiol"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   812   C0014912:Estradiol [Hormone,Pharmacologic Substance,Steroid]
   756 E C0699352:Estrace [Hormone,Pharmacologic Substance,Steroid]
   756 E C0878472:Progynon [Hormone,Pharmacologic Substance,Steroid]

Phrase: "attenuates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0599946:Attenuate [Activity]

Phrase: "programmed cell death after stroke-like injury."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   814   C0162638:Programmed Cell Death [Cell Function]
   778   C0007587:Cell Death [Cell Function]
   774   C0599732:cell injury [Cell or Molecular Dysfunction]
   748   C0007634:Cell [Cell]
   748   C0011065:Death [Organism Function]
   748   C1269647:Cell [Cell]
   748   C1306577:Death, NOS [Finding]
   748   C1704653:Cell [Medical Device]
   748   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.283: J Neurosci 23:1142011426[Abstract/Free FullText] Clark JH, Williams M, Upchurch S, Eriksson H, Helton E, Markaverich BM 1982 Effects of estradiol-17 on nuclear occupancy of the estrogen receptor, stimulation of nuclear type II sites and uterine growth. 

Phrase: "J Neurosci 23"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0450348:23 [Quantitative Concept]

Phrase: ":"

Phrase: "1142011426"

Phrase: "[Abstract/Free FullText"

Phrase: "] Clark JH,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0268060:JH [Disease or Syndrome]
   861   C1415529:JH [Gene or Genome]

Phrase: "Williams M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Upchurch S,"

Phrase: "Eriksson H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Helton E,"

Phrase: "Markaverich BM 1982 Effects of estradiol-17"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C1280500:effects [Qualitative Concept]
   714 E C2348382:Effect [Qualitative Concept]

Phrase: "on nuclear occupancy"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2827063:Occupancy [Qualitative Concept]

Phrase: "of the estrogen receptor,"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0034804:Estrogen receptor [Amino Acid, Peptide, or Protein,Receptor]
  1000   C1414461:ESTROGEN RECEPTOR [Gene or Genome]
  1000   C1521863:Estrogen Receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
   861   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C2936882:Estrogen [Pharmacologic Substance]
   789 E C0720298:Estrogenic [Hormone,Organic Chemical,Pharmacologic Substance]

Phrase: "stimulation of nuclear type II sites"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   803   C0449708:Site of stimulation [Spatial Concept]
   753   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   753   C1948023:Stimulation [Natural Phenomenon or Process]

Phrase: "and"

Phrase: "uterine growth."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0018270:'growth' NOS [Organism Function]
   861   C0220844:growth [Physiologic Function]
   861   C1621966:Growth [Organ or Tissue Function]
   861   C2911660:Growth [Activity]
Processing 00000000.tx.284: J Steroid Biochem 16:323328[CrossRef][Medline] McEwen BS 1999 Clinical review 108: the molecular and neuroanatomical basis for estrogen effects in the central nervous system. 

Phrase: "J Steroid Biochem 16"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0038317:Steroid [Steroid]

Phrase: ":"

Phrase: "323328"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] McEwen BS 1999 Clinical review 108"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   799   C0205210:Clinical [Qualitative Concept]
   799   C0282443:Review [Intellectual Product]
   799   C1552617:Review [Idea or Concept]

Phrase: ":"

Phrase: "the molecular"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1521991:Molecular [Qualitative Concept]
   928 E C0567416:Molecule [Substance]

Phrase: "and"

Phrase: "neuroanatomical basis for estrogen effects"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1527178:Basis [Functional Concept]
   760   C1874451:Basis [Pharmacologic Substance]

Phrase: "in the central nervous system."
Meta Candidates (Total=19; Excluded=7; Pruned=0; Remaining=12)
  1000   C0927232:Central Nervous System [Body System]
  1000   C1269563:Central nervous system [Body System]
   901   C0027763:Nervous System [Body System]
   901   C0422837:NERVOUS SYSTEM [Finding]
   901   C1269560:Nervous system [Body System]
   845 E C0205494:Neurologic [Qualitative Concept]
   827   C0027769:Nervous [Sign or Symptom]
   827   C0205099:Central [Spatial Concept]
   827   C0449913:System [Functional Concept]
   827   C0599851:Nervous [Functional Concept]
   827   C1553451:System [Manufactured Object]
   827   C1704459:System [Medical Device]
   827   C1879652:Central - [Laboratory Procedure]
   808 E C0027855:Neurology [Biomedical Occupation or Discipline]
   790 E C2707261:Neurological [Clinical Attribute]
   755 E C0205373:Systemic [Functional Concept]
   711 E C0027740:Nerve [Tissue]
   711 E C0027757:NERVE [Tissue]
   711 E C1280541:Nerve [Body Part, Organ, or Organ Component]
Processing 00000000.tx.285: J Clin Endocrinol Metab 84:17901797[Free FullText] Hajek RA, Robertson AD, Johnston DA, Van NT, Tcholakian RK, Wagner LA, Conti CJ, Meistrich ML, Contreras N, Edwards CL, Jones LA 1997 During development, 17-estradiol is a potent estrogen and carcinogen. 

Phrase: "J Clin Endocrinol Metab 84"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C1315013:CLIN [Intellectual Product]

Phrase: ":"

Phrase: "17901797"

Phrase: "[Free FullText"

Phrase: "] Hajek RA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3538806:Ra [Spatial Concept]

Phrase: "Robertson AD,"

Phrase: "Johnston DA,"

Phrase: "Van NT,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332126:NT [Qualitative Concept]
   861   C1449832:NT [Diagnostic Procedure]

Phrase: "Tcholakian RK,"

Phrase: "Wagner LA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0023031:La [Element, Ion, or Isotope]

Phrase: "Conti CJ,"

Phrase: "Meistrich ML,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439526:/mL [Quantitative Concept]

Phrase: "Contreras N,"

Phrase: "Edwards CL,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0596019:Cl - [Element, Ion, or Isotope]

Phrase: "Jones LA 1997 During development,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0023031:La [Element, Ion, or Isotope]
   760   C0243107:development [Physiologic Function]
   760   C0443013:Jones [Intellectual Product]
   760   C0678723:Development [Organism Function]
   760   C1527148:Development [Functional Concept]

Phrase: "17-estradiol"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0014912:Estradiol [Hormone,Pharmacologic Substance,Steroid]
   805 E C0699352:Estrace [Hormone,Pharmacologic Substance,Steroid]
   805 E C0878472:Progynon [Hormone,Pharmacologic Substance,Steroid]

Phrase: "is"

Phrase: "a potent estrogen"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
   861   C2936882:Estrogen [Pharmacologic Substance]
   789 E C0720298:Estrogenic [Hormone,Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "carcinogen."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0007090:Carcinogen [Hazardous or Poisonous Substance]
   900 E C0858970:Carcinogenicity [Neoplastic Process]
   900 E C2699976:CARCINOGENICITY [Regulation or Law]
Processing 00000000.tx.286: Environ Health Perspect 105(Suppl 3):577581 This Article Abstract Full Text (PDF) All Versions of this Article: 146/9/3843 most recent Author Manuscript (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Google Scholar Articles by Toran-Allerand, C. 

Phrase: "Environ"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1568941:Environ [Organic Chemical]

Phrase: "Health Perspect 105"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0018684:Health [Idea or Concept]
   727 E C0031206:healthiness [Finding]

Phrase: "(Suppl 3"

Phrase: ")"

Phrase: ":"

Phrase: "577581"

Phrase: "This Article Abstract Full Text"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C1527021:Text [Intellectual Product]
   812   C1554111:Text [Idea or Concept]
   812   C1705606:Text [Intellectual Product]
   812   C3541382:Text [Intellectual Product]

Phrase: "(PDF)"

Phrase: "All Versions of this Article"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0333052:versions [Functional Concept]
   726 E C2607870:Version [Spatial Concept]

Phrase: ":"

Phrase: "146/9/3843 most recent Author Manuscript"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C0600659:Manuscript [Intellectual Product,Manufactured Object]

Phrase: "(PDF) Purchase Article View Shopping Cart"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0441061:Shopping cart [Manufactured Object]
   799   C0179636:Cart [Manufactured Object]
   799   C1824528:CART [Gene or Genome]

Phrase: "Alert"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0239110:ALERT [Finding]

Phrase: "me"

Phrase: "when"

Phrase: "this article"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1706852:Article [Intellectual Product]

Phrase: "is"

Phrase: "cited"

Phrase: "Alert"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0239110:ALERT [Finding]

Phrase: "me"

Phrase: "if"

Phrase: "a correction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1705565:CORRECTION [Intellectual Product]
  1000   C1947976:Correction [Functional Concept]

Phrase: "is"

Phrase: "posted"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0687676:Post [Temporal Concept]
   966   C1704687:Post [Manufactured Object]

Phrase: "Citation Map Services"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0557854:Services [Occupational Activity]
   793 E C2825316:Service [Manufactured Object]
   793 E C3245478:service [Idea or Concept]

Phrase: "Email"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0013849:E-Mail [Intellectual Product]
  1000   C1705961:E-mail [Intellectual Product]

Phrase: "this article to a friend Similar articles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1706852:Article [Intellectual Product]

Phrase: "in this journal Similar articles"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   896   C0282420:Journal Article [Intellectual Product]
   793   C1706852:Article [Intellectual Product]

Phrase: "in PubMed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1138432:PubMed [Intellectual Product]

Phrase: "Alert"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0239110:ALERT [Finding]

Phrase: "me to new issues of the journal Download"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C0162443:Journal [Intellectual Product,Manufactured Object]
   744   C0205314:New [Temporal Concept]
   711   C0033213:Issue [Finding]
   711   C1706387:Issue [Intellectual Product]

Phrase: "to citation manager Request Copyright Permission Google Scholar Articles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1706852:Article [Intellectual Product]

Phrase: "by Toran-Allerand,"

Phrase: "C."
Processing 00000000.tx.287: D. 

Phrase: "D."
Processing 00000000.tx.288: Articles by Nethrapalli, I. 

Phrase: "Articles by Nethrapalli,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1706852:Article [Intellectual Product]

Phrase: "I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.289: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.290: Articles citing this Article PubMed PubMed Citation Articles by Toran-Allerand, C. 

Phrase: "Articles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1706852:Article [Intellectual Product]

Phrase: "citing"

Phrase: "this Article PubMed PubMed Citation Articles by Toran-Allerand,"

Phrase: "C."
Processing 00000000.tx.291: D. 

Phrase: "D."
Processing 00000000.tx.292: Articles by Nethrapalli, I. 

Phrase: "Articles by Nethrapalli,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1706852:Article [Intellectual Product]

Phrase: "I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.293: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.294: HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS Endocrinology Endocrine Reviews J. 

Phrase: "HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS Endocrinology Endocrine Reviews J."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   735   C0039224:Table [Manufactured Object]
   735   C1706073:Table [Medical Device]
   735   C1706074:Table [Intellectual Product]
Processing 00000000.tx.295: Clin. 

Phrase: "Clin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1315013:CLIN [Intellectual Product]
Processing 00000000.tx.296: End. 

Phrase: "End."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0444930:End [Spatial Concept]
  1000   C2746065:End [Temporal Concept]
   944 E C0205088:Terminal [Temporal Concept]
   944 E C1705314:Terminal [Manufactured Object]
   944 E C1705315:Terminal [Spatial Concept]
Processing 00000000.tx.297: & Metab. 

Phrase: "& Metab."
Processing 00000000.tx.298: Molecular Endocrinology Recent Prog. 

Phrase: "Molecular Endocrinology Recent Prog."
Processing 00000000.tx.299: Horm. 

Phrase: "Horm."
Processing 00000000.tx.300: Res. 

Phrase: "Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347379:RES [Finding]
Processing 00000000.tx.301: All Endocrine Journals

Phrase: "All Endocrine Journals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0162443:journals [Intellectual Product,Manufactured Object]

